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The attainment of precise measurements of the molecular forces that influence protein folding is 
important in order to further understand peptide dynamics and stability. A hybrid synthetic-
natural peptide motif, combining an o,o,o’-trisubstituted biphenyl with an (ortho-tolyl)-amide, 
was synthesized in multiple formats and studied by NMR to probe the effects of amino acid 
substitutions on antiparallel beta-sheet configuration and stability. The potential of this 
“molecular torsion balance” as a beta-turn mimic was demonstrated by quantifying the rotational 
barriers about several axes. The free-energy rotational barrier of the aryl-aryl bond was found to 
be 35.7 kcal mol
-1
 at 418 K in hexanes.  EXSY analysis was also used to measure barriers about 
the N-aryl (20.9 kcal mol
-1
 at 343 K in toluene-d8) and N-CO bonds (17.2 kcal mol
-1
 at 298 K in 
chloroform-d). The N-aryl barriers of a zwitterionic torsion balance containing a single alanine 
residue (19.7 kcal mol
-1
 in acetonitrile-d3 at 343 K, and 22.6 kcal mol
-1
 in deuterated buffer pD 
6.9 at 373 K) showed that rotation about this bond is slower in water, most likely due to the 
propensity of water to form hydrogen bonds with the charged moieties participating in a salt 
bridge. Torsion balances were used to study intramolecular hydrogen bond preference by 
analyzing 
1
H NMR peak data. An amino acid chain (a single alanine or glycine residue) was 
found to preferably hydrogen bond with an amide versus an ester carbonyl (1.4:1.0 at 298 K in 
toluene-d8), and with a secondary amide versus a tertiary amide carbonyl (observation of tertiary 
amide proton coalescence via variable temperature NMR, from 303 K to 343 K, in toluene-d8). 
SYNTHESIS AND NMR STUDIES OF A β-TURN MIMETIC MOLECULAR 
TORSION BALANCE 
Melissa Ann Liberatore, PhD 
University of Pittsburgh, 2012
 
 v 
The overall findings suggest that this hybrid torsion balance is a valuable tool that can provide 
data on conformational dynamics and can examine hydrogen bond and salt bridge interactions of 
an antiparallel beta-sheet scaffold.  
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 1 
1.0  INTRODUCTION 
1.1 INTRODUCTION TO THE TORSION BALANCE 
The Wilcox group has introduced the “molecular torsion balance” as a tool to investigate 
the various molecular forces (i.e. hydrogen bonding, salt bridging) that influence biological 
phenomena, such as protein folding, drug-receptor binding, and enzyme catalysis.
1
 The torsion 
balance is a molecule designed to have two different configurations, set apart by gently restricted 
rotation around a single bond, that represent the folded and unfolded states of a protein folding 
model. These two conformations have well separated thermodynamic states that allow for 
precise measurement of their relative energies. Any deviation from a 1:1 ratio of states discloses 
intramolecular force effects that can be deduced by observations of NMR peak variations and 
provide essential experimental data to enhance theoretical folding models.
1
  
 The first torsion balance from the Wilcox group employs a Trӧger’s base moiety 
(dibenzodiazocine) to serve as the aromatic T-shaped backbone and examine the edge-to-face 
aromatic interactions that affect molecular recognition; an example is shown in Figure 1.
1
  
 
 
 
 2 
 
Figure 1. Two conformational states of a torsion balance designed to measure edge-to-face 
aromatic interactions. 
 
 
 
The Trӧger’s base is situated as the “bottom half” of the torsion balance, while the “top 
half” comprises an aromatic ring with two different ortho-substituents. Interconversion by 
rotation around the aryl–aryl bond provides the two conformational substrates for analysis. In the 
"unfolded" configuration, the aromatic ortho-substituent is further from the toluenic ring of the 
Troger’s base; the "folded" configuration is defined to be the form in which these two rings are 
closest in distance. Analysis by 
1
H NMR spectroscopy revealed how much of a preference the 
molecule had for the folded versus the unfolded states. This preference was further investigated 
by the addition of different electron–donating or electron–withdrawing groups to the aromatic 
ortho-substituent. Folding energies ranged from 0.2 to 0.8 kcal∙mol-1. Subsequent torsion balance 
models expanded upon this structural motif by incorporating, for example, amino acid side 
chain
2
 mimics as the ortho-substituents for analysis or a water-solubilizing group on the axis of 
rotation to allow for measuring the effects of water on folding.
1, 3
 Efforts by others to utilize the 
torsion balance system include that of Diederich and coworkers,
4
 in which they make use of our 
balance design to give evidence of an attractive noncovalent dipolar Csp
2–F∙∙∙C=O interaction 
between organic fluorine and amide groups.  
 3 
1.2 DEVELOPMENT OF A NOVEL TORSION BALANCE RELEVANT TO 
PEPTIDES 
Enzyme and drug–receptor binding rely upon several inter– and intramolecular 
interactions to increase binding activity and specificity. We desired to apply our torsion balance 
concept toward studying such interactions and therefore formulate a new balance that would 
allow us to investigate both amino acid interactions in an antiparallel β-sheet configuration and 
also short β-strand stability with changes in amino acids. This balance, emulating a β-turn, would 
be incorporated as part of a hybrid synthetic-natural peptide that would allow for direct 
comparison of the energies of these pair-wise amino-acid interactions. Thus far, the previous 
torsion balances had utilized the dibenzodiazocine scaffold in acquiring data for implementation 
in molecular recognition and protein folding models.
1-3
 However, previous computer modeling 
efforts led to the conclusion that this scaffold did not have the correct shape to match with the 
ends of an antiparallel β-sheet and enforce the configuration and distance required between 
hydrogen-bonded amino acids. 
The β-sheet substructures of enzymes were examined for the interactions that provide 
conformational stability. For example, lysozyme has six surface salt bridges that contribute 
toward the stability of the protein.
5
 Mutational analysis can aid in an understanding of protein 
stability. A mutational analysis of lysozyme showed that the contributions were small when the 
salt bridges were readily accessible by solvent and larger (by 9 kJ∙mol-1) when they were 100% 
inaccessible and emulating a buried salt bridge.
5
 Another enzyme, chorismate lyase, has an 
unusual internal ligand-binding cavity behind two flaps.
6
 A computer model of the enzyme 
binding site and its inhibitor, vanillate, is depicted in Figure 2.  
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Figure 2. Computer modeling of the chorismate lyase binding site with vanillate inhibitor 
depicted; the inhibitor is nestled in the hydrophobic pocket (Ile-78, Leu-79, and Leu-80) 
but also forms a hydrogen bond with neighboring Arg-76. 
 
 
Either the lyase substrate or the inhibitor vanillate enter the binding site upon opening of the 
flaps. These flaps contain many hydrophobic side chains (i.e. Ile and Leu) on the interior and are 
in proximity to the central sheet of the enzyme, which is a hydrophobic and densely packed 
region.
6 
Probing the product release mechanism and binding activity by mutation and modeling 
has shown that three important hydrogen bonds hold the flaps together and must be broken to 
initiate product release.
7
 These enzyme studies and computer modeling of the binding sites have 
been important for determining a good structure for our model with which to measure inter– and 
intramolecular protein interactions.  
 A torsion balance could be used to directly imitate the primary and secondary structures 
of a binding site upon computer modeling analysis. For example, the chorismate lyase binding 
site could be mimicked by incorporating a Leu-Leu-Ile-Glu-Arg-NH2 chain (amino acid nos. 80 
to 76) on the top portion of the balance, while the bottom would have a Leu-Ala-Ala-Arg-CO2H 
chain (amino acid nos. 88 to 91). The aromatic backbone of the balance would be devised to take 
 5 
the place of the amino acid sequence that comprises the β-turn (Ser-Ala-Asp-Gly-Glu-Pro-Trp, 
amino acid nos. 81-87); the correct structure of this backbone would be determined from the 
computer model. The completed balance could then be utilized to investigate conformational 
dynamics and hydrogen bond interactions between the "top" and "bottom" sequences.  
We have devised a new torsion balance that relies on the rotation around an aryl-nitrogen 
bond
8
 to realize our goal; a general example is shown in Figure 3. There have been many 
synthetic efforts to structurally emulate a β-turn, but this balance is the first in our group and in 
the general scientific community to do so and can still be used to obtain conformational data 
similar to our previous generation balances.   
 
 
Figure 3. Example of two conformers of a β-turn mimetic torsion balance. The R groups 
are different and each represents an amino acid side chain. 
 
 
This new torsion balance combines the established biaryl structural unit with an (ortho-
tolyl)amide unit.
8
 This unit has been of interest over the past 40 years. The N-aryl rotation is 
restricted; Mislow found a barrier of G‡ = 20.0 kcal∙mol-1 at 408 K for one acyclic amide 
example shown in Figure 4.
8
 The rate constant for this rotation is k = 95 s
-1
. For a related (ortho-
tolyl)amide in which the N-CO bond was also restricted in the form of a cyclic amide, the barrier 
was lowered to G‡ = 17.3 kcal∙mol-1 at 346 K, with a rate constant of k = 51 s-1. 
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    (a)       (b) 
Figure 4. Examples of a Mislow (a) acyclic and (b) cyclic (ortho-tolyl)amide, with rotation 
around the N-aryl bond depicted. 
 
 
 
Curran and coworkers employed the use of o-haloanilide atropisomers in asymmetric 
radical cyclizations;
9
 the atropisomers utilized had an additional o-methyl substituent present in 
which the barriers to rotation around the N-aryl bond were 28-31 kcal∙mol-1 (without the 
additional o-methyl susbstituent, the barriers were less than 20 kcal∙mol-1). The additional ortho- 
group increased the stability of the atropisomers
10
 at room temperature and allowed for easier 
separation.  
This is the first time our group has incorporated a o,o,oʹ-trisubstituted biphenyl in a 
torsion balance, which is meant to structurally emulate a β-turn. The biphenyl unit contributes an 
additional site for restricted rotation.
11
 The barrier to rotation around an aryl–aryl bond is mostly 
dependent upon the ortho-substituents; however, a stabilizing buttressing effect can also be 
observed (by an increase in the rotational barrier) when meta-substituents also are present.
11a, b
 
Based on work by Kawano,
11c
 we used computer simulations to estimate the barrier for rotation 
around the aryl-aryl bond to be G‡ = 27 kcal∙mol-1 at 343 K. One biphenyl example of Kawano 
is shown in Figure 5,
11c
 with a barrier of 28.2 kcal∙mol-1; this barrier was from the combination 
of optical rotation measurements and half-life times for racemization at various temperatures. 
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Figure 5. Kawano biphenyl compound with three ortho-substituents. 
 
 
The combination of the o,o,oʹ-trisubstituted biphenyl with the N-aryl atropisomer gives a 
molecule that would serve as a β-turn mimic, by imitating the familiar bonds and dihedral angles 
necessary to connect and bring two antiparallel β-strands close enough together (to form 
hydrogen bonds), and also exhibit two conformational states. 
There have been many efforts in designing and analyzing an appropriate antiparallel β-
strand mimic
12
 for protein folding studies. Gellman
13
 and coworkers have reported the use of a β-
hairpin motif containing a hydrophobic cluster of naturally occurring amino acids to probe the 
folding and stability of antiparallel β-sheets in water.13a NOE and variable temperature 1H NMR 
data provided insight into the thermodynamic profiles of their folded and unfolded two-state 
system and showed that a well-defined β-hairpin conformation was generated by the nonpolar 
side chain cluster. Nowick
14
 and coworkers describe several β-sheet mimics that utilize specific 
combinations of natural and unnatural amino acids to induce folding and interaction in 
peptides.
14a
 In one example, shown in Figure 6, an artificial amino acid “Orn(i-PrCO-Hao)” 
(natural amino acid ornithine in addition to unnatural amino acid “Hao”: hydrazine, 5-amino-2-
methoxybenzoic acid, and oxalic acid) was incorporated into a peptide to act as an artificial β-
turn in a β-strand. 
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(a)             (b) 
Figure 6. (a) Nowick’s unnatural amino acid “Orn(i-PrCO-Hao)”. (b) Nowick’s β-sheet 
mimic containing “Orn(i-PrCO-Hao)”. 
 
 
It was shown that “Orn(i-PrCO-Hao)” was able to induce the structure and interactions similar to 
those seen in a natural β-sheet, with minimal perturbation of the peptide sequence. The results of 
these studies have been useful in the design of our new peptidic mimic by demonstrating the 
molecular spacing needed to maintain the hydrogen bonding found in the natural peptide 
structure; our torsion balance would act as the artificial β-turn in the short hybrid synthetic-
natural β-strand. Furthermore, longer amino acid chains can be appended to the torsion balance 
to more fully emulate β-strand and peptidic dynamics, by providing more hydrogen bonds for 
stabilization. 
1.3 ASSIGNMENT OF TORSION BALANCE CONFORMERS BY TWO-
DIMENSIONAL NMR ANALYSES 
 Structural assignment of the torsion balance targets is required to accurately determine 
the effects of amino acid changes on β-strand configuration and stability. We desired to use the 
scaffold of our novel torsion balance to create select protein folding models, which would then 
be studied using two-dimensional NMR spectra analyses. Relevant models will focus on small 
 9 
changes to the two ortho-sites of the top aromatic ring of the biaryl structure; one model type 
would incorporate different amino acid side chains on each ortho-site, while another type would 
have a different number of amino acids on each ortho-site (therefore differing in the number of 
available hydrogen bonding sites). A related model type, while also featuring different amino 
acids, will concentrate on observing salt-bridge effects on configuration and stability. Two-
dimensional (2D) NMR spectra analyses and assignments of these models will help determine 
which torsion balance conformers are more stable. 
 Williamson
15
 and coworkers utilize several methods to determine the structures of 
specific RNA targets and their variants; these methods include both 2D and one-dimensional 
(1D) NMR. In one example,
15a
 shown in Figure 7, two oligonucleotides that were varied at only 
one position were studied by NMR techniques to determine and compare the secondary 
structures. It had been observed that the function of the corresponding tRNA was distinctly 
affected by the single change in discriminator base; the change involved substituting uracil for 
adenine at position 19. The 1D NMR spectra (not shown) depicted a shift downfield of the imino 
proton of the uracil variant compared to the adenine variant; the 2D NMR spectra (i.e. NOESYs), 
show a 'fold-back' conformer structure for only the uracil variant that is also detected at different 
temperatures.             
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                3'   
              A22
              C21
              C20
   5'          A19           U19
    G1  -   C18
    G2  -  C17
    C3   -  G16
    G4  -  C15
    G5  -   C14
    G6  -   C13
    G7  -   C12
  U8           G11
      U9   C10
.     
Figure 7. Secondary structure of Williamson's tRNA variants and the corresponding 
NOESY spectra (reprinted from the literature).
15a
 NOESY spectra (A) and (B) show  
the NOEs of interest for variants A19 and U19, respectively. (Copyright (1994) National 
Academy of Sciences, U.S.A. Printed with permission.) 
 
 
NMR assignments of other similar compounds, such as TAR RNA that is located in all viral 
mRNAs,
15b, c
 were also performed by the Williamson group. The use of NOESY experiments, in 
addition to COSY, TOCSY, and various 
13
C-detected experiments, aided in determining the 
conformation of the wild-type and mutant RNAs as well as some of the exchangeable imino- and 
amino-protons. In addition, the 2D NMR analyses were also able to suggest partial base stacking 
and a minor distortion in conformation. It is clear that heavy use of the aforementioned 2D NMR 
techniques (and others such as ROESYs
15d
) can lead to a complete or near-complete assignment 
of a desired compound, therefore elucidating conformational data that can reveal new 
information about protein stability. 
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2.0  SYNTHESIS AND ANALYSIS OF INITIAL TORSION BALANCES 
2.1 RETROSYNTHETIC ANALYSIS 
The primary targets for our β-turn mimetic torsion balance synthesis, biaryl amide 
analogs 1 and 2, are shown in Scheme 1. These torsion balance analogs are versatile because 
they are differentially protected at the positions a, b, and c to facilitate an orthogonal 
deprotection strategy that allows for independent amino acid couplings. In addition, the methyl 
ester can also be cleaved to enhance the water solubility of the torsion balance.  
 
Scheme 1. Retrosynthetic pathway for β-turn mimetic torsion balance. 
 
 
 
The biaryl amides 1 and 2 could be synthesized by an amide coupling of the biaryl amine 
3 with the Fmoc-protected amino acid chloride derivatives of either alanine or glycine, followed 
 12 
by deprotection and acylation. We envisioned that biaryl amine 3 could be prepared by a Suzuki–
Miyaura cross-coupling reaction
16
 between asymmetric bromide 4 and boronic ester 5. The 
preparation of 4 could be achieved efficiently from the Fischer esterification
17
 of starting 
material 4-bromo-3,5-dihydroxybenzoic acid, followed by dual application of the Williamson 
aryl ether synthetic protocol.
18
 The retrosynthetic plan for 5, shown in Scheme 2, involves a 
Miyaura boration
19 
of bromide 6; bromide 6 could be prepared from aniline 7 by successive 
protection, alkylation, and deprotection reactions. 
 
Scheme 2. Retrosynthetic pathway for boronate 5. 
 
 
2.2 SYNTHESIS OF THE TORSION BALANCE 
2.2.1 Synthesis of the Bromide Coupling Fragment 
The synthesis of the first coupling fragment, bromide 4, is shown in Scheme 3. Methyl 
benzoate 9 was synthesized in 99% yield by a Fischer esterification
17 
on commercially available 
4-bromo-3,5-dihydroxybenzoic acid 8. The literature procedure was slightly modified by using 
solid sodium bicarbonate to quench the reaction before workup; recrystallization was found to be 
unnecessary. A similar procedure using thionyl chloride in methanol
20
 also gave benzoate 9, but 
with a slightly lower yield of 90%. Reaction of 9 with 1 equiv of commercially available tert-
 13 
butyl bromoacetate by the Williamson aryl ether protocol
18 
afforded ether 10 in a moderate 35% 
yield; the major product in 48% yield was the symmetrical ether 11, but this was readily 
separated from the desired product by flash chromatography. Synthesis of the symmetrical ether 
11 was also accomplished in an excellent 89% yield as the sole product by using 2 equiv of tert-
butyl bromoacetate. The same reaction conditions
18
 were applied to 10 with commercially 
available benzyl bromoacetate to obtain 4 in an excellent 90% yield. 
 
Scheme 3. Synthesis of coupling fragment bromide 4. 
 
 
2.2.2 Synthesis of the Arylboronic Ester Coupling Fragment 
We next synthesized the second coupling fragment, boronic ester 5. Following upon 
Hudson’s report of reductive monoalkylation of aromatic amines,21 we initially focused on 
synthesizing N-ethylaniline 13, shown in Scheme 4, instead of N-methylaniline 6 because the 
direct monoalkylation of aniline 7 would shorten the synthetic route toward targets 1 and 2 by 
two steps. In a model reaction, o-toluidine 12 underwent monoalkylation with palladium and 
ammonium formate in acetonitrile to yield N-ethyl-o-toluidine 14 as product in quantitative 
yield.
21
 However, when the same monoalkylation conditions were applied to commercially 
 14 
available 3-bromo-2-methylaniline 7, product 13 was not obtained. The 
1
H NMR spectrum of the 
byproduct obtained matched that of N-ethyl-o-toluidine, demonstrating that cleavage of the 
bromine from 7 had occurred. We observed the formation of a fine brown solid sideproduct, not 
observed in the model reaction, which readily dissolved in water. 
 
Scheme 4. Reductive monoalkylation of anilines 7 and 12. 
 
 
 
The modified synthetic route is based on the protection and later deprotection of the 
aniline, and is shown in Scheme 5. Protection of aniline 7 was effected by reaction with di-tert-
butyl dicarbonate (Boc anhydride, or Boc2O) to afford carbamate 15, which was in turn treated 
with bromoethane and sodium hydride to arrive at alkylated carbamate 16. Deprotection of the 
Boc group with trifluoroacetic acid (TFA) produced desired aniline 13 in quantitative yield.  
 
Scheme 5. Successful synthesis of aniline 13. 
 
 
 
 15 
The synthesis of the N-methylaniline 6 counterpart was carried out in similar fashion and 
is shown in Scheme 6. Methylation of 15 with methyl iodide and sodium hydride gave carbamate 
17 in quantitative yield; deprotection with TFA afforded aniline 6, also in quantitative yield. 
 
Scheme 6. Synthesis of N-methylaniline 6. 
 
 
 
With the alkylated anilines constructed, we next endeavored to carry out an amidation 
reaction involving a protected amino acid. Aniline 13 was initially treated with commercially 
available N-acetyl-alanine 18 using various standard amino acid coupling conditions, and the 
results, summarized in Table 1, had poor to moderate yields. Treatment of 13 and 18 with bis(2-
oxo-3-oxazolindinyl)phosphinic chloride (BOP-Cl), triethylamine (NEt3), in CH2Cl2
22
 gave only 
14% yield of expected amide 19 (Entry 1). Reaction of 13 and 18 with N,N’-
dicyclohexylcarbodiimide (DCC) and 4-(dimethylamino)pyridine (DMAP) in CH2Cl2
23 
resulted 
in a 61% recovery of the starting material (SM) 13 but with no product isolated (Entry 2). 
Employment of reagents N-ethyl-N'-(3-dimethylaminopropyl)carbodiimide hydrochloride 
(EDCI), 1-hydroxybenzotriazole (HOBt) with 13 and 18 in CH2Cl2
24 
afforded 19 in the best yield 
at 34% (Entry 3). Changing the solvent to DMF caused a drop in the yield to 14% (Entry 4); 
likewise, using a 1:1 mixture of CH2Cl2 and DMF gave a similar 15% yield (Entry 5). Use of 
either of the phosphate salts o-benzotriazole-N,N,N´,N´-tetramethyl-uronium-
hexafluorophosphate (HBTU) or o-(7-azabenzotriazol-1-yl)-N,N,N´,N´-tetramethyl-uronium-
hexafluorophosphate (HATU) with the corresponding triazoles and N,N'-diisopropylethylamine 
 16 
(DIEA) in CH3CN
25 
only resulted in recovered aniline starting material (Entries 6 and 7, 
respectively). We propose that steric hindrance and reduced nucleophilic activity of the aniline 
(as a secondary alkyl (aryl) amine) contributed to the failure of these reactions.  
 
Table 1. Conditions and results for amidation reactions between aniline 13 and N-acetyl-
alanine 18. 
 
 
 
Entry 
 
Conditions
 a
 
 
Yield 
 
1 
 
 
BOP-Cl, NEt3, CH2Cl2, 2 d 
 
14%
b
 
2 DCC, DMAP, CH2Cl2, 12 h SM 
3 EDCI, HOBt, CH2Cl2, 3 d 34%
 b
 
4 EDCI, HOBt, DMF, 2 d 14%
 b
 
5 EDCI, HOBt, CH2Cl2/DMF (1:1), 3 d 15%
 b
 
6 HBTU, HOBt, DIEA, CH3CN, 24 h SM 
7 HATU, HOAt, DIEA, CH3CN, 24 h SM 
a
 The reaction temperature of Entry 1 began at 18 °C and was increased to room temperature; the 
temperatures of all other entries began at 0 °C and were increased to room temperature 
b
 Isolated yield of product; aniline starting material (SM) was also recovered 
 
 
We next turned to an approach, based on Carpino’s conditions,26 involving initial 
conversion of the protected amino acid 18 to the protected amino acid chloride intermediate 18-
int before reaction with the amine. This reaction, shown in Scheme 7, was unsuccessful, as the 
 17 
amino acid decomposed in the first step with thionyl chloride when performed at either room 
temperature or at reflux, and neither starting material nor product was observed in the 
1
H NMR 
spectrum.     
 
Scheme 7. Attempted synthesis of amide 19 by using Carpino’s conditions. 
 
 
 
According to Montalbetti,
27
 formation of amino acid halides can be difficult due to 
possible cyclization to a five-membered N-carboxyanhydride ring; however, this can be 
suppressed with other protecting groups, such as the 9-fluorenylmethyloxycarbonyl (Fmoc) 
groups. Therefore, N-acetyl-alanine was replaced by commercially available N-Fmoc-alanine as 
the amino acid substrate. 
Treatment of N-Fmoc-alanine 20 and aryl amine 13 with the same conditions from Table 
1, Entry 3 (EDCI and HOBt in CH2Cl2) gave amide 22 in a 24% yield. In another attempt, we 
utilized a Carpino procedure
28
 involving initial conversion of the amino acid to its corresponding 
fluoride by treatment with cyanuric fluoride and DIEA in CH2Cl2 before reaction with the amine; 
the reaction generated 22 in a moderate yield of 22%, most likely due to facile hydrolysis of the 
amino acid fluoride.  
The most successful amide coupling reactions involve amino acid chlorides from our 
previous implementation of Carpino’s procedure,26 and are summarized in Table 2. We 
converted N-Fmoc-alanine 20 to its corresponding acid chloride intermediate 20-int, with use of 
 18 
thionyl chloride in CH2Cl2, before reaction with 13 and achieved our first good yield of 68% 
(Entry 1). We then expanded our scope to also include aniline 6 and N-Fmoc-glycine 21 as 
reagents to arrive at amides 23 (Entry 2, 96%), 24 (Entry 3, 85%), and 25 (Entry 4, 94%). Using 
an amino acid chloride as the substrate had the advantage of being slightly less susceptible to 
hydrolysis in comparison to the amino acid fluoride. Although more stable than acyl fluorides, 
the amino acid chlorides were used immediately upon their syntheses because hydrolysis could 
be seen (via 
1
H NMR) after one day. Another advantage of the acyl chloride was to increase the 
electrophilicity of the amino acid toward the less nucleophilic secondary aniline. It is also 
important to note the role of steric effects in formation of the amides 22-25; the yields of N-
methyl-anilides 23 and 25 were higher in comparison to their N-ethyl- counterparts 22 and 24. In 
a model reaction completed with commercially available N-ethylaniline and N-Fmoc-alanine 
(with conversion to the acid chloride) as the substrates, the corresponding amide product was 
formed in 81% yield (compared to 68% for 22); this suggests that not only did the alkyl group on 
the nitrogen provide steric hindrance for attack, but that the aryl methyl group did as well. 
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Table 2. Results for amidation reactions between anilines 13 and 6 and N-Fmoc amino 
acids 20 and 21. 
 
 
 
Entry Amine Amino Acid Product R Rʹ % Yield 
 
1 
 
 
13 
 
20 
 
22 
 
CH2CH3 
 
CH3 
 
68 
2 6 20 23  CH3 CH3 96 
3 13 21 24 CH2CH3 H 85 
4 6 21 25  CH3 H 94 
 
 
The next step enroute to the formation of the torsion balance was a Miyaura boration,
19
 
with bis(pinacolato)diboron used as the boronate reactant. The N-methylanilide 23 was first 
employed due to its simplicity in structure and 
1
H NMR interpretation in comparison with its N-
ethyl counterpart 22. However, as seen in Scheme 8, no product was isolated. The crude 
1
H 
NMR spectrum revealed that the Fmoc group was cleaved during the reaction; a singlet at δ = 
6.08 ppm corresponded to the cleavage sideproduct dibenzofulvene (DBF). The Fmoc group was 
possibly cleaved due to the high reaction temperature (100 °C) and the base (KOAc) used. 
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Scheme 8. Attempted boration of anilide 23. 
 
 
 
We then endeavored to synthesize 26 first by boration of aniline 6, followed by 
amidation; this is shown in Scheme 9. Use of the same Miyaura conditions
19
 afforded 5 in 64% 
yield; the presence of the aryl methyl group may have provided steric hindrance and influenced 
the yield. Boronic ester 5 was then coupled with N-Fmoc-alanine acid chloride, generated by the 
method of Carpino,
26
 to produce amide 26 in 72% yield.   
 
Scheme 9. Synthesis of boronic esters 5 and 26. 
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2.2.3 Final Steps to Synthesize the Torsion Balance 
At this point we envisioned that a Suzuki–Miyaura cross-coupling reaction between 
bromide 4 and amide 26 would produce biaryl amide 27, which could be Fmoc-deprotected and 
acylated to generate torsion balance 1. However, there are few examples in the literature that 
show cross-coupling of two substrates with a total of three ortho-substituents
29
 with and without 
an additional bulky meta-substituent.  The attempts to synthesize 27 are summarized in Scheme 
10. Small amounts of both starting materials 4 and 26 were recovered, along with boronic ester 
homocoupling sideproducts, but no product was isolated. An observation was the cleavage of the 
Fmoc group as evidenced by the formation and relatively large quantity of DBF recovered. In 
addition, the tert-butyl ester may have also been cleaved due to its sensitivity to high 
temperatures, and the reaction temperature of 130 °C (used in all entries) may have been too 
high.
30
 For subsequent Suzuki–Miyaura cross-coupling reactions, the reaction temperature used 
was 90 °C. 
 
Scheme 10. Attempted Suzuki-Miyaura cross-coupling of fragments 4 and 26. 
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Based upon these results, the synthetic route was modified by replacing amide 26 with 
amine 5 for the cross-coupling; the various conditions and results are summarized in Table 3. 
Previously used reaction conditions of tetrakis(triphenylphosphine)Pd(0) [Pd(PPh3)4] in 1,2- 
dimethoxyethane (DME) and H2O gave 3 in 28% (Entry 1). Substituting DMF as the co-solvent 
led to no recovered product (Entry 2). Employing different palladium catalysts, palladium (II) 
acetate [Pd(OAc)2] and tris[dibenzylideneacetone]dipalladium(0) [Pd2(dba)3], in DME, 
accompanied by the Buchwald ligand JohnPHOS
®
,
16
 also did not result in any product (Entries 3 
and 4). However, using Pd2(dba)3 and JohnPHOS
® 
in DMF afforded 3 in 10% yield (Entry 5). 
Switching the ligand to Buchwald’s 2-dicyclohexylphosphino-2′,6′-dimethoxybiphenyl 
(SPHOS
®
)
16
 and the base from KF to K3PO4∙H2O in DME gave 3 in 31% (Entry 6). Addition of 
water as a co-solvent to the conditions in Entry 6 lowered the product yield to 9% (Entry 7). 
Substitution of isopropanol as the solvent, to suppress formation of the boronic ester 
homocoupling sideproduct,
31
 did not afford product (Entry 8). However, use of toluene
16
 as the 
solvent gave the best yield of 47% (Entry 9); the yield dropped to 37% upon reaction scale-up 
from 0.1 mmol to 2.5 mmol (based upon bromide 4) (Entry 10), most likely due to the higher 
probability of oxygen being present in the reaction vessel, even after degassing the system. 
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Table 3. Conditions and yields for Suzuki-Miyaura cross-coupling between fragments 4 
and 5. 
 
 
 
Entry 
 
Conditions
 a
 
 
Yield
 b
 
 
1 
 
Pd(PPh3)4, NaHCO3, H2O, DME           
 
 
28% 
2 Pd(PPh3)4, NaHCO3, H2O, DMF 
 
0% 
3 Pd(OAc)2, JohnPHOS
®
, KF, DME 0% 
4 Pd2(dba) 3, JohnPHOS
®
, KF, DME 0%  
5 Pd2(dba) 3, JohnPHOS
®
, KF, DMF 10% 
6 Pd2(dba) 3, SPHOS
®
, K3PO4∙H2O, DME 31% 
7 Pd2(dba) 3, SPHOS
®
, K3PO4∙H2O, H2O, DME 9% 
8 Pd2(dba) 3, SPHOS
®
, K3PO4∙H2O, isopropanol 0% 
9 Pd2(dba) 3, SPHOS
®
, K3PO4∙H2O, toluene 47% 
10 Pd2(dba) 3, SPHOS
®
, K3PO4∙H2O, toluene 37% 
a
 Reaction scale based on 0.1 mmol of 4, except Entry 10 where the scale was 2.5 mmol; all 
reactions were run for 14 h at 90 °C  
b
 Isolated yield of product; recovered material also included both starting materials 4 and 5, the 
homocoupling sideproduct of 5, and the bromine-proton exchange side product of 4 
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With biaryl amine 3 constructed, the last steps to form the torsion balance were 
implemented, and are shown in Scheme 11. Again using Carpino’s amino acid chloride 
procedure,
26
 N-Fmoc-alanine acid chloride 20-int and N-Fmoc-glycine acid chloride 21-int were 
generated and added to 3 to produce 27 and 28 in good yields of 82% and 81%, respectively. 
These amides were then each treated with piperidine in DMF to cleave the Fmoc group, followed 
by acylation using acetic anhydride and pyridine in CH2Cl2
32 
to give torsion balances 1 and 2 in 
yields of 99% and 97%, respectively. 
 
Scheme 11. Final steps to synthesize torsion balance. 
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3.0  NMR STUDIES OF INITIAL TORSION BALANCES 
3.1 EVALUATION OF TORSION BALANCE BOND ROTATIONS 
3.1.1 Analysis of Carbamates and the N-CO Bond Rotation 
We observed interesting conformational dynamics of carbamates 16 and 17 via 
1
H NMR 
analysis. At room temperature, the spectra for both carbamates showed two conformations. Both 
carbamates, for example, exhibit two signals in approximately a 2:1 ratio that represent the nine 
tert-butyl protons. This suggested that there was a higher than expected barrier to rotation around 
the N-CO bond.  According to Smith and coworkers,
33  
hindered rotation around the C-N single 
bond of N-phenylcarbamates gave rise to a low rotational barrier equal to 12.5 kcal∙mol-1. 
However, Smith’s carbamates, unlike ours, did not possess ortho-substituents. Therefore, 
variable temperature 
1
H NMR studies, ranging from 278 K to 323 K (5 to 50 °C), were 
performed to analyze the rotational barriers of our carbamates 16 and 17. The 
1
H variable 
temperature spectra for carbamate 17 are shown in Figure 8; the spectra for carbamate 16 were 
similar. Carbamate (E)-17 is thought to be the more favored rotamer because the (Z) rotamer is 
more prone to electron-electron repulsion.
33-34 
 
In comparing the 
1
H variable temperature spectra of 16 and 17, we could see signal 
coalescence for the nine tert-butyl protons beginning at approximately 35 °C (308 K) for both 
 26 
carbamates. The signals corresponding to the ethyl group of carbamate 16 were already 
exhibiting line broadening at room temperature (298 K). We eventually utilized only methyl 
carbamate 17 toward generating our torsion balances because the 
1
H NMR of the methyl 
carbamate displayed fewer signals; this would allow for a less complicated assignment of our 
larger molecules once completed. Therefore, we concentrated our determination of the N-CO 
rotational barrier to carbamate 17. By using both dynamic line shape analysis
35
 and an EXSY 
experiment,
36
 we found the barrier to be G‡ = 17.2 kcal∙mol-1 at 298 K in CDCl3. This barrier to 
isomerization is higher than for Smith’s carbamates. The phenyl group of our carbamate is 
rotated out of resonance with the nitrogen and this may allow the nitrogen to become more 
electron-donating toward the carbonyl. By comparing the variable temperature 
1
H NMR spectra 
for 16 and 17, we saw that coalescence begins to occur at approximately the same temperature, 
and so we can deduce that the barrier of carbamate 16 is approximately 17 kcal∙mol-1 as well, 
and that the difference between the methyl and ethyl groups did not exert a significant change in 
the dynamics. 
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Figure 8. Carbamates (Z)-17 and (E)-17 and a selected area of the variable temperature 
1
H 
NMR spectra from 278 K to 323 K (5 to 50 °C, chloroform-d, 500 MHz). Protons of interest 
are denoted. 
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We performed a related model study to investigate if the 
1
H NMR spectrum of an aryl 
carbamate without an ortho- substituent would also reveal two signals for the nine tert-butyl 
protons (at 298 K). Our model carbamate was tert-butyl 3-bromophenyl(methyl)carbamate — an 
analog of 17 with a proton instead of a methyl group in the ortho- position — which was 
synthesized by treatment of commercially available 3-bromoaniline with previously utilized Boc 
protection and methylation conditions. However, we observed only one sharp peak for the tert-
butyl group at δ = 1.46 ppm. In comparison to Smith’s carbamates, the presence of the aryl o-
methyl group of our carbamates 16 and 17 accounts for the increase in rotational barrier of 
almost 5 kcal∙mol-1, and allows for the observation of two conformer peaks for each carbamate at 
room temperature.  
3.1.2 Analysis of Torsion Balance Amides and the N-Aryl Bond Rotation 
Although amides 23 and 25 could not be applied toward the synthesis of torsion balances 
1 and 2, they could potentially supply information about the rotational barrier of the N-aryl bond; 
rotation around this bond will provide the conformational switch necessary for our studies. Four 
conformers of 1 and two conformers of 2 were observed (by 
1
H NMR at room temperature), and 
so it was speculated that rotation around either the N-aryl or the N-CO bond contributed toward 
the two additional conformers; rotation around the aryl-aryl bond was estimated to have a higher 
barrier and therefore not contribute much or at all toward the conformational switch.  
In a study performed to further examine the rotational barriers present in the torsion 
balance targets, the 
1
H NMR spectra of 23 and 25 was first obtained at room temperature to 
compare to those of 1 and 2, respectively. To complement the 
1
H NMR findings of 1, the 
1
H 
NMR spectrum of 23 at room temperature displayed evidence of four conformers. The spectra of 
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analogs 2 and 25 had similar results. Therefore, we subjected both 23 and 25 to variable 
temperature 
1
H NMR experiments,
35b
 ranging from 5 to 50 °C (278 to 323 K). For both 
molecules, we were able to observe broadening of all peaks starting at 35 °C (308 K). To provide 
a more accurate account of the torsion balance bottom half, however, we needed to replace the 
bulky Fmoc protecting group with the acyl group. This exchange would also simplify the 
1
H 
NMR analysis by eliminating the three non-aromatic Fmoc protons from the δ = 4.0–4.5 ppm 
range.  
The synthesis of acyl amides 29 and 30 is shown in Scheme 12, and is similar in fashion 
to the final steps toward formation of 1 and 2. Amides 23 and 25 were each treated with 
piperidine in DMF to cleave the Fmoc group, followed by acylation using acetic anhydride and 
pyridine in CH2Cl2
32
 to give 29 and 30 in yields of 89% and 82%, respectively. 
 
Scheme 12. Synthesis of torsion balance precursor amides 29 and 30. 
 
 
 
The 
1
H NMR spectra of these amides were less complicated because of the absence of the 
Fmoc group, and so we subjected both amides 29 and 30 to variable temperature 
1
H NMR 
studies,
35b
 ranging from 25 to 80 °C (298 to 353 K); the results of the studies for both 29 and 30 
were similar, and so only those for 29 are shown (Figure 9). We observed broadening of the set 
of three quintets at δ = 4.40–5.10 ppm (representing the alanine α-methine proton) and the set of 
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four doublets at δ = 0.90–1.30 ppm (representing the three α-methyl protons of alanine) as the 
temperature approached 70 °C. These results showed that the interconversion between the 
conformers was fast; however it was possible that rotation around both the N-aryl and the N-CO 
bonds contributed to the conformational changes detected for this amide. 
We subjected 29 to dynamic line shape
35
 and EXSY
36
 analyses in order to determine the 
barrier to rotation around the N-aryl bond, because it is rotation around the N-aryl bond that 
should give rise to the desired conformational states of our torsion balances 1 and 2 (as proposed 
in Figure 3). The line shape simulation verified that the peak broadening was due to both N-aryl 
and N-CO bond rotations; we observed interference of the minor conformer peaks (most notably 
at δ = 5.10 and 1.30 ppm, representing the alanine α-methyl and methine groups) with the major 
peaks. Therefore, it was determined that the EXSY analysis would be the most reliable method 
because it focused more on cross-peak integration of the target conformer peaks. The cross-peaks 
of the two largest alanine α-methyl isomer peaks (at δ = 1.10 and 0.90 ppm) were used to 
calculate the barrier to rotation around the N-aryl bond to be G‡ = 20.9 kcal∙mol-1 at 343 K in 
toluene-d8.  
The small peaks at, for example, δ = 1.30 ppm (two doublets) and 5.10 ppm (one quintet), 
observed in the 
1
H NMR spectra of 29 suggested that a small amount of a “minor anti amide” 
was present due to rotation around the N-CO amide bond. These rotamers and their suggested 
pathways to formation are shown in Scheme 13 (glycine analog 30 showed similar results and is 
also depicted). The two major conformers 29a and 29b, present together in 93% by 
1
H NMR, 
arise from the higher barrier to rotation around the N-aryl bond of G‡ = 21 kcal∙mol-1 and 
possess a racemization half life of 2.2 minutes at 298 K. The two minor conformers arising from 
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the N-CO bond rotation, 29c and 29d, are present together in 7% by 
1
H NMR and have a lower 
barrier of G‡ = 17 kcal∙mol-1. 
 
Scheme 13. Possible rotations around N-aryl and N-CO bonds of amides 29 and 30. 
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Figure 9. Variable temperature 
1
H NMR spectra of amide 29 from 298 K to 353 K (25 to 80 
°C, toluene-d8, 500 MHz). Protons of interest are denoted as follows and coincide with 
Scheme 13: a and a´ correspond to the two major conformers that arise from N-aryl bond 
rotation; a´´ and a´´´ correspond to the two minor conformers that arise from N-CO bond 
rotation. 
 
 
 33 
3.1.3 Analysis of Biaryl Amine and the Torsion Balance Aryl-Aryl Bond Rotation   
An essential rotational barrier to analyze was that of the aryl-aryl bond.
11
 The barriers in 
earlier torsion balances were usually measured by NMR spectroscopy. In our case, we initially 
subjected biaryl amine 3 to variable temperature 
1
H NMR experiments, in similar fashion to 
those used for amides 29 and 30. Amine 3 was dissolved in toluene-d8 and subjected to a 
temperature range of ˗20 to 50 °C. The 1H NMR spectra are shown in Figure 10; the 
diastereotopic protons of the two enantiomeric forms of 3 are shown also in Scheme 14. From 
the analysis of the 
1
H NMR spectrum (300 MHz) of 3 in chloroform-d and comparison to the 
analogous spectrum (700 MHz) of the core target 59 in acetonitrile-d3, the diastereotopic protons 
of 3 were determined to be present at 4.48 ppm (a and a', one singlet) and 4.63 ppm (b and b', 
one singlet). Diastereotopic protons b and b' are more downfield most likely because the nearby 
benzyl group is an electron withdrawing group, which would lead to deshielding of the 
neighboring nuclei and cause a downfield shift in the 
1
H spectrum.     
 
Scheme 14. Enantiomers of biaryl amine 3 and rotation around the aryl-aryl bond. 
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Figure 10. Variable temperature 
1
H NMR spectra of amine 3 from 253 K to 323 K (˗20 to 
50 °C, toluene-d8, 500 MHz). Dichloromethane (DCM) impurity is denoted. The 
diastereotopic protons of interest, coinciding with Scheme 14, are designated as a, aʹ, b and 
bʹ. 
 
 
 
Only peak shifting was observed for the denoted diastereotopic protons and no peak 
broadening was detected. Kinetic equilibrium experiments were attempted via HPLC.
37 
Resolution of 3 would allow the rotation rate to be measured directly through observing 
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racemization via 
1
H NMR. Resolution on both a Chiralcel and Whelk analytical HPLC column 
was unsuccessful.  
Therefore, amine 31, a derivative of 3 with a phenolic group, was synthesized
16
 to obtain 
better chiral recognition by the HPLC analytical column. The synthesis is shown in Scheme 15; 
the reaction conditions are identical to those used in the formation of 3 with the exception of the 
bromide substrate 10. The yield for 31 was low at 9%; the low yield is most likely due to the 
presence of not only an amine, but also a phenol that is acidic enough to experience 
deprotonation during the course of the reaction and interfere with the C–C bond coupling.  
 
Scheme 15. Synthesis of biaryl amine 31. 
 
 
 
To increase the yield of the Suzuki–Miyaura coupled product, bromide 10 was first 
protected with tert-butyl dimethylsilyl chloride (TBS-Cl) and imidazole;
38
 bromide 32 was 
furnished in a good 68% yield. Bromide 32 was combined with boronic ester 5 in a Suzuki–
Miyaura cross coupling reaction,
16
 shown in Scheme 16, and then the crude was subjected to 
TBS deprotection with TBAF
38b
 to give amine 31 in an improved 31% yield. The ortho-
methylene protons of 31 were present at 4.49 ppm (one singlet, 300 MHz, chloroform-d), which 
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is a similar chemical shift value in comparison to that of the analogous protons of 3 (at 4.48 ppm, 
near the tert-butyl ester group).     
 
Scheme 16. Syntheses of TBS protected benzoate 32 and use toward biaryl amine 31. 
 
 
 
The enantiomers of derivative 31 were separated by chiral preparatory HPLC. From a 
racemic mixture of 18 mg, the first eluting enantiomer (31-FEE) was obtained in 5.4 mg (93.6% 
ee) with a retention time (RT) of 14.7 min, and the second eluting enantiomer (31-SEE) was 
obtained in 7.1 mg (90.4% ee) with a retention time of 18.4 min. Therefore, derivative 31 was 
utilized in the kinetic experiment to measure the rotational barrier around the aryl–aryl bond.37 
The two enantiomers of 31 are shown in Scheme 17, and the HPLC separation is depicted in 
Figure 11, depicting an expected 1:1 ratio of the enantiomers.  
The kinetic experiment involved using a solution of 1.0 mg of an enantioenriched sample 
of 31-SEE in 1.0 mL hexanes that was placed in a sealable thick–walled tube and heated at 145 
°C (418 K). Aliquots of 10 μL were removed at 1 h or 2 h increments, with the exception of an 
overnight run, and submitted to chiral HPLC analysis. 
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Scheme 17. Enantiomers of biaryl amine 31. 
 
 
 
 
Figure 11. Analytical HPLC analysis of amine 31. The two peaks (enantiomers) were 
separated successfully by chiral preparatory HPLC, and enantiomer 31-SEE (18.4 min 
retention time) was used in the kinetic experiment. 
 
 
A plot of the logarithmic decrease in enantiomeric excess (ee) versus time is shown in 
Figure 12, and showed a first–order rate for racemization.37 Using the Arrhenius kinetics, the rate 
of racemization was krac = 0.363 μs
-1
 at 418 K, which translates to a free energy rotational barrier 
of the aryl-aryl bond for 31 of 35.7 kcal∙mol-1 (149.5 kJ∙mol) at 418 K in hexanes, with a 
racemization half life of 2.2 days at 418 K. 
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Figure 12. Equilibrium plot for amine 31 based upon the logarithmic decrease in ee from 
31-SEE (denoted as S in the y-axis label) to 31-FEE (denoted as F in the y-axis label) over 
time.  
3.2 EVALUATION OF HYDROGEN BOND SELECTIVITY OF INITIAL TORSION 
BALANCES 
3.2.1 Hydrogen Bond Selectivity and Folding Preferences of Initial Torsion Balances 
 It was necessary to test our torsion balance scaffold for the proper antiparallel β-sheet 
configuration and hydrogen bonding distance before further appending amino acids to construct 
the β-turn mimic. Therefore, both torsion balances 1 and 2 were first examined for any 
selectivity in hydrogen bond formation between the amino acid proton and either the benzyl ester 
or tert-butyl ester carbonyl. Because the rotational barrier of the aryl-aryl bond was large with a 
half life of 2.2 days at 418 K, it is only rotation around the N-aryl bond that would provide the 
conformational switch, as illustrated in Figure 2. Although our β-turn mimic will not contain the 
aforementioned ester carbonyls once more amino acids are added to the balance, the analysis 
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with the ester carbonyls should offer insight into the selectivity of the amino acid for one side 
over another when considering the constraints of the biphenyl core. 
 Torsion balance 2 was examined first based upon its simplicity in having only two 
distinct conformers arising from rotation around the N-aryl bond, compared to balance 1 which 
has four. The two conformers are shown in Scheme 18. 
 
Scheme 18. Two conformers of glycine torsion balance 2 by rotation around the N-aryl 
bond, with diastereotopic glycine protons Ha and Hb denoted. 
 
 
 
Before our examination into the folding preferences of 2, we carried out a variable 
temperature 
1
H NMR study,
35b
 in similar fashion to 29, to check for an observable sign of N-aryl 
bond rotation. We noted the beginnings of peak broadening of the six diastereotopic protons at 
70 °C (343 K), which coincided with our analysis of 29 and showed that rotation around the N-
aryl bond dominated.  
For the selectivity studies, we compared 
1
H NMR spectra of 2 at 298 K when dissolved 
in either chloroform-d or toluene-d8; this comparison is shown in Figure 13. The two N-methyl 
group singlets are ultimately the best indicator of the two conformers present; the chemical shifts 
for these signals are more deshielded in chloroform-d (δ = 3.29 ppm) than in toluene-d8 (δ = 3.06 
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ppm). In both solvents, the two singlets are seen in almost a 1:1 conformer ratio: in chloroform-d 
the ratio is 1.04:1.00, while in toluene-d8 the ratio is 1.00:1.23 with a slight change toward the 
more upfield peak. However, the essentially 1:1 ratio observed from both spectra shows that 
there is no significant selectivity of either ester in forming a hydrogen bond with the amino acid 
proton.    
 
 
 
Figure 13. Ester hydrogen bonding selectivity of the glycine torsion balance 2 can be 
studied from the ratios of the denoted N-methyl protons in chloroform-d and toluene-d8 
(500 MHz). Both ratios were essentially 1:1, meaning that there was little selectivity. 
 
  
An assignment of the diastereotopic ortho-methylene protons of 2 was performed. From 
the analysis of the 
1
H and COSY NMR spectra (500 MHz) of 2 in chloroform-d, the two ortho-
methylene protons nearest to the benzyl ester group were determined to be present at 4.70-4.81 
 41 
ppm (one AB quartet and one singlet), and the two nearest to the tert-butyl ester group were 
present at 4.52-4.66 ppm (one AB quartet and one multiplet). These data are on par with the 
assignments from biaryl 3. The 
1
H NMR spectrum (500 MHz) of 2 in toluene-d8, however, 
showed two singlets (4.15 and 4.16 ppm) and both AB quartets overlapping (4.45-4.81 ppm). 
With the hydrogen-bonding selectivity measured, our next goal was to determine if the 
amino acid itself had a preference for the left or right side of the biphenyl scaffold by rotation 
around the N-aryl bond. We utilized balance 1 because the L-alanine chain provided an 
additional site of chirality and therefore four conformers; these are shown in Scheme 19.  
 
Scheme 19. Four conformers of alanine torsion balance 1. 
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Because rotation around the aryl-aryl bond is slow, the four conformers are not at 
equilibrium at 298 K. The conformers 1-RaRaS and 1-RaSaS are in equilibrium with each other 
because N-aryl bond rotation is fast; likewise, 1-SaRaS and 1-SaSaS are in equilibrium with each 
other. However, because the biphenyl core was a racemate before amide coupling and cannot 
rotate, the combined amount of 1-RaRaS and 1-RaSaS must equal the amount of 1-SaRaS and 1-
SaSaS. In similar fashion to balance 2, balance 1 was dissolved in either chloroform-d or toluene-
d8 at 298 K; this comparison is shown in Figure 14. 
 
 
Figure 14. Differences in folding preference exhibited by alanine torsion balance 1 can be 
seen from the ratios of the N-methyl protons (denoted) and others in chloroform-d and 
toluene-d8 (500 MHz).  
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From the 
1
H NMR analysis, we observed a conformer ratio of 1.4:1.6:1.0:1.1 in 
chloroform-d and a ratio of 1.0:1.0:4.5:4.5 in toluene-d8. Toluene-d8 promotes a higher degree of 
hydrogen bonding compared to chloroform-d. Deuterated chloroform is known to compete for 
hydrogen bonding sites because it is acidic in comparison to its relatively low polarity.
39
 Given 
our analysis of balance 2, the conformers 1-RaRaS and 1-SaRaS are present in an equal amount 
(either the signal ratios 1.0:1.0 or 4.5:4.5), as are the conformers 1-RaSaS and 1-SaSaS.  
An assignment of the diastereotopic ortho-methylene protons of 1 was attempted; 
however, excessive overlap of the AB quartets and multiplets was observed in the 
1
H NMR 
spectra (4.00-5.00 ppm in chloroform-d and toluene-d8, 500 MHz). In addition, the multiplets of 
the alanine α-proton were also present in this region. In the future, a set of experiments that 
includes HMQC and HMBC NMR spectra would facilitate a more definitive assignment. 
We then performed another 
1
H NMR study with 1 to better understand the behavior of 
the peaks (the ratios and chemical shifts of a particular moiety, for example the N-methyl group 
depicted in Figure 14) when subjected to a second solvent. Balance 1 was dissolved in 
chloroform-d at room temperature, and then 0.09 mL aliquots of toluene-d8 were added until the 
solution was comprised of 50% toluene-d8. We initially hypothesized that with the introduction 
of toluene-d8, the set of four singlets would shift upfield without mixing or crossing over of 
peaks, while the peak integrations increased or decreased accordingly. However, upon addition 
of the first aliquot, we observed the peaks beginning to converge. With additional aliquots, the 
peaks at first shifted upfield and continued to converge, followed by the emergence of two small 
singlets and a much larger upfield singlet. Therefore, this mixing of the singlets revealed how 
different solvents can have a profound effect on not only the chemical shifts, but also the 
populations of hydrogen-bonded conformers.   
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The selectivity observed in toluene-d8 cannot be based on the preference of the amino 
acid proton to hydrogen bond to one ester over another, as established by the analysis of torsion 
balance 2. There must be a preference of the amino acid to be on the left or right side (perhaps 
influenced by proximity of the alanine α-methyl to the aryl group of the biphenyl core). An 
EXSY
36
 experiment was performed at 343 K. We did not observe ester selectivity from the 
EXSY analysis; therefore, it is likely that the selectivity for the amino acid to be on either side 
was more influenced by potential negative interactions between the aforementioned α-methyl 
and aryl groups, which might have been exacerbated by the hydrogen bond. Molecular modeling 
predicted that without the hydrogen bond present, there should be less selection upon N-aryl 
rotation and the ratios would be closer to 1:1:1:1, and so this remains to be tested.  
3.2.2 Hydrogen Bond Selectivity Analysis with Torsion Balance Derivatives 
In our NMR analyses of the torsion balances 1 and 2, we were not able to detect a higher 
selectivity of the amino acid proton towards the carbonyl oxygen of either the tert-butyl or the 
benzyl esters. Therefore, we next changed one ester carbonyl to an amide in order to test whether 
we could observe the expected hydrogen bond selectivity toward the amide carbonyl versus the 
ester carbonyl. 
3.2.2.1 Synthesis of the Dimethylamide Torsion Balance Derivatives and NMR Analysis 
The synthesis of the torsion balance derivatives 35 and 36 is shown in Scheme 20. Biaryl 
amides 27 and 28 were both subjected to hydrogenolysis conditions
40
 using 10% palladium on 
carbon and a balloon filled with hydrogen gas and at atmospheric pressure to afford carboxylic 
acids 33 and 34 in essentially quantitative yields. These acids were then treated with 
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dimethylamine hydrochloride and standard coupling reagents EDCI, HOBt, and triethylamine 
(NEt3) in acetonitrile for 80 h at room temperature;
41
 this resulted in both the amide coupling and 
also the cleavage of the Fmoc protecting group in preparation for acylation. Although this 
shortened the synthetic route by one step, it resulted in lower yields because the dramatic 
increase in polarity of these molecules had made purification by flash chromatography more 
difficult. The intermediates were recovered, still containing some impurities, and treated with 
acetic anhydride and pyridine to yield biaryl amide derivatives 35 and 36 in two-step yields of 
52% and 48%, respectively. A tertiary amide in the form of dimethylamide was chosen over a 
secondary amide (i.e. methylamide) because there would be no ambiguity over whether the 
amide functionality was participating as a hydrogen bond donor as well as a hydrogen bond 
acceptor. 
 
Scheme 20. Synthesis of torsion balance derivatives 35 and 36. 
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The torsion balance derivatives 35 and 36 were examined by NMR studies for any 
preference in carbonyl selectivity. If a carbonyl selectivity was in effect, we predicted that the 
equally sized peaks (ratios 4.5:4.5 or 1.0:1.0 from torsion balance 1) would become unequal. The 
selectivity was first analyzed with 35; the four possible conformations are shown in Scheme 21. 
Similar to alanine balance 1, all four conformers of 35 are not in equilibrium with each other. 
Based upon the analysis of the four N-methyl signals (the N-methyl adjacent to the amino acid), 
we observed the four isomers of 35 to be present in a ratio of approximately 1.0:3.0:6.0:7.0 in 
toluene-d8 (1.7:1.4:1.3:1.0 in chloroform-d), in comparison to the 1.0:1.0:4.5:4.5 selectivity 
observed for balance 1.  
 
Scheme 21. Four conformers of alanine torsion balance derivative 35. 
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The 
1
H NMR spectra of 35 with either chloroform-d or toluene-d8 are shown in Figure 
15. There is a stronger preference for an amide proton to hydrogen bond with the dimethylamide 
carbonyl than with the tert-butyl ester carbonyl.
42
 We therefore propose that the conformer 
present in the highest population (the largest signal in toluene-d8) has both the hydrogen bond 
between the amino proton and the amide carbonyl, as well as little interaction between the 
alanine α-methyl and the aryl group. 
 
 
 
Figure 15. Differences in folding preference exhibited by alanine torsion balance derivative 
35 can be seen from the ratios of the denoted N-methyl protons in chloroform-d and 
toluene-d8 (500 MHz). 
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An assignment of the diastereotopic ortho-methylene protons of 35 was also attempted; 
however, similar to alanine balance 1, excessive overlap of the AB quartets and multiplets was 
observed in the 
1
H NMR spectra (4.10-5.10 ppm in chloroform-d and toluene-d8, 500 MHz). In 
addition, the multiplets of the alanine α-proton were also present in this region. Therefore, a 
future set of experiments that includes HMQC and HMBC NMR spectra would facilitate a more 
definitive assignment.  
3.2.2.2 Introduction of a Beta-Alanine Torsion Balance Analog and its Dimethylamide 
Derivative 
 We also subjected derivative 36 to the same studies as 35, and we noted a carbonyl 
preference of 1.4:1.0 in toluene-d8 in comparison to the ratio of 1.0:1.2 for balance 2. Further 
analyses involving 36 and other balances were done in comparison with β-alanine derivatives. It 
was important to discern if the amino acid proton on the (o-tolyl)amide portion of the balance 
was spaced appropriately in relation to the ester (or amide) carbonyls on the benzoate portion to 
ensure hydrogen bond formation. The choice of β-alanine was made because it provided an 
additional methylene spacer to separate the nitrogen proton from the β-turn core. The syntheses 
of the β-alanine amides 38, 39, and dimethylamide 41 were performed in similar fashion to their 
alanine and glycine analogs, and are shown in Schemes 22 and 23.  Using Carpino’s amino acid 
chloride procedure,
26
 N-Fmoc-β-alanine acid chloride was generated from N-Fmoc-β-alanine 37 
and added to 3 to produce biaryl amide 38 in an 82% yield.  
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Scheme 22. Synthesis of β-alanine biaryl amide 38. 
 
 
 
Amide 38 was then treated with DBU in CH2Cl2 to cleave the Fmoc group,
43
 and the 
product was acylated using acetic anhydride and pyridine in CH2Cl2
32
 to give torsion balance 
analog 39 in a moderate 50% yield. DBU was substituted for piperidine to compare its potency 
to cleave the Fmoc group, and it was found to be equally effective. Amide 39 was then subjected 
to hydrogenolysis conditions
40
 to afford carboxylic acid 40 in quantitative yield, after which 40 
was treated with dimethylamine hydrochloride and standard coupling reagents EDCI, HOBt, and 
triethylamine (NEt3) in acetonitrile for 80 h at room temperature
41
 to give dimethylamide 41 in 
74% yield. The route used to synthesize 41, although containing an extra step in comparison with 
35 and 36, gave less trouble in terms of purification via flash chromatography.   
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Scheme 23. Synthesis of β-alanine torsion balance analog 39 and its dimethylamide 
derivative 41. 
 
 
 
We compared the derivatives 36 and 41 in both chloroform-d and toluene-d8 to test for 
any carbonyl selectivity. This comparison was appropriate because both derivatives existed as 
two conformations (based upon rotation around the N-aryl bond) and they only differed by a 
methylene spacer. The conformers are shown in Scheme 24, and the 
1
H NMR comparison at 298 
K in toluene-d8 is shown in Figure 16. We observed that both dimethylamides 36 and 41 
exhibited the same selectivity ratio of 1.0:1.9 in favor of one of the carbonyls. The similarity in 
ratios is most likely due to the lack of an amino acid side chain that could interact with the aryl 
group of the biaryl core. 
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Scheme 24. Two conformers each of glycine 36 and β-alanine 41 torsion balance 
derivatives. 
 
 
 
 
Figure 16. Folding preference exhibited by glycine derivative 36 and β-alanine derivative 
41 in toluene-d8 at 298 K (500 MHz). The N-methyl protons are denoted; both derivatives 
have conformer ratios of 1.0:1.9.  
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Assignments of the diastereotopic ortho-methylene protons of 36 and 41 were performed. 
From the analysis of the 
1
H and NOESY NMR spectra (500 MHz) of 36 in toluene-d8, the two 
ortho-methylene protons nearest to the dimethylamide group were determined to be present at 
4.46-4.81 ppm (one AB quartet at 4.46-4.81 ppm and one singlet at 4.64 ppm) and the two 
nearest to the tert-butyl ester group were present at 4.15-4.19 ppm (one singlet at 4.15 ppm and 
one multiplet at 4.19-4.19 ppm). For the analysis of 41 (500 MHz, toluene-d8), the two ortho-
methylene protons nearest to the dimethylamide group were determined to be present at 4.32-
4.38 ppm (one multiplet) and the two nearest to the tert-butyl ester group were present at 4.12-
4.17 ppm (one multiplet). The diastereotopic protons nearest to the dimethylamide group are 
more downfield most likely due to the increased basicity and enhanced resonance of the amide 
functionality.     
In a final study, we compared target balance 2 to its β-alanine derivative 39 to again test 
for any hydrogen bond selectivity. The conformers are shown in Scheme 25, and the 
1
H NMR 
comparison at 298 K in toluene-d8 is shown in Figure 17. 
 
Scheme 25. Two conformers each of glycine balance 2 and its β-alanine 39 derivative. 
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Figure 17. Folding preference exhibited by glycine balance 2 and β-alanine derivative 39 in 
toluene-d8 at 298 K (500 MHz). The N-methyl protons are denoted. 
 
 
We observed that derivative 39 showed a slightly higher selectivity of 1.0:1.7 between 
the ester carbonyls in contrast with 2, which showed a much lower selectivity of 1.0:1.2. It is 
possible that the extra methylene spacer in 39 is placing the acyl group in close proximity to the 
tert-butyl group (depicted by 39-RaSa) and creating a negative steric effect that would promote 
selectivity of the amino acid for the benzyl ester carbonyl. 
An assignment of the diastereotopic ortho-methylene protons of 39 was performed. From 
the analysis of the 
1
H NMR spectrum (300 MHz) of 39 in chloroform-d, the two ortho-
methylene protons nearest to the benzyl ester group were determined to be present at 4.67 ppm 
(one broad singlet), and the two nearest to the tert-butyl ester group were present at 4.50 ppm 
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(one broad singlet). These data are on par with the assignments from glycine balance 2. 
Interestingly, the 
1
H NMR spectrum (500 MHz) of 39 in toluene-d8 showed two overlapping 
singlets and also a large multiplet between 4.00 and 4.50 ppm. 
3.3 CONCLUSION, AND PROGRESSION TOWARD THE ADVANCED ΒETA-
STRAND TORSION BALANCE  
 We have described the attainment of an initial set of new molecular torsion balance 
targets that can be applied toward the study of dynamics in the antiparallel β-sheet motif. This 
balance utilizes the restricted rotation around an aryl–aryl bond and an N-aryl bond to impose a 
two–state nature of folding. Our 1H and EXSY NMR analyses of the torsion balance have 
revealed interesting effects of solvent on hydrogen-bonding conformers and have allowed for 
suitable calculation of rotational barriers. Overall, our scaffold has the correct shape to simulate 
intramolecular interactions between the ends of an antiparallel β-sheet.  
 Our goal for the hybrid synthetic-natural peptidic torsion balance is to append additional 
amino acids to the biaryl core 27 and 28 by selective deprotection and amide couplings at the 
position of choice. A small peptide generally contains six amino acids or less, and so having a 
chain of two or three amino acids long on the (o-tolyl)amide portion of the torsion balance, in 
addition to having chains of one or two amino acids on either side of the benzoate portion of the 
torsion balance would be a good initial target to mimic peptidic dynamics.  
We introduced a second amino acid in the form of glycine benzyl ester to each torsion 
balance; the synthesis is shown in Scheme 26. Carboxylic acids 33 and 34 were each treated with 
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glycine benzyl ester hydrochloride, in addition to solid sodium bicarbonate, EDCI, and HOBt
44
 
to yield amides 42 and 43 in 99% and 93%, respectively. 
 
Scheme 26. Synthesis of biaryl amides 42 and 43 via amide coupling. 
 
 
 
 The 
1
H NMR spectra of these bis(amino acid) torsion balances were examined to 
determine the amount of conformers present; similar to biaryl amides 27 and 28, we observed 
four configurations for alanine-glycine amide 42 and two for glycine-glycine amide 43. We hope 
to overcome the issue of having more than two conformers present when performing studies to 
monitor the changes of amino acids on peptide folding and stability. With further amino acid 
couplings, the hydrogen bonding between the strands will hopefully restrict rotation around the 
N-aryl bond or the N-CO bond. The hydrogen bonding from these additional amino acids would 
allow for comparisons in β-sheet stability (with the smaller balances) and lock in the torsion 
balance conformations; this would provide new experimental data relevant to the dynamics of 
the β-turn of a small peptide.  
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4.0  DESIGN AND SYNTHESIS OF ADVANCED TORSION BALANCE TARGETS. 
4.1 RETROSYNTHETIC ANALYSIS 
We next planned to expand upon the torsion balance and create target molecules to test 
how specific changes of amino acids or functional groups would affect peptide folding in 
antiparallel β-sheets. The first torsion balance design, amide 44, would test the preference of an 
amino acid chain to form a hydrogen bond with either a secondary amide or a tertiary amide 
functional group. Amide 44, shown in Scheme 27, could be synthesized by an amide coupling
26
 
of biaryl amine 45 with the Fmoc-protected glycine acid chloride derivative, followed by 
deprotection and acylation.
32
 Biaryl amine 45 could be prepared by a Suzuki–Miyaura cross-
coupling reaction
16
 between asymmetric bromide 46 and boronic ester 5. The generation of 46 
could be realized from a Williamson ether synthesis
18
 of a dimethyl bromoacetamide with 
asymmetric ether 10. 
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Scheme 27. Retrosynthetic pathway for priority target amide 44. 
 
 
 
The second set of torsion balances, amides 47 and 48, are shown in Scheme 28 and would 
share the same asymmetrical precursor compounds. Amide 47 would test for the preference of an 
amino acid chain to hydrogen bond more strongly when there are one or two sites for hydrogen 
bonding in a chain; amide 48 would test the potential of an amino acid chain to form hydrogen 
bonds more strongly with an alanine or leucine side chain. Amides 47 and 48 would be 
synthesized by an amidation reaction of acid precursor 49 with either methylamine 
hydrochloride
41
 or methylated leucine
44
, respectively. Acid 49 would be prepared by performing 
several successive deprotections and amidation reactions with biaryl amine 3. The amidation 
reagents would include a methylated alanine
44
, N-acetyl-alanine
45
, and Fmoc-protected glycine 
acid chloride derivative
26
.  
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Scheme 28. Retrosynthetic pathway for target amides 47 and 48. 
 
 
 
The third set of torsion balances, amides 50 and 51, zwitterions 52 and 53, and controls 
54 and 55, are shown in Scheme 29 and would share some of the same symmetrical precursor 
compounds. Amide 50 would test the preference of an amino acid chain to hydrogen bond when 
a restrictive steric effect is involved (a potentially negative interaction between the methyl of an 
alanine and a neighboring aryl methyl group). Amide 50 would be prepared by performing 
several successive deprotections and amidation reactions with symmetrical alanine torsion 
balance 56. The amidation reagents would include a methylated alanine
44
 and N-acetyl-alanine
45
. 
Amide 56 would be synthesized by an amide coupling
26
 of symmetrical biaryl amine 58 and 
Fmoc-protected alanine acid chloride derivative. Amine 58 would be generated by a Suzuki–
Miyaura cross-coupling reaction
16
 between symmetrical bromide 11 and boronic ester 5.  
Amide 51 would test the effect of salt-bridging between ammonium and carboxylate 
moieties of amino acid chains on the rate of rotation around the N-aryl bond. Amide 51 would be 
 59 
prepared from deprotections and amidation reactions with symmetrical glycine torsion balance 
57. The amidation reagents would include a benzyl protected alanine
45
 and N-Cbz-alanine
45
. 
Amide 57 would be synthesized by an amide coupling of symmetrical biaryl amine 58 and 
Fmoc-protected glycine acid chloride derivative.
26
 
Zwitterions 52 and 53 would test the effect of salt-bridging between an amino acid 
ammonium and a simple carboxylate moiety on the rate of rotation around the N-aryl bond. 
These zwitterions would be produced by performing both Fmoc- and tert-butyl ester 
deprotections
45,46
 on symmetrical alanine 56 and glycine 57 torsion balances, respectively. 
Control amides 54 and 55 would aid in the test for the effect of salt-bridging between an 
amino acid ammonium and a simple carboxylate moiety on the rate of rotation around the N-aryl 
bond. These controls would be produced by performing Fmoc-deprotection and acylation,
32
 
followed by tert-butyl ester deprotection
46
 on symmetrical alanine 56 and glycine 57 torsion 
balances, respectively. 
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Scheme 29. Retrosynthetic pathway for torsion balance targets amide 50, amide 51, 
zwitterions 52 and 53, and controls 54 and 55. 
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The fourth torsion balance type, biaryl amine 59, is shown in Scheme 30 and would be 
used as a core tool for either solution- or solid-phase peptide synthesis with the introduction of a 
tert-butyl aryl ester moiety. Amine 59 would be prepared by a Suzuki–Miyaura cross-coupling 
reaction
16
 between asymmetric bromide 60 and boronic ester 5. The generation of 60 would be 
realized from two Williamson aryl ether syntheses
18
 with asymmetric phenol 61, using para-
nitrobenzyl bromoacetate and benzyl bromoacetate with asymmetric ether 10, upon selective 
removal of an allyl group. Phenol 61 would be furnished from a Fisher esterification
17
 of 
commercially available acid 8, then protection of the phenolic groups, with allyl bromide,
47
 
followed by conversion of the methyl ester to a tert-butyl ester
48
. 
 
Scheme 30. Retrosynthetic pathway for core target 59. 
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4.2 SYNTHESIS OF ADVANCED TORSION BALANCE TARGETS 
4.2.1 Synthesis of the Priority Target 44 
The synthesis of the priority target 44 is shown in Scheme 31. Reaction of ether 10 with 
dimethylacetamide 62 by a Williamson aryl ether protocol
18
 afforded bromide 46 in a good 79% 
yield. A Suzuki–Miyaura cross-coupling reaction16 between bromide 46 and boronic ester 5 
produced biaryl amine 45 in 24% yield. Carpino's amino acid chloride procedure
26
 was then used 
to generate N-Fmoc-glycine acid chloride 21-int, which was combined with 45 to give amide 63 
in 83% yield. Amide 63 was then subjected to a one-pot Fmoc deprotection and acylation, using 
DBU
43
 in DMF followed by acetic anhydride and pyridine,
32
 to supply amide 64 in an excellent 
88% yield. Cleavage of the tert-butyl ester with TFA
46
 and amidation
49
 with methylamine 
hydrochloride, EDCI, HOBt, and DIEA gave the priority target 44 in 17% yield. 
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Scheme 31. Synthesis of priority target 44. 
 
 
 
Dimethyl bromoacetamide 62 was generated by reacting bromoacetyl chloride 65 with 
dimethylamine hydrochloride and triethylamine. The procedure used was found in a lone 
patent,
50
 and the moderate 39% yield of 62 is on par with that literature; the synthesis of 62 is 
shown in Scheme 32.    
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Scheme 32. Synthesis of dimethyl bromoacetamide 62. 
 
 
4.2.2 Synthesis of the Asymmetrical Targets 47 and 48 
The syntheses of target 47 and target 48 are shown in Scheme 33; the overall synthesis is 
efficient because these two target torsion balance compounds differ only by one amidation step 
at the end of the route. Amide 28 was first subjected to Fmoc deprotection using DBU
43
 in DMF; 
the DBU was removed by flash chromatography, and the crude was then reacted with N-acetyl-
alanine 18, (benzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate (PyBOP)
45
 
and DIEA to produce amide 66 in a moderate two step yield of 58%. In a previous one-pot 
deprotection-amidation trial with DBU, no amidation product was isolated and only a biaryl side 
product was found by analysis of the 
1
H NMR spectrum. In another trial with tris (2-
aminoethyl)amine (TAEA)
45
 as the amine base used instead, the benzyl ester was also cleaved. 
Therefore, it was determined that DBU should be used in the deprotection, but should be 
removed from the crude product before amidation. The tert-butyl ester of 66 was cleaved with 
TFA to yield the free acid, and then an amidation reaction
44
 with methylated alanine 67, EDCI, 
HOBt and sodium bicarbonate was performed to give amide 68 in a one-pot yield of 62%. 
Amide 68 was then treated with standard hydrogenation conditions
40
 to provide acid 49 in an 
excellent 92% yield. Acid 49 was subjected to amidation reactions to generate both final targets 
47 and 48: treatment with methylamine hydrochloride, EDCI, HOBt and DIEA
49
 produced target 
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47 in 6% yield, and treatment with methylated leucine 69, EDCI, HOBt and sodium 
bicarbonate
44
 supplied target 48 in 45% yield. 
 
 
Scheme 33. Synthesis of target 47 and target 48. 
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The methylated alanine 67 and leucine 69 were synthesized from N-Cbz-alanine 70 and 
N-Cbz-leucine 71, respectively. These protected amino acids were subjected to amidation 
conditions
49
 with methylamine hydrochloride, EDCI, HOBt and DIEA to provide N-methyl-N-
Cbz-alanine 72 and N-methyl-N-Cbz-leucine 73 both in quantitative yields. Subsequently, these 
modified amino acids were submitted to hydrogenation conditions
40
 to furnish 67 and 69 in 85% 
and 65% yields, respectively; this synthesis is shown in Scheme 34. The yields of 72 and 73 
were noticeably much higher than that of 44 and 47; it is hypothesized that steric hindrance via 
the torsion balance scaffold could be a contributing factor. 
 
Scheme 34. Synthesis of N-methylated Cbz-protected amino acids 67 and 69.  
 
 
 
 The targets 47 and 48 were examined by HPLC in an effort to separate the diastereomers 
present. We aimed to separate the conformers and then perform 2D NMR analyses to determine 
their absolute configuration. Both targets were run through Chiralcel OD and Whelk chiral 
columns, using various mixtures of hexanes, isopropanol and methanol, with no successful 
separation. RegisPack and RegisCell columns were also tried, with methanol and carbon dioxide 
as eluents, and were unsuccessful. Use of a reverse-phase Phenomenex Luna C-18 column with 
water and acetonitrile produced slightly promising analytical results (the best was on a 20-35% 
acetonitrile gradient), as depicted in Figure 18; however, the separation was too poor for the full-
preparative scale, and so targets 47 and 48 were recovered as their respective isomeric mixtures. 
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Figure 18. Best analytical HPLC trace of target 48 conformer peaks; target 47 was similar 
in appearance. 
 
 
 We then examined the suitability of precursor carboxylic acid 49 for HPLC separation. 
By using the Phenomenex reverse-phase column with a 20-32% acetonitrile gradient, we were 
able to obtain an analytical result, illustrated in Figure 19, that showed enough baseline 
separation between the conformers (at 13 and 15 min). Full-preparative HPLC runs yielded 
approximately 2 mg of each constituent, which was enough for 2D NMR analysis.  
 
   
Figure 19. Analytical HPLC chromatogram of the precursor carboxylic acid 49; the two 
conformer peaks are at 13 and 15 minutes and eluted out with a 20-32% acetonitrile 
gradient. 
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4.2.3 Synthesis of the Symmetrical Targets 50-53 and Controls 54-55 
 The symmetrical targets were our next aim, and were generated from a symmetrical 
biaryl amine. Biaryl amine 58, shown in Scheme 35, was synthesized from symmetrical bromide 
11 and boronic ester 5 in a modest 26% yield. The Suzuki–Miyaura cross-coupling conditions16 
used were identical to those used to furnish previously synthesized asymmetrical biaryl amine 3.  
 
Scheme 35. Synthesis of symmetrical Suzuki-coupled starting material 58. 
 
 
 
 The synthesis of target 50 is shown in Scheme 36, and is similar to that of 47 and 48. 
Carpino's amino acid chloride procedure
26
 was used to generate N-Fmoc-alanine acid chloride 
20-int, which was combined with biaryl amine 58 to give amide 56 in a good 84% yield. Amide 
56 was then treated with TAEA
45
 to remove the Fmoc group, and then coupled with N-acetyl-
alanine 18 using PyBOP
45
 and DIEA to give amide 74 in 83% yield. Cleavage of the tert-butyl 
ester with TFA,
46
 followed by an amide coupling
44
 with methylated alanine 67, EDCI, HOBt, 
and sodium bicarbonate produced target 50 in a good one-pot yield of 56%. 
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Scheme 36. Synthesis of target 50. 
 
 
 
 The synthesis of target 51, which showcases a final global deprotection, is depicted in 
Scheme 37. Carpino's amino acid chloride procedure
26
 was utilized to generate N-Fmoc-glycine 
acid chloride 21-int, which was then combined with biaryl amine 58 to give amide 57 in an 
excellent 92% yield. Amide 57 was then treated with TAEA
45
 to remove the Fmoc group, and 
then coupled with N-Cbz-alanine 70 using PyBOP
45
 and DIEA to give amide 75 in 77% yield. 
Cleavage of the tert-butyl ester with TFA
46
 and amidation
44
 with commercially available L-
alanine benzyl ester hydrochloride, EDCI, HOBt, and sodium bicarbonate produced amide 76 in 
a good one-pot yield of 78%. Global deprotection of 76, using standard hydrogenation 
conditions,
40
 gave target 51 in 85% yield. 
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Scheme 37. Synthesis of target 51. 
 
 
 
 The synthesis of alanine and glycine zwitterion targets 52 and 53, respectively, is 
depicted in Scheme 38. Symmetrical amides 56 and 57 were subjected to Fmoc deprotection 
using TAEA
45
 to reveal the free amine; the crude was then treated with TFA
46
 to cleave the tert-
butyl groups and yield the alanine 52 and glycine 53 zwitterion targets in 87% and 89%, 
respectively. The order of deprotections was reversed and found to have no significant effect on 
the yield; DBU in DMF
43
 was substituted for TAEA in CH2Cl2, also with minimal effect. 
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Scheme 38. Synthesis of zwitterion targets 52 and 53. 
 
 
 
The synthesis of the alanine and glycine control targets 54 and 55, respectively, is shown 
in Scheme 39. Amides 56 and 57 were subjected to a one-pot Fmoc deprotection and acylation, 
using DBU in DMF
43
 followed by acetic anhydride and pyridine,
32
 to supply amides 77 and 78 in 
excellent 90% and 89% yields, respectively. Cleavage of the tert-butyl ester with TFA
46
 resulted 
with the control targets 54 and 55 in 100% and 99% yield, respectively. There was a small 
amount (<5% by 
1
H NMR) of an acetic anhydride derivative impurity present with the alanine 
target 54 that remained even after extraction and column chromatography were performed; this 
impurity did not interfere with the subsequent 2D NMR studies. 
 
Scheme 39. Synthesis of control targets 54 and 55. 
 
 
 72 
4.2.4 Synthesis of the Core Target 59 
 The core target 59 was devised with solid-phase peptide synthesis in mind — the tert-
butyl aryl ester of a torsion balance could be concurrently deprotected with the resin (i.e. FMP 
resin
51
) to which it was attached. This synthetic plan would be useful in the event a target torsion 
balance became less organic-soluble (with the addition of more amino acid moieties) and 
therefore more difficult to synthesize via solution phase, and also would allow for enhanced 
water solubility for NMR studies.   
 Our plan was to synthesize 59 by initially generating the tert-butyl ester analog 79 of 
methyl ester 9, and subsequently generate an asymmetrical bromide similar to 4 via Williamson 
ether protocols. Several reaction conditions from the literature were tried, as depicted in Scheme 
40 — di-tert-butyl dicarbonate and magnesium perchlorate (Mg(ClO4)2),
52
 tert-butanol and 
DMAP,
46
 tert-butanol, EDCI and DMAP,
53
 tert-butanol, sulfuric acid and magnesium sulfate 
(MgSO4),
54
 tert-butanol, 1,1'-carbodiimidazole (CDI) and DBU,
55
 and N,N-dimethylformamide 
di-tert-butyl acetal
56
  — all reactions resulted in no isolation of product. We propose that these 
reactions were unsuccessful because either the two phenol moieties were deprotonated first 
before esterification, or because the position of the bromine on the aromatic ring did not allow 
for easy esterification. It is reported that 2,6-dibromo-3,5-dihydroxybenzoic acid was converted 
to its tert-butyl ester in 50% yield using the Lewis acid Mg(ClO4)2;
52a
 our benzoic acid substrate 
8 was different only with the bromine at the para-position (to the carboxylic acid moiety) instead 
of at the ortho- position. 
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Scheme 40. Attempts to synthesize tert-butyl 4-bromo dihydroxybenzoate 79. 
 
 
 
 Our next effort involved protecting the phenolic groups before esterification, shown in 
Scheme 41. A global protection with benzyl bromide, followed by selective ester cleavage with 
sodium hydroxide, afforded 80 in a two-step 99% yield.
57
 Acid 80 was then subjected to tert-
butyl esterification with tert-butanol, CDI and DBU to furnish ester 81 in quantitative yield.
57
 
Deprotection of the benzyl ethers with standard hydrogenation conditions
40
 led to an orange oil, 
and 
1
H NMR revealed that benzoate 79 was present in 60% yield, with a side product that had an 
additional aromatic proton in the ortho-position (between both phenolic groups). This side 
product is hypothesized to result from cleavage of the bromine due to an aryl halide 
hydrogenolysis side reaction that could occur in the presence of a palladium catalyst.
52b
 A TBS-
protected analog of 80 was alternatively generated in 96% yield from a one-pot reaction of 8 
with TBS-Cl and imidazole in DMF
38
 followed by acetic acid in a THF/water mixture;
58
 
however, we reasoned that this compound would be immediately deprotected by DBU in the 
next esterification step. Esterification with di-tert-butyl dicarbonate and Mg(ClO4)2
52
 was 
unsuccessful.  
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 Scheme 41. Second attempted synthesis of benzoate 79.  
 
 
 
 The purified benzoate 79 was then utilized in an attempt to perform a Williamson ether 
synthesis
18
 on one of the two phenolic groups, similar to synthesis of 10, and using 1 equiv of 
benzyl bromoacetate; the result was a complex mixture of product and symmetrical side product 
that was very difficult to separate by standard flash chromatography. We revised the synthetic 
plan to use a different protecting group strategy and tert-butyl esterification method. Allyl groups 
were chosen as hydroxy-protecting groups because single allyl ether cleavage was possible with 
a decent yield and would not result in bromine cleavage. Methyl groups had been considered as 
well; however, in a model reaction, selective methyl ether cleavage using BCl3
59
 was 
unsuccessful.  
 A successful synthesis leading to the ester 61 is depicted in Scheme 42. Commercially 
available 4-bromo 3,5-dihydroxybenzoic acid was subjected to a Fisher esterification
17
 to form 
the methyl aryl ester moiety, and then alkylation was performed with allyl bromide to protect the 
phenolic groups;
47
 the resulting methyl ester 82 was obtained in a quantitative two-step yield. 
Conversion of the methyl ester to the tert-butyl ester 83 was performed in an excellent 96% yield 
with 10 equiv of both tert-butyl acetate (tBuOAc) and potassium tert-butoxide (tBuOK) in THF 
in under 1 h.
48
 The tert-butyl ester 83 was then treated with 1 equiv of sodium borohydride 
(NaBH4) and tetrakis(triphenylphosphine)Pd(0) [Pd(PPh3)4] to cleave only one allyl ether 
group
60
 and give asymmetrical bromide 61 in 48% yield, in addition to unreacted starting 
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material 83 (30%). In other trials of this same reaction, the yields of 61 were noticeably lower 
when the Pd(PPh3)4 catalyst was not fresh and was deep orange-brown in color instead of yellow. 
In another test, 2 equiv of sodium borohydride
60
 were used to obtain 79 in 82% yield.  
 
Scheme 42. Revised synthesis toward tert-butyl esterification. 
 
 
 
 The remaining synthetic steps culminating with the core target 59 are shown in Scheme 
43. Bromide 61 was subjected to Williamson ether conditions
18
 with benzyl bromoacetate to 
produce bromide 84 in 96% yield. The remaining allyl group of bromide 84 was removed with 
NaBH4 and Pd(PPh3)4 to afford bromide 85 in 84% yield.
60
 Bromide 85 was treated with pNB 
bromoacetate 86 in a Williamson ether synthesis
18
 to generate asymmetrical bromide 60 in 96% 
yield. A Suzuki–Miyaura cross-coupling reaction16 between bromide 60 and boronic ester 5 
produced biaryl amine 87 in 31% yield. Amine 87 was then treated with 3 equiv of TBAF —1 
equiv was added every 15 min until a deep burgundy-purple color was observed and the starting 
material had disappeared via TLC monitoring — to selectively cleave the pNB ester61 and 
furnish the final core target amine 59 in a modest 29% yield. When this reaction was repeated 
with more than three equivalents of TBAF, complete cleavage of the benzyl ester moiety was 
also observed by analysis of the crude 
1
H NMR spectrum.  
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Scheme 43. Remaining synthesis toward core target 59. 
 
 
 
p-Nitrobenzyl (pNB) bromoacetate 86 was prepared by an esterification reaction
62
 with 
bromoacetic acid 88 and para-nitrobenzyl alcohol 89, using DCC and DMAP as coupling 
reagents. The pNB bromoacetate 86, depicted in Scheme 44, was furnished in 62% yield. 
Commercially available methyl bromoacetate and allyl chloroacetate had been previously used to 
generate the methyl ester and allyl ester analogs, respectively, of 60; however, attempts to cleave 
the methyl ester with NaOH
63
 after Suzuki–Miyaura coupling to give 59 resulted in additional 
cleavage of the benzyl ester, and Suzuki–Miyaura cross coupling16 of the allyl analog with 
boronic ester 5 resulted in no isolation of product by analysis of the 
1
H NMR spectrum. 
Therefore, the pNB ester was the best choice for our orthogonal deprotection strategy toward 59.    
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Scheme 44. Synthesis of p-nitrobenzyl bromoacetate 86. 
 
 
 
 We attempted to resolve the enantiomers of core target 59 by both crystallization with 
chiral amines and also chiral HPLC to aid in our absolute configuration assignments. Two chiral 
amines, (+)-quinidine
64
 and (S)-(-)-α-methylbenzylamine65, were each combined with the 
racemic mixture of 59 in unsuccessful crystallization efforts. The crude oily mixture of the (+)-
quinidine salt crystallization attempt was submitted for HPLC analysis on the Chiralcel OD 
chiral column and the Phenomenex Luna C-18 reverse-phase column. The Chiralcel run was 
ineffective, and the Phenomenex run, shown in Figure 20, was the best found. Several full-
preparative runs yielded less than 1 mg of each diastereomeric salt (both around 13 min), which 
was determined to be not enough for the subsequent amine salt cleavage step. Most of the 
diastereomeric salt had appeared to dissociate upon contact with the column to the original 
racemic mixture (at 19 min). 
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Figure 20. Analytical HPLC trace of the core target 59; the diastereomeric salt conformer 
peaks are grouped tightly together at 13 minutes, using a gradient of 40-45% acetonitrile. 
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5.0  NMR STUDIES OF ADVANCED TORSION BALANCE TARGETS 
All of the advanced torsion balance targets, with the exception of the small zwitterion targets 52-
55, were characterized and assigned by 
1
H and 
13
C NMR spectroscopy. As previously 
mentioned, individual assignments of each diastereomer of 47 and 48 were not possible because 
the separation methods employed were unsuccessful; therefore the assignments were performed 
by allotting one set of proton and carbon peaks to each moiety of each balance. 
5.1 ANALYSIS OF PRIORITY TARGET 
 Our first advanced torsion balance, amide 44, was designed to test the preference of an 
amino acid chain to form a hydrogen bond with either a secondary amide or a tertiary amide 
functional group in a peptide. Balance 44 has three possible conformers and was not a candidate 
for HPLC or crystallization separation techniques; these conformers are shown in Scheme 45. 
Conformers 44a and 44b differ by rotation around the N-aryl bond; 44c arises from the rotation 
around the N-CO bonds to present a different pattern of hydrogen bonding. We hypothesize that 
either hydrogen bonding motif depicted in 44b or 44c (with the secondary amide functional 
group) would be preferred over 44a. 
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Scheme 45. Three possible conformers of amide target 44. 
 
 
 
The assignment of the 
1
H and 
13
C signals of amide 44 were assisted by 2D NMR techniques, 
including COSY, TOCSY, HMQC, and HMBC experiments. The COSY and TOCSY 
experiments were especially useful in determining the amide proton assignments. The allocation 
of signals to atom location is depicted in Figure 21 and Table 4. If an assignment could not be 
determined ("nd"), it is noted in the table. There was typical overlap observed in the aromatic 
region, and there was also overlap of the aryl methyl (location no. 19) and acetyl methyl 
(location no. 25) protons; some but not all of these peaks were resolved with the aid of HMQC 
and HMBC spectra. 
 
 
Figure 21. Representation of balance 44 with numbering of atom location (hydrogen, 
carbon, or nitrogen) for structure assignment. 
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Table 4. Target 44 assignments (700 MHz) in both chloroform-d (left) and toluene-d8 
(right). 
 
No. 1H, ppm, CDCl3 
13C, ppm 1H, ppm, Toluene-d8 13C, ppm 
1 -- 166.0 -- nd 
2 3.97 (s, 3H) 52.0 3.59 (s, 3H) 52.0 
3 -- 132.0 -- nd 
4 7.32-7.29 (singlets, 1H) 108.0 7.53-7.34 (singlets, 2H) 107.0 
5 7.32-7.29 (singlets, 1H) 108.0 7.53-7.34 (singlets, 2H) 107.0 
6 -- 123.0 -- nd 
7 -- 123.0 -- nd 
8 -- 157.0 -- nd 
9 4.55-4.47 (m, 2H) 68.0 4.24, 4.14-4.08 (ABq, m, 2H) 68.0 
10 -- 168.0 -- nd 
11 6.22, 6.07, 5.88 (three broad s, 1H) -- 6.21, 5.50 (two broad s, 1H) -- 
12 2.75, 2.71 (two s, 3H) 26.0 2.72, 2.35 (two app s, 3H) 25.0 
13 -- 126.0 -- nd 
14 7.39-7.16 (m, 1H) 127.0 nd nd 
15 -- 136.0 -- nd 
16 7.39-7.16 (m, 1H) 127.0 nd nd 
17 -- 141.0 -- nd 
18 7.39-7.16 (m, 1H) 131.0 nd nd 
19 2.07-1.92 (singlets, 3H) 15.0 2.13 (app s, 3H) 14.0 
20 3.83-3.30 (singlets, 3H) 38.0 3.10, 3.06 (two s, 3H) 36.0 
21 -- 168.0 -- nd 
22 3.82-3.54 (m, 2H) 42.0 3.86-3.49 (m, 2H) 42.0 
23 6.49, 6.41 (two broad s, 1H) -- 6.38, 6.21 (two broad s, 1H) -- 
24 -- 170.0 -- nd 
25 2.09-2.01 (singlets, 3H) 23.0 1.52, 1.49 (two s, 3H) 22.0 
26 4.87-4.71 (m, 2H) 66.0 4.59, 4.14-4.08 (ABq, m, 2H) 66.0 
27 -- 167.0 -- nd 
28 2.95-2.92 (singlets, 6H) 37.0 2.55, 2.44, 2.32, 1.95 (four s, 6H) 35.0 
 
 
 An assignment of the diastereotopic ortho-methylene protons (location nos. 9 and 26) of 
44 was performed, and can be seen in Table 4. The assignments in chloroform-d were facilitated 
by the corresponding HMQC and HMBC spectra. The protons nearest to the dimethylamide 
group were more downfield (location no. 26, 4.87-4.71 ppm in chloroform-d) in comparison to 
the protons closer to the methylamide group (location no. 9, 4.55-4.47 ppm in chloroform-d), as 
 82 
expected. The exact assignments in toluene-d8 were less clear due to overlap of the multiplets; an 
HMBC spectrum in toluene-d8 would be useful for the future.  
 An expansion of the TOCSY 2D NMR spectrum is displayed in Figure 22. The two 
amide protons, seen along the x-axis, have two large broad singlets each, corresponding to the 
two major conformers 44a and 44b. The small broad singlet corresponds to minor conformer 
44c, which arises from an additional rotation around the N-CO bond.  
 
 
Figure 22. Expansion of TOCSY NMR spectrum in chloroform-d at room temperature 
(700 MHz). The expansion shows the correlation of the two amide protons with their 
respective neighbors, which was necessary for assignment. 
 
 
 Comparison 
1
H NMR studies were performed in chloroform-d and toluene-d8 as the 
solvents of choice. In similar fashion to the investigations of initial torsion balances 1 and 2, 
target 44 displayed interesting upfield chemical shifts and a unique spreading-out of various N-
methyl peaks. The N-dimethyl peaks (location no. 28) for example, depicted by four singlets, 
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were spread between the range of 2.55 to 1.95 ppm in toluene-d8, compared with the smaller 
range in chloroform-d of 2.95-2.92 ppm. The comparison of these 
1
H NMR spectra is shown in 
Figure 23. These data reveal that hydrogen bonding with either the secondary or tertiary amide 
functional group can be heavily influenced by solvation, and that both groups have the ability to 
form intramolecular hydrogen bonds with the glycine moiety. 
 
 
Figure 23. Expansion of 
1
H NMR spectra comparison of target 44 in chloroform-d (top) 
and toluene-d8 (bottom) (700 MHz). The N-methyl peaks display the largest changes in 
chemical shift over a range of 2 ppm. 
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 High temperature 
1
H NMR studies were performed in toluene-d8, ranging from room 
temperature (303 K) to 343 K; these studies are shown in Figure 24.  
 
 
Figure 24. High temperature 
1
H NMR studies performed in toluene-d8 (700 MHz). The 
increase in temperature to 343 K shows a complete coalescence of the four N-dimethyl 
peaks, while the other N-methyl peaks showed less broadening and coalescence, if any. 
 
 
There was a distinct coalescence of the four N-dimethyl peaks, while the other N-methyl peaks 
showed much less broadening and coalescence, if any. This coalescence demonstrates that there 
is fast rotation occurring around the neighboring amide bond of the N-dimethyl moiety, which is 
expected because we previously observed barriers of such N-CO bonds approximately to be 17 
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kcal mol
-1
. However, the N-methyl (location no. 12) peaks do not show very much coalescence, 
most likely due to the N-methyl moiety forming intramolecular hydrogen bonds with the 
protected glycine chain, and therefore raising the barrier. An HMQC spectrum (not shown) was 
also obtained at 343 K, which depicted the disappearance of only the four N-dimethyl peaks.  
 The identification of exchangeable protons was also of interest in the advanced torsion 
balance targets. A small sample of amide 44 was dissolved in chloroform-d with a single drop of 
neutral pH deuterated water (D2O). The sample was sonicated for five minutes at room 
temperature; the 
1
H NMR spectrum acquired revealed no change. Then sonication was 
performed for 1 h at room temperature, after which a 
1
H NMR spectrum was obtained (shown in 
Figure 25); it was observed that both amide protons (with two broad singlets each) were readily 
exchanged. Therefore, these results revealed that both protons of interest were somewhat 
accessible to solvent, mimicking protons that are slightly buried in a protein instead of residing 
completely on the surface. Both protons most likely can participate in intramolecular hydrogen 
bonding that would be observed in a β-sheet motif secondary structure. 
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Figure 25. Expansion of 
1
H NMR spectra (400 MHz) depicting "before and after" exchange 
with deuterated water at 298 K. After sonication of the NMR sample for 1 h with D2O, all 
of the amide protons (between 6.6 and 5.9 ppm) had disappeared almost completely. 
 
 
 Low temperature 
1
H NMR studies were also performed to determine if any expected 
intramolecular hydrogen bonding was occurring. According to the procedure of Gellman and 
coworkers,
65
 a negative-slope trend ranging from 213 K to 273 K illustrates the presence of 
hydrogen bonding. Chemical shifts for the amide proton peaks in CD2Cl2 were graphed to show 
small or negligible intramolecular hydrogen bonding; the two amide protons (location nos. 11 
and 23) have two peaks each, corresponding to the two major conformers 44a and 44b. These 
trends can be seen in Figure 26. In accordance with the deuterium exchange study, the data 
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indicate that there is some hydrogen bonding occurring between the glycine moiety and one of 
the amide carbonyls, but that the interaction may be weaker than expected. The secondmost 
upfield amide proton peak exhibits different behavior which could suggest that this amide proton 
is in a particular conformation that acts most like a proton on the surface of a protein.  
 
  
Figure 26. Low temperature 
1
H NMR studies (methylene chloride-d2, 400 MHz) were 
performed on target 44 to probe for intramolecular hydrogen bonding. The two amide 
protons were studied (location nos. 11 and 23; each amide proton has two 
1
H NMR peaks, 
corresponding to the two major conformers 44a and 44b). A small trend in negative slope 
was observed that represents the occurrence of intramolecular hydrogen bonding; 
however, the secondmost upfield amide peak shows negligible hydrogen bonding. 
5.2 ASSIGNMENTS OF TARGETS 47, 48, AND PRECURSOR 49 
Amide 47 was designed to test the possibility that an amino acid chain may in our model 
hydrogen bond more strongly when there are one or two sites for hydrogen bonding in a chain; 
amide 48 would test the partiality of an amino acid chain to form hydrogen bonds more strongly 
with an alanine or leucine side chain. Each of these two targets were asymmetrical and therefore 
had four diastereomers; as discussed previously, attempts to separate each diastereomer were 
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unsuccessful. However, assignments of the 
1
H and 
13
C NMR spectra peaks to each moiety in 
each balance was accomplished. The four diastereomers of targets 47 and 48 are illustrated in 
Schemes 46 and 47, respectively.  
 
Scheme 46. Four diastereomers of target 47. 
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Scheme 47. Four diastereomers of target 48. 
 
 
 
In addition, Figure 27 shows the allocation of signals to atom location, and Table 5 (5A and 5B 
for balance 47 and 48, respectively) displays the assignments of both targets in order to showcase 
their similarities.  
 
            
Figure 27. Representation of balances 47 (left) and 48 (right) with numbering of atom 
location (hydrogen or carbon) for structure assignment. 
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Table 5. Target 47 (5A, left) and 48 (5B, right) 
1
H and 
13
C NMR assignments (700 MHz) in 
MeOD-d4. 
 
No. 1H, ppm, MeOD 13C, ppm 
 
No. 1H, ppm, MeOD 13C, ppm 
1 -- 166.0 
 
1 -- 167.0 
2 3.97 (singlets, 3H) 51.0 
 
2 3.96 (singlets, 3H) 52.0 
3 -- 131.0 
 
3 -- 131.0 
4 7.44-7.45 (singlets, 1H) 107.0 
 
4 7.43-7.43 (singlets, 1H) 107.0 
5 7.44-7.45 (singlets, 1H) 107.0 
 
5 7.43-7.43 (singlets, 1H) 107.0 
6 -- 124.0 
 
6 -- 123.0 
7 -- 124.0 
 
7 -- 123.0 
8 -- 156.0 
 
8 -- 156.0 
9 4.66-4.58 (m, 2H) 67.0 
 
9 4.69-4.52 (m, 2H) 67.0 
10 -- 168.0 
 
10 -- 168.0 
11 4.42-4.36 (m, 1H) 49.0 
 
11 4.39-4.37 (m, 1H) 48.0 
12 1.38-1.36 (m, 3H) 17.0 
 
12 1.38-1.37 (m, 3H) 17.0 
13 -- 173.0 
 
13 -- 172.0 
14 2.74-2.69 (singlets, 3H) 25.0 
 
14 2.74-2.69 (singlets, 3H) 25.0 
15 -- 127.0 
 
15 -- 127.0 
16 7.47-7.35 (m, 1H) 127.0 
 
16 7.48-7.36 (m, 1H) 127.0 
17 -- 135.0 
 
17 -- 136.0 
18 7.47-7.35 (m, 1H) 127.0 
 
18 7.48-7.36 (m, 1H) 127.0 
19 -- 141.0 
 
19 -- 141.0 
20 7.47-7.35 (m, 1H) 131.0 
 
20 7.48-7.36 (m, 1H) 130.0 
21 2.06-2.05 (singlets, 3H) 13.0 
 
21 2.07-2.05 (singlets, 3H) 14.0 
22 3.29-3.26 (singlets, 3H) 35.0 
 
22 3.29-3.27 (singlets, 3H) 34.0 
23 -- 169.0 
 
23 -- 169.0 
24 3.68-3.60 (m, 2H) 41.0 
 
24 3.70-3.55 (m, 2H) 42.0 
25 -- 173.0 
 
25 -- 172.0 
26 4.35-4.28 (m, 1H) 48.0 
 
26 4.36-4.28 (m, 1H) 48.0 
27 1.24-1.21 (m, 3H) 17.0 
 
27 1.24-1.20  (m, 3H) 18.0 
28 -- 171.0 
 
28 -- 172.0 
29 2.00-1.99 (singlets, 3H) 21.0 
 
29 2.06-2.00 (singlets, 3H) 22.0 
30 4.57-4.50 (m, 2H) 68.0 
 
30 4.69-4.52 (m, 2H) 67.0 
31 -- 168.0 
 
31 -- 167.0 
32 2.71-2.66 (singlets, 3H) 25.0 
 
32 4.39-4.37 (m, 1H) 52.0 
    
33 1.55-1.46 (m, 2H) 42.0 
    
34 1.41-1.37 (app m, 1H) 24.0 
    
35 0.93-0.84 (m, 6H) 23.0 
    
36 -- 173.0 
    
37 2.74-2.69 (singlets, 3H) 25.0 
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The aromatic proton peaks of 47, 48, and also 49 (shown later), were difficult to assign 
because of the overlap observed in their 
1
H, COSY, ROESY, HMQC, and HMBC NMR spectra; 
therefore their 
1
H assignments are listed as part of an aromatic multiplet or could not be assigned 
(not determined, "nd"). The multiplets of the diastereotopic ortho-methylene protons of 47 did 
not overlap (location nos. 9 and 30, at 4.66-4.58 ppm and 4.57-4.50 ppm, respectively in 
methanol-d4) and were therefore easier to assign (in comparison to those of 48 and 49). The 
ortho-methylene protons nearest to the alanine group (location no. 9) are more downfield most 
likely because there are two amide functionalities nearby, compared to location no. 30 which 
only has one adjacent amide. Due to each compound having four conformers (or two for the 
HPLC-separated conformer pairs of 49), and therefore many 
13
C peaks corresponding to each 
carbon atom, the 
13
C values are given as a single average value based upon the combined 
HMQC, HMBC and 
13
C NMR analyses; it has not been determined which individual 
13
C peak 
belongs to a specific diastereomer. In addition, only 
1
H and ROESY NMR spectral data were 
obtained for the conformer pairs of acid 49, in the interest of viewing any difference in splitting 
patterns or chemical shift of the diastereotopic protons. A ROESY NMR spectrum was obtained 
of 48 in CD3CN but did not provide any new information about any intramolecular hydrogen 
bonding or any new NOEs; however, the leucine methine (location no. 34) was more obvious as 
a multiplet at 1.30 ppm. 
A low temperature 
1
H NMR experiment was performed on 48 in similar fashion to 
balance 44, in order to determine if any hydrogen bonding could be observed. This experiment, 
also obtained in CD2Cl2, was not as successful; the presence of six amide protons in the 
1
H NMR 
spectrum provided much overlap which did not allow for many distinct chemical shifts. A J-
resolved 2D NMR experiment was next performed on balance 48 in CD2Cl2, shown in Figure 28, 
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which gave a projection of the 
1
H NMR spectrum and allowed for identification of any J-coupled 
protons.  The resulting spectrum showed the collapse of all six amide proton peaks, in addition to 
the glycine methylene and all alanine methine peaks. Although all of the amide proton peaks 
were decoupled, there was less overlap of the remaining peaks for identification.   
 
 
Figure 28. A J-resolution 2D NMR experiment (methylene chloride-d2, 700 MHz) was 
performed on target 48; the projected 1D NMR can be seen at the top, illustrating the 
collapse (disappearance) of all amide protons, glycine methylene protons, and alanine 
methine peaks. 
 
 
 
The conformers of precursor acid 49, shown in Scheme 49, could be assigned to their 
1
H 
and 
13
C NMR peaks; however, no absolute assignment for each individual diastereomer could be 
made. The separate data of these conformer pairs is shown in Table 6 and is accompanied by the 
allocation of signals to atom location, shown in Figure 29. 
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Scheme 48. Four diastereomers of precursor acid 49. 
 
 
 
 
 
 
Figure 29. Representation of balance 49 with numbering of atom location (hydrogen or 
carbon) for structure assignment. 
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Table 6. Precursor acid 49 
1
H NMR assignments (400 MHz) in MeOD-d4 of HPLC-
separated conformer pairs. 
 
No. 1H, ppm, MeOD, 13 min elution 1H, ppm, MeOD, 15 min elution 
1 -- -- 
2 3.96 (s, 3H) 3.96 (s, 3H) 
3 -- -- 
4 nd (aromatic 1H) nd (aromatic 1H) 
5 nd (aromatic 1H) nd (aromatic 1H) 
6 -- -- 
7 -- -- 
8 -- -- 
9 4.72-4.49 (singlets, ABq, 2H) 4.70-4.59 (singlets, 2H) 
10 -- -- 
11 4.40 (quintet, 1H) 4.39 (q, 1H) 
12 1.38 (dd, 3H) 1.37 (dd, 3H) 
13 -- -- 
14 2.74, 2.73 (two s, 3H) 2.70, 2.68 (two s, 3H) 
15 -- -- 
16 7.45-7.33 (m, 1H) 7.43-7.31 (m, 1H) 
17 -- -- 
18 7.45-7.33 (m, 1H) 7.43-7.31 (m, 1H) 
19 -- -- 
20 7.45-7.33 (m, 1H) 7.43-7.31 (m, 1H) 
21 2.06 (s, 3H) 2.08, 2.06 (two s, 3H) 
22 3.28, 3.26 (two s, 3H) 3.30, 3.26 (two s, 3H) 
23 -- -- 
24 3.73-3.55 (m, 2H) 3.77-3.57 (m, 2H) 
25 -- -- 
26 4.33-4.25 (m, 1H) 4.35-4.29 (m, 1H) 
27 1.22, 1.20 (two d, 3H) 1.28, 1.23 (two d, 3H) 
28 -- -- 
29 2.01, 2.00 (two s, 3H) 2.01, 2.00 (two s, 3H) 
30 4.72-4.49 (singlets, ABq, 2H) 4.70-4.59 (singlets, 2H) 
31 -- -- 
 
 
A ROESY NMR spectrum was obtained for precursor 49 in CD3CN at 343 K; however, 
no EXSY crosspeaks were observed (two mixing times, 0.2 s and 0.1 s, were used to confirm this 
observation). ROESYs at room temperature in CD3CN for both sets of diastereomers revealed 
 95 
better crosspeaks, in the same fashion as for 47 and 48 (ROESY NMR spectra are available in 
the Appendix), and were used in the assignments. 
5.3 ASSIGNMENT OF AMIDE TARGET 50 
Amide 50, shown in Scheme 50, was designed to test the preference of an amino acid 
chain to hydrogen bond when a restrictive steric effect is involved (a potentially negative 
interaction between the methyl of an alanine and a neighboring aryl methyl group). Due to the 
presence of a symmetrical element in this torsion balance, assignments of the 
1
H and 
13
C NMR 
data were easier. The atom locations and assignments are given in both Figure 30 and Table 7. 
The ROESY NMR spectrum obtained showed various crosspeaks; however, it was difficult to 
pinpoint a particular NOE that would strongly suggest one (preferred) set of intramolecular 
hydrogen bonds over its symmetrical counterpart. 
 
Scheme 49. Conformers of target 50. 
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Figure 30. Representation of balance 50 with numbering of atom location (hydrogen or 
carbon) for structure assignment. 
 
Table 7. Target 50 
1
H and 
13
C NMR assignments (700 MHz) in MeOD-d4. 
 
No. 1H, ppm, MeOD 13C, ppm 
1 -- 166.0 
2 3.97, 3.96 (singlets, 3H) 52.0 
3 -- 134.0 
4 7.44-7.43 (singlets, 2H) 107.0 
5 -- 124.0 
6 -- 156.0 
7 4.63-4.48 (m, 4H) 68.0 
8 -- 169.0 
9 4.35-4.30 (m, 2H) 48.0 
10 1.38-1.11 (doublets, m, 6H) 18.0 
11 -- 173.0 
12 2.77-2.70 (singlets, 6H) 26.0 
13 -- 128.0 
14 7.44-7.35 (m, 1H) 130.0 
15 -- 136.0 
16 7.44-7.35 (m, 1H) 130.0 
17 -- 142.0 
18 7.44-7.35 (m, 1H) 132.0 
19 2.07-2.04 (singlets, 3H) 14.0 
20 3.50-3.23 (singlets, 3H) 38.0 
21 -- 174.0 
22 4.35-4.30 (m, 1H) 50.0 
23 1.38-1.11 (doublets, m, 3H) 18.0 
24 -- 168.0 
25 4.35-4.30 (m, 1H) 50.0 
26 1.38-1.11 (doublets, m, 3H) 18.0 
27 -- 172.0 
28 2.00-1.96 (singlets, 3H) 21.0 
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5.4 ASSIGNMENT OF AMIDE ZWITTERION TARGET 51 
Amide zwitterion 51 was designed to test the effect of salt-bridging between ammonium 
and carboxylate moieties of amino acid chains on the rate of rotation around the N-aryl bond. 
This torsion balance, shown in Scheme 51, is also symmetrical but has the additional ability to 
form salt-bridges. The atom locations and assignments of the 
1
H and 
13
C NMR data are given in 
both Figure 31 and Table 8. The ROESY obtained for 51 was similar in appearance and 
complexity to that of amide 50. 
 
Scheme 50. Conformers of target 51. 
 
 
 
 
Figure 31. Representation of balance 51 with numbering of atom location (hydrogen or 
carbon) for structure assignment. 
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Table 8. Target 51 
1
H and 
13
C NMR assignments (700 MHz) in MeOD-d4. 
 
No. 1H, ppm, MeOD 13C, ppm 
1 -- 167.0 
2 3.98-3.97 (two s, 3H) 51.0 
3 -- 133.0 
4 7.47-7.46 (two s, 2H) 107.0 
5 -- 123.0 
6 -- 156.0 
7 4.64-4.51 (m, 4H) 67.0 
8 -- 167.0 
9 4.39, 4.27 (two quintets, 2H) 
47.0, 
48.0 
10 1.33-1.28 (m, 6H) 18.0 
11 -- 175.0 
12 -- 127.0 
13 7.46-7.44 (m, 1H) 129.0 
14 -- 135.0 
15 7.39-7.35 (m, 1H) 129.0 
16 -- 142.0 
17 7.39-7.35 (m, 1H) 132.0 
18 2.07, 2.06 (two s, 3H) 13.0 
19 3.29, 3.27 (two s, 3H) 36.0 
20 -- 168.0 
21 3.73-3.66 (m, 2H) 42.0 
22 -- 169.0 
23 3.98-3.97 (m, 1H) 52.0 
24 1.53-1.52 (dd, 3H) 27.0 
 
5.5 ANALYSIS OF ZWITTERION TARGETS 52 AND 53 
 Zwitterion targets 52 and 53 would test the effect of salt-bridging between an amino acid 
ammonium and a simple carboxylate moiety on the rate of rotation around the N-aryl bond. 
These targets were designed as simple tools to investigate phenomena observed, for example, in 
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thermophilic proteins,
66
 where the presence of salt-bridges contribute to their stability and to a 
particular organism's overall ability to survive abnormal temperature conditions. These 
aforementioned targets and their corresponding control compounds are shown in Scheme 52 and 
Scheme 53. Each target has either one alanine or one glycine, and the controls are capped with 
an acyl group to subdue any potential hydrogen bonding with the ammonium moiety. 
 
Scheme 51. Alanine zwitterion 52 and corresponding control 54. 
 
 
 
Scheme 52. Glycine zwitterion 53 and corresponding control 55. 
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5.5.1 Evaluation of Zwitterion Dynamics and Rates 
 We observed interesting conformational dynamics of zwitterions 52 and 53 via 
1
H NMR 
analysis, more so for alanine zwitterion 52. At room temperature, the spectra for 52 showed four 
conformations, while 53 had two (as expected). Target 52 exhibited clear signals (in deuterated 
methanol) for the alanine methyl group, with two large doublets corresponding to the two major 
conformers, and two small downfield doublets for the minor rotamers. Therefore, variable 
temperature 
1
H NMR studies, ranging from room temperature to 373 K (25 to 100 °C), were 
performed on 52 and its control 54 in different pD buffers (pD's 2.8, 6.9 and 9.4) to investigate 
any effects that pH may have on dynamics. The charged structures of alanine zwitterion 52 in 
different buffers are depicted in Figure 32; control 54 was only subjected to pD 6.9 buffer due to 
the presence of the added acyl group. The 
1
H NMR spectra results are shown in Figure 33, with 
corresponding integration values listed in Table 9. 
 
 
Figure 32. Structures of alanine zwitterion 52 in different pD buffers. 
 
In comparing the 
1
H variable temperature spectra of 52 and 54, we could see signal 
broadening for all alanine methyl peaks at 373 K in comparison to those at room temperature; in 
addition, all high temperature spectra showed chemical shifts that were more than 0.5 ppm 
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downfield from the room temperature data. There was no coalescence of the major conformer 
peaks, which is compatible with our expectation of a higher barrier for the N-aryl rotation; 
coalescence of the minor conformer peaks was more evident and is also on par with our 
expectation that rotation around the N-CO bond has a lower rotational barrier (estimated to be 17 
kcal∙mol-1 at 298 K, from our previous work). 
 
 
Figure 33. Variable temperature and buffer 
1
H NMR spectra (600 MHz) of alanine            
α-methyl protons of zwitterion 52 in three pD buffers 2.8, 6.9, and 9.4 (left), and control 54 
only in pD buffer 6.9 (right). Both compounds were subjected to either room temperature 
or 373 K and all showed chemical shift changes and peak broadening.  
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 The integrations of all downfield major conformer peaks are all larger and similar in 
value in comparison with their upfield counterparts (Table 9), whether at 373 K or room 
temperature, which shows the prevalence of salt bridging throughout the experiment. However, 
the noticeable downfield chemical shifts around 2.0 ppm at 373 K and larger integration values 
of the more downfield peaks (i.e. 0.661 vs. 0.588 for pD 9.4) could suggest that at higher 
temperatures, the zwitterion molecule has an even higher tendency to form salt bridges and is 
therefore more thermodynamically stable. Even the control compound 54 displayed similar salt 
bridge trends with the presence of the acyl group. The data for pD 2.8 at 373 K appears 
contradictory because while the chemical shifts are more downfield than the others, the 
integration of the downfield peak (1.00) is slightly less than the upfield peak (1.04). Also, 
additional methyl doublets were observed in all of these 
1
H spectra in D2O buffer (however, not 
in MeOD-d4, not shown) at room temperature; these peaks were investigated and will be 
discussed later. 
 
Table 9. Integration ratios of alanine α-methyl major conformer peaks for zwitterion 52 
and control 54, corresponding to Figure 32 (listed in "upfield/downfield" format). 
 
 
       Zwitterion 52          Control 54 
pD 373K rt 373K rt 
2.8 1.04/1.0 0.773/1.0 
  6.9 0.862/1.0 0.785/1.0 0.924/1.0 0.78/1.0 
9.4 0.661/1.0 0.588/1.0     
 
 
 Zwitterion 52 was also compared to amide zwitterion 51 in order to ascertain any 
similarities in dynamics. High temperature NOESYs were obtained for 52 in either buffer pD 6.9 
or CD3CN, and high temperature ROESYs were obtained for 51 in either buffer pD 6.9 or 
CD3CN; these data, focusing on crosspeaks of interest, are displayed in Figure 34. 
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Figure 34. EXSY analyses were performed on alanine zwitterion 52 and amide zwitterion 
51 to obtain rate calculations. The alanine α-methyl protons of 52 were examined using 
NOESYs (600 MHz, 1.4 s mixing time) in (A) D2O buffer 6.9 at 373 K and (B) CD3CN at 
343 K. The glycine protons of 51 (highlighted in boxes) were examined using ROESYs (600 
MHz, 0.2 s mixing time) in (C) D2O buffer 6.9 at 343 K and (D) CD3CN at 343 K.  
 
Using EXSY analysis, the rates for 52 were calculated to be 22.6 kcal∙mol-1 at 373 K in 
D2O buffer pD 6.9 and 19.7 kcal∙mol
-1
 at 343 K in CD3CN, and the rate for 51 was calculated to 
A B 
C D 
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be 18.6 kcal∙mol-1 at 343 K in CD3CN. The corresponding rate in the buffer solution could not be 
determined because there was interference from regular NOEs present with the exchange 
crosspeaks; in the future, a method to saturate the NMR sample with oxygen gas may aid in 
removing all unwanted NOE peaks from the experiment. It is interesting to note that the rate in 
water is much higher, which may be due to solvation effects where the water molecules readily 
interact with the charged moieties of the zwitterion compound. 
5.5.2 Observation of an Alanine Zwitterion Dimer 
 As previously mentioned, there were unexpected doublets present with the alanine α-
methyl peaks in our buffer experiments with zwitterion 52. Examination of this compound via 
low resolution mass spectrometry (LRMS) showed a surprising mass at twice the value of the 
regular molecular weight. Although these peaks were not visible in methanol, LRMS data 
(depicted in Figures 35 and 36) showed this doubled-mass value when the compound was 
dissolved in either neutral water, buffer pH 4.0, or methanol. Therefore, we surmised that there 
must be a dimer present (along with the monomer) for zwitterion 52. Similar data (not shown) 
for glycine zwitterion 53 was obtained and also displayed the doubled value in molecular weight. 
Zwitterion 52 was also dissolved in deuterated DMSO — DMSO is known to disrupt 
intramolecular hydrogen bonding — however, there was little difference observed with the extra 
doublets via 
1
H NMR examination. 
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Figure 35. ESI negative ion mode LRMS of zwitterion 52 in methanol, directly injected into 
the source of the mass spectrometry instrument. The peaks of interest showing the 
monomer and dimer are highlighted at masses of 473.0581 and 947.2698, respectively. 
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Figure 36. ESI negative ion mode LRMS of 52 in water. The peaks of interest showing the 
monomer and dimer are highlighed at masses of 473 and 948, respectively. The ESI positive 
ion mode LRMS, not shown, also displayed monomer and dimer peak masses. 
 
The formation of the dimer is not completely understood; however, some of the data suggest that 
strong hydrophobic interactions may be a cause. The zwitterion is small and compact enough 
where the charged moieties strongly attract another zwitterion and prohibit any water molecules 
from interfering; also, the torsion balance's aryl backbone may be a factor. A possible depiction 
of the alanine zwitterion 52 dimer, with electrostatic interactions highlighted, is shown in Figure 
37. The zwitterion compounds were either gels or foams, and so x-ray crystallography could not 
be used to confirm or refute our hypothesis. 
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Figure 37. MOE illustration of the electrostatic map of alanine zwitterion 52, depicting a 
possible dimer based upon hydrophobic interactions. 
 
 
 Another control was synthesized with no unprotected amino acid coupled to the o-tolyl 
amine moiety; this synthesis occurred by deprotection of biaryl amine 58 with TFA
46
 to give acid 
90 in quantitative yield; this acid is depicted in Scheme 53. This acid 90 was designed to observe 
if dimer would be present if carboxylates alone were present in the balance scaffold; it was 
determined that no dimer had formed because 
1
H and NOESY NMR analyses did not show any 
additional proton peaks or any NOEs.  
 
Scheme 53. Synthesis of control acid 90. 
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5.6 ANALYSIS OF CORE TARGET 
 The fourth torsion balance type, biaryl amine 59, would be used as a core tool for either 
solution- or solid-phase peptide synthesis with the presence of a tert-butyl aryl ester moiety. 
Ideally, the enantiomers of this balance 59 would have been separated by traditional methods 
(HPLC, salting-out by crystal formation) in order to lend additional information to the absolute 
configuration assignments of the other targets; either the x-ray crystallography or vibrational 
circular dichroism (VCD) techniques could have been employed on a pure enantiomer to 
determine whether it had an R or S stereochemistry.  However, our resolution attempts were 
unsuccessful, and we were not able to obtain pure enantiomers of 59. 
 The balance 59 in its racemic form was analyzed by 2D NMR techniques to determine as 
much about the structure as possible. The HMBC and HMQC were the most helpful, because we 
were able to utilize these spectra to assign the diastereotopic o-methylene groups. These groups 
are shown in Scheme 54 and are denoted as a, a', b and b'. 
 
Scheme 54. Diastereotopic o-methylene groups of interest in target 59. 
 
 
 
The 2D crosspeaks of the o-methylenes are highlighted in Figure 38. The HMQC depicted all 
three methylenes of 59 in close proximity to each other (within 1 ppm). The HMBC gave the 
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final assignment of the peak representing the o-methylene protons b and b'. These protons were 
in the same plane as the benzyl methylene and were slightly more upfield in the 
13
C axis in 
comparison to the other peak representing methylene protons a and a'. Therefore, the peak at 4.68 
ppm represents the protons b and b', and the peak at 4.60 ppm represents the protons a and a'.        
       
Figure 38. HMQC (left) and HMBC expansion (right) of target 59 (acetonitrile-d3, 700 
MHz), with focus on the o-methylenes and also the adjacent benzyl methylene. The HMBC 
shows the o-methylene protons b and b' at 4.68 ppm in alignment with the benzyl 
methylene protons at 5.16 ppm; both are highlighted by boxes. 
 
 
 
 
 
 
 
 
 
 
 110 
5.7 CONCLUSION, AND FUTURE WORK 
 It is widely known that the most stabilizing interactions in protein folding are hydrogen 
bonds and salt bridges. Out of all of the secondary structures, the β-sheet is the least understood, 
especially pertaining to their stabilizing interactions and their folding preferences (parallel versus 
antiparallel). Therefore, a hybrid synthetic-natural peptide motif, combining an o,o,o’-
trisubstituted biphenyl with an (ortho-tolyl)-amide, was synthesized in multiple formats and 
studied by NMR to probe the effects of amino acid substitutions on antiparallel beta-sheet 
configuration and stability. 
 The potential of this “molecular torsion balance” as a beta-turn mimic was demonstrated 
by quantifying the rotational barriers about several axes. The free-energy rotational barrier of the 
aryl-aryl bond was found to be 35.7 kcal mol
-1
 at 418 K in hexanes.  EXSY analysis was also 
used to measure barriers about the N-aryl (20.9 kcal mol
-1
 at 343 K in toluene-d8) and N-CO 
bonds (17.2 kcal mol
-1
 at 298 K in chloroform-d). The N-aryl barriers of a zwitterionic torsion 
balance containing a single alanine residue (19.7 kcal mol
-1
 in acetonitrile-d3 at 343 K, and 22.6 
kcal mol
-1
 in deuterated buffer pD 6.9 at 373 K) showed that rotation about this bond is slower in 
water, most likely due to the propensity of water to form hydrogen bonds with the charged 
moieties participating in a salt bridge.  
Torsion balances were used to study intramolecular hydrogen bond preference by 
analyzing 
1
H NMR peak data. An amino acid chain (a single alanine or glycine residue) was 
found to preferably hydrogen bond with an amide versus an ester carbonyl (1.4:1.0 at 298 K in 
toluene-d8), and with a secondary amide versus a tertiary amide carbonyl (observation of tertiary 
amide proton coalescence via variable temperature NMR, from 303 K to 343 K, in toluene-d8).  
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The overall findings suggest that this hybrid torsion balance is a valuable tool that can 
provide data on conformational dynamics and can examine hydrogen bond and salt bridge 
interactions of an antiparallel β-sheet scaffold.  
In the future, it is of great interest to investigate and obtain as many absolute structural 
assignments of the advanced torsion balance targets as possible. Separation of the enantiomers 
59-S and 59-R would allow for specific stereochemistry and therefore more enhanced proton 
assignment; also, generating a larger quantity of the separated conformers of precursor acid 49 
would allow for the synthesis of conformationally pure advanced targets 47 and 48, which could 
also be used to obtain folding ratios and preferences.  
It would be wise to further analyze the torsion balance scaffold first by using CD 
spectroscopy. The balance would need at least two intramolecular hydrogen bonds (i.e. target 48) 
for analysis with the CD spectrometer. This experiment would tell us if the scaffold was actually 
in the β-sheet conformation, compared with α-helix or random-coil conformations. Another 
experiment would involve selective bromination of the “top” aromatic ring, shown in Scheme 
55. It is of interest to know if the o-methylene ether side chains are aligned properly to promote 
hydrogen bonding (at 90
o
, relative to the plane of the aromatic ring). Modeling suggests that 90
o
 
is the best angle to provide alignment. We propose incorporation of bromine atoms ortho- to the 
aryl methyl ether and o-methylenes to see if additional intramolecular hydrogen bonding is 
occurring between the amino acids of the torsion balance (observed by NOESY or ROESY NMR 
analyses).  
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Scheme 55. Scaffold of torsion balance with proposed bromine incorporation. 
 
 
 
Adding another three amino acids to the balance scaffold would allow for three hydrogen bonds 
to be made, which would allow for a solidification of the β-sheet alignment and provide 
additional stability. In addition, charged amino acid side chains (i.e. Arg, Glu) should be 
considered for torsion balance studies in order to answer more questions regarding salt bridges: 
what is the likelihood of the charged side chains forming a salt bridge, and would the β-sheet 
conformation be conserved? If the termini of the amino acid chains are already charged (i.e. 
amide zwitterion 51), would one or more salt bridges arise? The pH studies should also be 
expanded upon; one experiment of interest would be to generate a pD buffer of even greater 
acidity than was previously used in this work (used here was pD 2.8, therefore a value of at least 
2.0 would be desired), in order to assure that the zwitterion targets truly had two carboxylic acid 
moieties instead of carboxylates.  
 A new related target could be created that would measure the preference of a β-strand to 
form a hydrogen bond or a salt-bridge; an example of a small balance is shown in Scheme 56. 
This balance and the others previously mentioned would enhance and expand upon the database 
available about β-sheet conformational dynamics and preferences for hydrogen bond and salt 
bridge formations. 
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Scheme 56. Torsion balance to measure preference of hydrogen bond over salt-bridge. 
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6.0  EXPERIMENTAL 
Supporting Information: All 
1
H and 
13
C NMR spectra were recorded on a 300, 400, 500, 600, 
or 700 MHz spectrometer (Bruker Avance). The chemical shifts are given in parts per million 
(ppm) on the delta scale (δ), and the coupling constant values (J) are in hertz. Chemical shifts 
were referenced to TMS (
1
H) or solvent (
13
C). Abbreviations for NMR data assignments
67
 are as 
follows: (s) singlet, (d) doublet, (t) triplet, (q) quartet, (dd) doublet of doublets, (dt) doublet of 
triplets, (dq) doublet of quartets, (tt) triplet of triplets, (m) multiplet, (br) broad, (app) apparent, 
and (ABq) AB quartet. All NMR spectra were obtained at room temperature (20–27 °C) unless 
otherwise noted.  
 High and low resolution mass spectra were recorded on a VG 7070 spectrometer. IR 
spectra were collected on an Avatar 380 Nicolet FT-IR spectrometer. Samples for IR were 
prepared as a thin film on a NaCl plate by dissolving the sample in CH2Cl2 and evaporating the 
CH2Cl2. Melting points were determined using a Mel-Temp apparatus and are uncorrected. 
Optical rotations were measured on a Perkin-Elmer 241 polarimeter at the Na D-line (λ = 589 
nm) using a 1-dm cell at 25 °C and CHCl3 or MeOH as the solvent unless noted otherwise. 
 Analytical chiral normal phase HPLC analysis was conducted using either an (S,S)-
Whelk-O 1 column (Pirkle, 250 mm x 4.6 mm ID) or a Chiralcel OD column (Daicel, 250 mm x 
4.6 mm ID) typically eluting with hexanes:i-PrOH at 1.0 mL/min, 10 μg per injection. 
Preparatory chiral normal phase HPLC resolutions were performed on either an an (S,S)-Whelk-
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O 1 column (Pirkle, 25 mm x 21.1 mm ID) or a Chiralcel OD column (Daicel, 250 mm x 20.0 
mm ID) typically eluting with hexanes:i-PrOH at 10.0 mL/min, 20 μg per injection. All HPLC 
injections were monitored with a Waters model 440 UV detector at wavelength 254 nm, when 
the solvent system was hexanes:i-PrOH.  
 Analytical reverse phase HPLC analysis was conducted using a Luna 5u C18(2) 100 Å 
column (Phenomenex, 250 mm x 4.6 mm ID) typically eluting with H2O (0.1% TFA):CH3CN 
(0.1% TFA) at 1.0 mL/min, 1-2 μg per injection. Preparatory reverse phase HPLC resolutions 
were performed on a Luna 10u C18(2) 100 Å column (Phenomenex, 250 mm x 21.2 mm ID) 
typically eluting with H2O (0.1% TFA):CH3CN (0.1% TFA) at 10.0 mL/min, 10 μg per 
injection. All HPLC injections were monitored with either a Hitachi Elite LaChrom UV detector 
model L-2400 or diode array detector model L-2455 at wavelengths 226 nm and 254 nm, when 
the solvent system was H2O (0.1% TFA):CH3CN (0.1% TFA).  
 Line-shape and EXSY analyses were performed using the iNMR lineshape analysis 
software.
35, 36, 69
 NMR simulations were conducted on the tert-butyl protons of carbamates 13 
and 17, the diastereotopic glycine methylene and alanine α-methyl protons of amides 29-30, and 
the diastereotopic o-methylene protons of biaryl amine 3. The simulated spectra were overlaid 
with the experimental spectra and were used to determine conformer ratios and rotational 
barriers. EXSY analyses were also performed on zwitterions 51-53 and control 54. The cross 
peaks and diagonal peaks of either the diastereotopic glycine methylene protons or the alanine α-
methyl protons were integrated and used to calculate rotational barriers.  
 Thin-layer chromatography (TLC) was performed using silica gel analytical glass plates 
(Merck, 60F-254, 0.25 mm). Light absorption by compounds was observed using ultraviolet light 
(254 nm). Columns used for flash chromatography
68
 were prepared with silica gel 60 (Merck, 
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230-240 mesh ASTM). When a solvent elution gradient method was employed for flash 
chromatography, the gradient was changed upon TLC confirmation that no compound was 
eluting out. 
 Dry solvents were distilled shortly before use from an appropriate drying agent under a 
nitrogen atmosphere. Tetrahydrofuran (THF) and diethyl ether (Et2O) were distilled from sodium 
and benzophenone. CH2Cl2 was distilled from CaH2. Methanol (anhydrous) was used as 
obtained. N,N-dimethylformamide (DMF) and dimethylsulfoxide (DMSO) were purchased in 
sure-seal bottles (Acros) and used without purification. Other commercially available reagents 
and solvents were reagent grade and used without further purification. 
An oil bubbler was attached to reaction vessels in which the reactions required either the 
maintenance of a nitrogen atmosphere or the evacuation and addition of nitrogen. Ambient 
temperature and pressure for “room temperature” reactions varied between 20–27 °C and 720–
770 mmHg, respectively.  
 All percent yields reported are for compounds that have a purity of approximately 95% or 
better as determined by NMR analysis, and the compound was used for subsequent reactions 
without further purification unless otherwise noted.  
6.1 HPLC KINETIC EQUILIBRIUM EXPERIMENTAL PROCEDURE 
The enantiomers of derivative 31 were separated by chiral preparatory HPLC (using the 
Chiralcel OD column) after the analytical HPLC run (shown in Figure 9). From a racemic 
mixture of 18 mg, the first eluting enantiomer (31-FEE) was obtained in 5.4 mg (93.6% ee) with 
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a retention time of 14.7 min, and the second eluting enantiomer (31-SEE) was obtained in 7.1 
mg (90.4% ee) with a retention time of 18.4 min. 
A solution of 1.0 mg of an enantioenriched sample of 31-SEE in 1.0 mL hexanes was 
placed in a sealable thick–walled tube and heated at 145 °C (418 K) by using a Thermo-Watch 
115V and an oil bath setup. Aliquots of 10 μL were removed at 1 h or 2 h increments, with the 
exception of an overnight run, and measured using chiral analytical HPLC analysis (using the 
Chiralcel OD column and a solvent system of 95:5 hexanes:isopropanol). The % ee (shown 
below in Table 4, from 31-SEE to 31-FEE) was measured from each aliquot and plotted against 
time (10
6
 s) in order to calculate the rotational barrier, according to Lapierre
37a
 and Eliel
37b
. 
An initial trial that used a solvent system of 9:1 hexanes/isopropanol proved unsuccessful 
because additional peaks appeared in the HPLC chromatogram after a few hours had progressed 
in the experiment. 
 
Table 10. Kinetic equilibrium data for 31-SEE.       
 
    Time (s)   % ee 
0 
3900 
90.4 
86.6 
7800 85.9 
11820 84.6 
15540 84.0 
19140 83.0 
22860 81.4 
30240 80.5 
36660 78.8 
88500 64.8 
99420 61.5 
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6.2 PREPARATION OF BUFFER SOLUTIONS USED AS NMR SOLVENTS FOR 
TORSION BALANCE ANALYSES 
Preparation of Stock Solutions 
 Deuterium chloride (35% wt in D2O) was purchased from Aldrich. To a 5 mL volumetric 
flask was added 0.043 mL of the DCl solution, which was diluted to 5 mL with D2O. This stock 
solution was 0.10 M in DCl and was used to adjust the pD of the buffer solutions.
69
 
 Sodium deuteroxide (40% wt in D2O) was purchased from Cambridge Isotopes. To a 5 
mL volumetric flask was added 0.035 mL of the concentrated NaOD solution, which was diluted 
to 5 mL with D2O. This stock solution was 0.10 M in NaOD and used to adjust the pD of the 
buffer solutions.
69
 
Preparation of the 0.050 M Potassium Deuterium Phthalate Buffer 
 A solution of 2.0 g of potassium hydrogen phthalate (KHP) in 20 mL of D2O was dried 
by lyophilization. The solid was redissolved in another 20 mL portion of D2O, and the solvent 
was again removed by lyophilization. A solution of 0.1026 g of the deuterated potassium salt and 
2.2 mL of the 0.10 M DCl stock solution was diluted to 10 mL with D2O in a 10 mL volumetric 
flask. The solution was 0.050 M in phthalate and was used as an NMR solvent for the torsion 
balances. The pD of the solution was calculated as 2.8, which was determined from a reading 
taken from a glass electrode pH meter.
69
 
Preparation of the 0.050 M Deuterated Phosphate Buffer 
 A solution of 1.4196 g (0.0100 mol) of Na2HPO4 and 1.3609 g (0.0100 mol) of KH2PO4 
in 10 mL of D2O was dried by lyophilization. The solid was redissolved in another portion of 
D2O, and the solvent was again removed by lyophilization. The deuterated solid was transferred 
to a 100 mL volumetric flask and diluted to 100 mL with D2O. This stock solution was 0.200 M 
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in phosphate and diluted to 0.050 M by standard methods. The 0.050 M solution was used as an 
NMR solvent for the torsion balances. The pD of the solution was calculated as 6.9.
69
 
Preparation of the 0.050 M Deuterated Borate Buffer 
 A solution of 0.0478 g of sodium tetraborate and 0.4 mL of the 0.10 M DCl stock 
solution was diluted to 10 mL with D2O in a 10 mL volumetric flask. The solution was 0.050 M 
in borate and was used as an NMR solvent for the torsion balances. The pD of the solution was 
calculated as 9.4.
69
  
6.3 EXPERIMENTAL PROCEDURES 
 General procedure A for generating Fmoc-protected 
amino acid chlorides: To a solution of N-(9-fluorenylmethoxycarbonyl)-Xaa (1.0 equiv.) in 
CH2Cl2 (0.176 M) was added thionyl chloride (10 equiv.), and the reaction mixture was refluxed 
for 30–45 min. The solution was cooled to room temperature, and the volatile components were 
removed under reduced pressure. The residue was dissolved in minimal CH2Cl2 followed by 
hexanes to produce an off-white precipitate. The solid was filtered and dried in vacuo to afford 
the amino acid chloride product (83–90%) as an off-white solid. Amino acids (Xaa) used include 
L-alanine, glycine, and β-alanine. Only IR spectra were obtained to confirm these highly reactive 
intermediates: Fmoc-Ala-Cl 20-int (thin film, cm
-1
) 3328, 3044, 2947, 2888, 2786, 1948, 1911, 
1780, 1693, 1534, 1478, 1450, 1382, 1340, 1282, 1261, 1125, 1103, 1085, 1040, 963, 939, 903, 
875, 780, 756, 738; Fmoc-Gly-Cl 21-int (thin film, cm
-1
) 3315, 3066, 2967, 2947, 1811, 1702, 
1540, 1477, 1448, 1395, 1349, 1271, 1182, 1104, 1087, 1051, 991, 955, 919, 780, 758, 742; 
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Fmoc-β-Ala-Cl 37-int (thin film, cm-1) 3349, 3066, 2956, 2885, 1912, 1790, 1695, 1537, 1476, 
1448, 1407, 1257, 1159, 1102, 1084, 1049, 1010, 960, 776, 758, 740. 
 
Methyl 4-bromo-3,5-dihydroxybenzoate (9) To 5.0 g (21.5 mmol) of carboxylic acid 8 in 33.1 
mL of methanol was added 1.98 mL (37.1 mmol) of H2SO4 dropwise, and the reaction mixture 
was refluxed for 16 h. The reaction was quenched by addition of NaHCO3 (6.24 g, 74.3 mmol), 
and the volatile components were removed under reduced pressure. The residue was diluted with 
ethyl acetate (120 mL) and water (120 mL); the organic layer was extracted, and the aqueous 
layer was washed with additional ethyl acetate (3  120 mL). The organic layers were dried over 
MgSO4 and filtered, and the volatile components were removed under reduced pressure to give 
5.27 g (99.4%) of 9 as a white solid: Rf 0.34 (hexanes/ethyl acetate, 3:2); mp 225–227 °C; IR 
(thin film, cm
-1
) 3416, 3329, 1701, 1594, 1421, 1353, 1270, 1233, 1118, 1033, 990, 907, 857, 
760, 705; 
1
H NMR (300 MHz, DMSO) δ 10.52 (s, 2H), 7.00 (s, 2H), 3.79 (s, 3H); 13C NMR (300 
MHz, DMSO) δ 166.3, 156.0, 129.7, 107.4, 103.9, 52.7; HRMS (EI) m/z calcd for C8H7O4Br 
245.9528, found 245.9519. 
 
Methyl 4-bromo-3-(2-tert-butoxy-2-oxoethoxy)-5-hydroxybenzoate (10). In a round-bottom 
flask, 5.2 g (21.1 mmol) of benzoate 9, 3.11 mL (21.1 mmol) of tert-butyl bromoacetate, 6.1 g 
(44.2 mmol) of K2CO3, and 0.27 g (1.1 mmol) of 18-crown-6 were dissolved in acetone (105.2 
mL), and the reaction mixture was refluxed for 24 h. The volatile components were removed 
under reduced pressure, and the residue was diluted with ethyl acetate (250 mL) and water (250 
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mL); the organic layer was extracted, and the aqueous layer was washed with additional ethyl 
acetate (3  250 mL). The organic layers were dried over MgSO4 and filtered, and the volatile 
components were removed under reduced pressure to give a crude yellow oil. The oil was 
purified by flash chromatography (SiO2, hexanes/ethyl acetate, elution gradient 5:1/3:2/0:1) to 
give 2.63 g (34.6%) of 10 as a white solid: Rf 0.44 (hexanes/ethyl acetate, 3:2); mp 117–118 °C; 
IR (thin film, cm
-1
) 3393, 2923, 2852, 1724, 1590, 1497, 1438, 1354, 1247, 1158, 1117, 1011, 
904, 870, 843, 767; 
1
H NMR (300 MHz, CDCl3) δ 7.38 (d, J = 2 Hz, 1H), 7.03 (d, J = 2 Hz, 1H), 
5.80 (s, 1H), 4.65 (s, 2H), 3.91 (s, 3H), 1.50 (s, 9H); 
13
C NMR (500 MHz, CDCl3) δ 166.9, 
166.0, 154.9, 153.7, 130.6, 110.4, 105.7, 105.2, 82.9, 66.4, 52.5, 28.0; HRMS (EI) m/z calcd for 
C14H17O8Br 360.0209, found 360.0205. 
 
Methyl 4-bromo-3,5-bis(2-tert-butoxy-2-oxoethoxy)benzoate (11). In a round-bottom flask, 
0.25 g (1.0 mmol) of benzoate 9, 0.45 mL (3.0 mmol) of tert-butyl bromoacetate, 0.41 g (3.0 
mmol) of K2CO3, and 0.26 g (1.0 mmol) of 18-crown-6 were dissolved in acetone (25.0 mL), 
and the reaction mixture was refluxed for 16 h. The volatile components were removed under 
reduced pressure, and the residue was diluted with CH2Cl2 (50 mL) and water (50 mL); the 
organic layer was extracted, and the aqueous layer was washed with additional CH2Cl2 (3  50 
mL). The organic layers were dried over MgSO4 and filtered, and the volatile components were 
removed under reduced pressure to give a crude yellow oil. The oil was purified by flash 
chromatography (SiO2, hexanes/ethyl acetate elution gradient 3:1) to give 0.39 g (89%) of 11 as 
a white solid: Rf 0.47 (hexanes/ethyl acetate, 7:3); mp 103-105 °C; IR (thin film, cm
-1
) 3090, 
2980, 1753, 1725, 1588, 1423, 1394, 1369, 1339, 1304, 1239, 1161, 1132, 1030, 1000, 951, 900, 
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844, 763; 
1
H NMR (400 MHz, CDCl3) δ 7.16 (s, 2H), 4.67 (s, 4H), 3.92 (s, 3H), 1.51 (s, 18H); 
13
C NMR (400 MHz, CDCl3) δ 167.0, 166.0, 155.8, 129.9, 108.0, 107.1, 82.8, 66.6, 52.5, 28.0; 
HRMS (Q-TOF) m/z calcd for [M+Na]
+
 C20H27O8BrNa 497.0787, found 497.0819. Benzoate 11 
was also generated as the major product (48%) in the reaction used to furnish benzoate 10. 
 
Methyl 3-(2-(benzyloxy)-2-oxoethoxy)-4-bromo-5-(2-tert-butoxy-2-oxoethoxy) benzoate (4). 
In a round-bottom flask, 2.56 g (7.09 mmol) of benzoate 10, 1.35 mL (8.51 mmol) of benzyl 
bromoacetate, 1.17 g (8.51 mmol) of K2CO3, and 0.46 g (1.77 mmol) of 18-crown-6 were 
dissolved in acetone (35.4 mL), and the reaction mixture was refluxed for 24 h. The volatile 
components were removed under reduced pressure, and the residue was diluted with CH2Cl2 
(120 mL) and water (120 mL); the organic layer was extracted, and the aqueous layer was 
washed with additional CH2Cl2 (3  120 mL). The organic layers were dried over MgSO4 and 
filtered, and the volatile components were removed under reduced pressure to give a crude 
yellow oil. The oil was purified by flash chromatography (SiO2, hexanes/ethyl acetate, elution 
gradient 7:1/6:1/3:1) to give 3.37 g of impure product, which was recrystallized twice with 
hexanes to yield 3.26 g (90.2%) of 4 as a white solid: Rf 0.48 (hexanes/ethyl acetate, 3:2); mp 
68–70 °C; IR (thin film, cm-1) 2978, 1753, 1724, 1587, 1423, 1369, 1337, 1241, 1194, 1133, 
1029, 1000, 844, 763;  
1
H NMR (300 MHz, CDCl3) δ 7.35 (s, 5H), 7.15 (d, J = 2 Hz, 1H), 7.14 
(d, J = 2 Hz, 1H), 5.25 (s, 2H), 4.81 (s, 2H), 4.66 (s, 2H), 3.88 (s, 3H), 1.50 (s, 9H); 
13
C NMR 
(500 MHz, CDCl3) δ 167.8, 166.9, 165.9, 155.8, 155.7, 149.9, 149.1, 143.4, 141.7, 140.0, 135.0, 
130.5, 130.0, 128.7, 128.6, 128.6, 128.5, 128.5, 108.2, 107.4, 107.2, 82.9, 67.3, 67.2, 66.7, 66.3, 
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60.7, 52.5, 28.0; HRMS (Q-TOF) m/z calcd for [M+Na]
+
 C23H25O8NaBr 531.0630, found 
531.0663. 
 
tert-Butyl 3-bromo-2-methylphenylcarbamate (15). In a round-bottom flask, 4.0 mL (32.5 
mmol) of amine 7 and 14.2 g (64.9 mmol) of Boc anhydride were dissolved in THF (48.4 mL), 
and the reaction mixture was refluxed for 4 h. The volatile components were removed under 
reduced pressure; the residue was diluted with ethyl acetate (100 mL), washed with 1.0 M HCl (2 
 100 mL) and water (100 mL), dried over MgSO4 and filtered, and the volatile components 
were removed under reduced pressure to give a crude light pink solid. The solid was purified by 
recrystallization (ethanol/water) to yield 5.87 g (95.6%) of 15 as light pink crystals: Rf 0.69 
(hexanes/ethyl acetate, 3:2); mp 98–99 °C; IR (thin film, cm-1) 3247, 2977, 1680, 1573, 1523, 
1450, 1434, 1388, 1364, 1287, 1247, 1160, 1080, 1055, 1000, 845, 775, 753; 
1
H NMR (300 
MHz, CDCl3) δ 7.72 (d, J = 8 Hz, 1H), 7.32 (d, J = 8 Hz, 1H), 7.05 (t, J = 8 Hz, 1H), 6.32 (broad 
s, 1H), 2.36 (s, 3H), 1.52 (s, 9H); 
13
C NMR (300 MHz, CDCl3) δ 153.0, 137.4, 128.3, 127.4, 
125.3, 121.0, 80.8, 28.3, 17.6; HRMS (EI) m/z calcd for C12H16NO2Br 285.0364, found 
285.0368. 
 
tert-Butyl 3-bromo-2-methylphenyl(ethyl)carbamate (16). To a stirred solution of 0.80 g (2.8 
mmol) of carbamate 15 in DMF (6.0 mL) at 0 °C was added 0.34 g (8.4 mmol, 60% in mineral 
oil) of NaH, previously washed with hexanes (3  10 mL) to remove the mineral oil, over a 15 
min period. A solution of 0.63 mL (8.4 mmol) of ethyl bromide in DMF (2.0 mL) was then 
added dropwise at 0 °C over a 15 min period, and the reaction mixture was stirred at room 
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temperature for 3.5 h. The mixture was diluted with ethyl acetate (30 mL) and water (30 mL); 
the aqueous layer was extracted, and the organic layer was washed with additional water (40 
mL). The aqueous layers were washed with ethyl acetate (3  40 mL); all organic layers were 
dried over MgSO4 and filtered, and the volatile components were removed under reduced 
pressure to give a crude yellow oil. The oil was purified by flash chromatography (SiO2, 
hexanes/ethyl acetate, 20:1) to give 0.85 g (96.6%) of 16 as a colorless oil: Rf 0.51 
(hexanes/ethyl acetate, 4:1); IR (thin film, cm
-1
) 2975, 2932, 1702, 1591, 1563, 1462, 1391, 
1307, 1255, 1179, 1155, 1114, 1080, 1011, 992, 948, 858, 781, 715; 
1
H NMR (300 MHz, 
CDCl3) δ 7.46-7.42 (m, 1H), 7.14-6.93 (m, 2H), two protons of two conformers [3.75-3.60 
(doublet of quartets, J = 7, 7 Hz), 3.55-3.29 (doublet of quartets, J = 7, 7 Hz)], 2.26 (s, 3H), nine 
protons of two conformers in 1:2 ratio [1.50 (s), 1.31 (s)]; 1.08 (broad t, J = 7 Hz, 3H); 
13
C NMR 
(300 MHz, 323 K, CDCl3) δ 154.8, 142.9, 137.2, 131.8, 128.2, 127.6, 126.2, 80.4, 45.1, 28.9, 
18.8, 14.0; HRMS (EI) m/z calcd for C14H20NO2Br 313.0677, found 313.0669. 
 
tert-Butyl 3-bromo-2-methylphenyl(methyl)carbamate (17). To a stirred solution of 5.0 g 
(17.5 mmol) of carbamate 15 in DMF (45.0 mL) at 0 °C was added 2.1 g (52.5 mmol, 60% in 
mineral oil) of NaH, previously washed with hexanes (3  20 mL) to remove the mineral oil, 
over a 15 min period. A solution of 3.27 mL (52.5 mmol) of methyl iodide in DMF (5.0 mL) was 
then added dropwise at 0 °C over a 15 min period, and the reaction mixture was stirred at room 
temperature for 3.5 h. The mixture was diluted with ethyl acetate (100 mL) and water (100 mL); 
the aqueous layer was extracted, and the organic layer was washed with additional water (2  50 
mL). The aqueous layers were washed with ethyl acetate (3  100 mL); all organic layers were 
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dried over MgSO4 and filtered, and the volatile components were removed under reduced 
pressure to give a crude red oil. The oil was purified by flash chromatography (SiO2, 
hexanes/ethyl acetate, 3:2) to give 5.23 g (99.7%) of 17 as a red oil: Rf 0.65 (hexanes/ethyl 
acetate, 3:2); IR (thin film, cm
-1
) 3521, 3390, 3068, 2976, 2930, 2720, 1927, 1693, 1592, 1563, 
1464, 1358, 1305, 1255, 1164, 1102, 1074, 1036, 1002, 976, 901, 866, 825, 789, 767, 718; 
1
H 
NMR (300 MHz, CDCl3) δ 7.40 (app d, J = 8 Hz, 1H), 7.14-6.93 (m, 2H), 3.09 (s, 3H), 2.24 (s, 
3H), nine protons of two conformers in 1:2 ratio [1.48 (s), 1.30 (s)]; 
13
C NMR (300 MHz, 323 K, 
CDCl3) δ 155.1, 144.4, 136.6, 131.9, 127.9, 127.2, 126.1, 80.5, 37.5, 28.8, 18.5; HRMS (EI) m/z 
calcd for C13H18NO2Br 299.0521, found 299.0513. 
 
3-Bromo-N,2-dimethylbenzenamine (6). To a stirred solution of 5.23 g (17.4 mmol) of 
carbamate 17 in CH2Cl2 (26.4 mL) at room temperature was added 26.4 mL of trifluoroacetic 
acid, and the reaction mixture was stirred for 2 h. The mixture was dissolved in chilled saturated 
NaHCO3 solution (100 mL) and CH2Cl2 (100 mL); the organic layer was extracted and washed 
with additional chilled saturated NaHCO3 solution (100 mL). The aqueous layers were washed 
with CH2Cl2 (3  100 mL); all organic layers were dried over MgSO4 and filtered, and the 
volatile components were removed under reduced pressure to give 3.48 g (99.8%) of 6 as a 
yellow oil: Rf 0.46 (hexanes/ethyl acetate, 4:1); IR (thin film, cm
-1
) 3446, 3077, 2985, 2907, 
2815, 2733, 2592, 1900, 1805, 1673, 1595, 1503, 1464, 1424, 1378, 1310, 1283, 1205, 1169, 
1128, 1063, 996, 829, 762, 704; 
1
H NMR (300 MHz, CDCl3) δ 7.07-6.97 (m, 2H), 6.58 (dd, J = 
2, 2 Hz, 1H), 3.70 (broad s, 1H), 2.91 (s, 3H), 2.29 (s, 3H);  
13
C NMR (300 MHz, CDCl3) δ 
148.4, 127.8, 125.5, 121.2, 121.0, 108.2, 31.0, 16.7; HRMS (EI) m/z calcd for C8H10NBr 
198.9997, found 198.9999. 
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3-Bromo-N-ethyl-2-methylbenzenamine (13). To a stirred solution of 0.85 g (2.7 mmol) of 
carbamate 16 in CH2Cl2 (4.1 mL) at room temperature was added 4.1 mL of trifluoroacetic acid, 
and the reaction mixture was stirred for 1 h. The mixture was dissolved in chilled saturated 
NaHCO3 solution (30 mL) and CH2Cl2 (30 mL); the organic layer was extracted and washed 
with additional chilled saturated NaHCO3 solution (30 mL). The aqueous layers were washed 
with CH2Cl2 (3  30 mL); all organic layers were dried over MgSO4 and filtered, and the volatile 
components were removed under reduced pressure to give 0.58 g (99.9%) of 13 as a light brown 
oil: Rf 0.56 (hexanes/ethyl acetate, 4:1); IR (thin film, cm
-1
) 3433, 3074, 2969, 2927, 2871, 2591, 
2434, 1898, 1805, 1712, 1573, 1458, 1380, 1313, 1279, 1204, 1163, 1119, 1093, 1062, 998, 937, 
910, 841, 796, 761, 702; 
1
H NMR (300 MHz, CDCl3) δ 7.01-6.94 (m, 2H), 6.56 (dd, J = 3, 3 Hz, 
1H), 3.48 (broad s, 1H), 3.19 (q, J = 7 Hz, 2H), 2.27 (s, 3H), 1.33 (t, J =  7 Hz, 3H);  
13
C NMR 
(300 MHz, CDCl3) δ 147.5, 127.8, 125.6, 121.0, 120.9, 108.7, 38.7, 16.8, 14.9; HRMS (EI) m/z 
calcd for C9H12NBr 213.0153, found 213.0150. 
 
N,2-Dimethyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) benzenamine (5). To a flame-
dried round-bottom flask were added 3.48 g (17.4 mmol) of amine 6, 4.86 g (19.1 mmol) of 
bis(pinacolato)diboron, 0.38 g (0.52 mmol) of [1,1′-bis(diphenylphosphino)ferrocene] 
dichloropalladium(II), and 5.12 g (52.2 mmol) of potassium acetate. DMSO (84.3 mL), and the 
solution was degassed using the freeze-pump-thaw method three times under a nitrogen 
atmosphere. The flask was sealed; the reaction mixture was stirred at 100 °C for 14 h, and cooled 
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to room temperature. The mixture was diluted with CH2Cl2 (150 mL) and water (150 mL); the 
organic layer was extracted, and the aqueous layer was washed with additional CH2Cl2 (3  150 
mL). The organic layers were dried over MgSO4 and filtered, and the volatile components were 
removed under reduced pressure to give a brown crude oil. The oil was purified twice by flash 
chromatography (SiO2, hexanes/ethyl acetate, elution gradient (two columns) 20:1/5:1, then 
6:1/4:1) to give 2.76 g (64.2%) of 5 as a green solid: Rf 0.41 (hexanes/ethyl acetate, 4:1); mp 87–
90 °C; IR (thin film, cm
-1
) 3441, 3065, 2978, 2928, 2816, 1724, 1654, 1582, 1507, 1469, 1449, 
1379, 1351, 1310, 1286, 1206, 1146, 1129, 1083, 1019, 964, 872, 852, 816, 787, 736; 
1
H NMR 
(300 MHz, CDCl3) δ 7.24-7.13 (m, 2H), 6.75 (dd, J = 7, 2, Hz, 1H), 3.64 (broad s, 1H), 2.90 (s, 
3H), 2.37 (s, 3H), 1.35 (s, 12H); 
13
C NMR (300 MHz, CDCl3) δ 147.2, 129.0, 128.8, 128.4, 
128.3, 126.1, 124.3, 111.7, 83.4, 31.0, 24.9, 15.6; HRMS (Q-TOF) m/z calcd for [M+H]
+
 
C14H23NO2B 248.1822, found 248.1805. 
 
(S)-(9H-Fluoren-9-yl)methyl 1-((3-bromo-2-methylphenyl) (ethyl)amino)-1-oxopropan-2-
ylcarbamate (22). To 0.09 g (0.41 mmol) of amine 13 in 4.0 mL of CHCl3 was added 0.15 g 
(0.44 mmol) of Fmoc-alanine acid chloride 20-int (generated according to General Procedure A 
and used immediately thereafter)  in 2.5 mL of CHCl3 followed by 4.0 mL of saturated NaHCO3 
solution, and the reaction mixture was stirred at room temperature for 20 min. The solution was 
diluted with CH2Cl2 (30 mL) and saturated NaHCO3 solution (30 mL), the organic layer was 
extracted, and the aqueous layer was washed with CH2Cl2 (3  30 mL). The organics were dried 
over MgSO4 and filtered, and the volatile components were removed under reduced pressure to 
give a light brown crude oil. The oil was purified by flash chromatography (SiO2, hexanes/ethyl 
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acetate, elution gradient 40:1/20:1/10:1/5:1/0:1) to give 0.14 g (67.8%) of 22 as a white foam: Rf 
0.40 (hexanes/ethyl acetate, 3:2); IR (thin film, cm
-1
) 3305, 3065, 2979, 2935, 1718, 1653, 1589, 
1561, 1529, 1451, 1411, 1377, 1334, 1248, 1112, 1072, 1035, 999, 783, 760, 739; 
1
H NMR (300 
MHz, CDCl3) δ 7.77 (d, J = 7 Hz, 2H), 7.71-7.57 (m, 3H), 7.41 (t, J = 7 Hz, 2H), 7.32 (t, J = 7 
Hz, 2H), 7.24-7.07 (m, 2H), 5.63 (app d, J = 8 Hz, 1H), 4.41-4.16 (m, 3H), two protons of 
conformers [4.03 (doublet of quartets, J = 7, 7 Hz), 3.93 (doublet of quartets, J = 7, 7 Hz), 3.47 
(doublet of quartets, J = 7, 7 Hz), 2.97 (doublet of quartets, J = 7, 7 Hz)], three protons of 
conformers [2.32 (s), 2.31 (s)], three protons of conformers [1.19 (d, J = 7 Hz), 1.14 (t, J = 7 
Hz), 1.11 (t, J = 7 Hz)]; 
13
C NMR (300 MHz, CDCl3) δ 172.9, 172.7, 155.6, 155.3, 144.0, 143.9, 
141.3, 140.7, 140.4, 140.2, 137.2, 135.8, 133.3, 133.1, 130.1, 129.5, 128.1, 127.7, 127.1, 127.0, 
126.8, 126.6, 125.2, 120.1, 120.0, 67.0, 66.9, 47.9, 47.6, 47.2, 47.1, 44.4, 43.9, 19.4, 18.7, 18.4, 
18.2, 12.7, 12.2; HRMS (Q-TOF) m/z calcd for [M+Na]
+
 C27H27N2O3NaBr 529.1103, found 
529.1123.  = +45.4, c = 1.00, CHCl3. 
 
(S)-(9H-Fluoren-9-yl)methyl 1-((3-bromo-2-methylphenyl) (methyl)amino)-1-oxopropan-2-
ylcarbamate (23). To 0.08 g (0.4 mmol) of amine 6 in 4.0 mL of CHCl3 was added 0.15 g (0.44 
mmol) of Fmoc-alanine acid chloride 20-int (generated according to General Procedure A and 
used immediately thereafter)  in 2.5 mL of CHCl3 followed by 4.0 mL of saturated NaHCO3 
solution, and the reaction mixture was stirred at room temperature for 20 min. The solution was 
diluted with CH2Cl2 (30 mL) and saturated NaHCO3 solution (30 mL), the organic layer was 
extracted, and the aqueous layer was washed with CH2Cl2 (3  30 mL). The organics were dried 
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over MgSO4 and filtered, and the volatile components were removed under reduced pressure to 
give a light brown crude oil. The oil was purified by flash chromatography (SiO2, hexanes/ethyl 
acetate, elution gradient 40:1/20:1/10:1/6:1/4:1) to give 0.19 g (96.3%) of 23 as a white foam: Rf 
0.34 (hexanes/ethyl acetate, 3:2); IR (thin film, cm
-1
) 3419, 3066, 2927, 1718, 1655, 1561, 1531, 
1450, 1392, 1327, 1248, 1107, 1070, 1029, 996, 789, 759, 739; 
1
H NMR (300 MHz, CDCl3) δ 
7.76 (d, J = 7.2 Hz, 2H), 7.68-7.55 (m, 3H), 7.40 (t, J = 7 Hz, 2H), 7.32 (t, J  = 7 Hz), 7.20-7.09 
(m, J = 7 Hz, 2H), one proton of conformers [5.73 (app t, J = 7 Hz), 5.58 (s)], 4.34 (app d, J = 7 
Hz, 2H), 4.28-4.15 (m, 1H), one proton of conformers [4.45-4.29 (m), 4.10 (quintet, J = 7 Hz)], 
three protons of conformers [3.34 (s), 3.33 (s), 3.21 (s), 3.19 (s)], three protons of conformers 
[2.34 (s), 2.33 (s), 2.26 (s), 2.24 (s)], three protons of conformers [1.53 (app t, J = 7 Hz), 1.22 (d, 
J = 7 Hz), 1.13 (d, J = 7 Hz)]; 
13
C NMR (300 MHz, CDCl3) δ 173.1, 172.9, 155.6, 155.3, 144.0, 
143.9, 142.2, 142.1, 141.3, 136.8, 135.6, 133.3, 133.1, 128.6, 128.1, 128.0, 127.7, 127.3, 127.1, 
126.9, 126.7, 125.2, 120.0, 66.9, 66.8, 47.7, 47.4, 47.2, 36.8, 29.7, 19.4, 18.5, 18.3, 17.9;  HRMS 
(EI) m/z calcd for C26H25N2O3Br 492.1049, found 492.1044.  = +46.9, c = 1.00, CHCl3. 
 
(9H-Fluoren-9-yl)methyl 2-((3-bromo-2-methylphenyl) (ethyl)amino)-2-oxoethylcarbamate 
(24). To 0.08 g (0.36 mmol) of amine 13 in 4.0 mL of CHCl3 was added 0.14 g (0.5 mmol) of 
Fmoc-glycine acid chloride 21-int (generated according to General Procedure A and used 
immediately thereafter)  in 2.5 mL of CHCl3 followed by 4.0 mL of saturated NaHCO3 solution, 
and the reaction mixture was stirred at room temperature for 20 min. The solution was diluted 
with CH2Cl2 (30 mL) and saturated NaHCO3 solution (30 mL), the organic layer was extracted, 
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and the aqueous layer was washed with CH2Cl2 (3  30 mL). The organics were dried over 
MgSO4 and filtered, and the volatile components were removed under reduced pressure to give a 
light brown crude oil. The oil was purified by flash chromatography (SiO2, hexanes/ethyl acetate, 
elution gradient 20:1/10:1/5:1/2:1) to give 0.15 g (85.3%) of 24 as a white foam: Rf 0.27 
(hexanes/ethyl acetate, 3:2); IR (thin film, cm
-1
) 3320, 3065, 2974, 2935, 1723, 1667, 1588, 
1561, 1512, 1450, 1415, 1379, 1341, 1246, 1167, 1125, 1062, 1038, 1000, 919, 783, 760, 739; 
1
H NMR (300 MHz, CDCl3) δ 7.76 (d, J = 7 Hz, 2H), 7.63 (app t, J = 8, 7 Hz, 3H), 7.40 (t, J = 7 
Hz, 2H), 7.31 (t, J = 7 Hz, 2H), 7.15 (t, J = 8 Hz, 1H), 7.09 (d, J = 8 Hz, 1H), one proton of 
conformers [5.87 (s), 5.75 (s), 5.49 (s)], 4.33 (d, J = 7 Hz, 2H), 4.21 (m, J = 7 Hz, 1H), 4.14 
(doublet of quartets, J = 7, 7 Hz, 1H), 3.69 (dd, J = 4, 17 Hz, 1H), 3.43 (dd, J = 4, 17 Hz, 1H), 
3.28 (doublet of quartets, J = 7, 7 Hz, 1H), 2.31 (s, 3H), 1.15 (t, J = 7 Hz, 3H); 
13
C NMR (500 
MHz, CDCl3) δ 167.8, 156.1, 143.9, 141.3, 139.6, 136.6, 133.5, 128.5, 128.2, 127.7, 127.1, 
127.0, 125.2, 120.0, 67.1, 47.1, 43.8, 43.5, 18.2, 12.7; HRMS (EI) m/z calcd for C26H25N2O3Br 
492.1049, found 492.1044. 
 
(9H-Fluoren-9-yl)methyl-2-((3-bromo-2-methylphenyl)(methyl)amino)-2-oxoethyl 
carbamate (25). To 0.08 g (0.437 mmol) of amine 6 in 4.0 mL of CHCl3 was added 0.14 g (0.44 
mmol) of Fmoc-glycine acid chloride 21-int (generated according to General Procedure A and 
used immediately thereafter)  in 2.5 mL of CHCl3 followed by 4.0 mL of saturated NaHCO3 
solution, and the reaction mixture was stirred at room temperature for 20 min. The solution was 
diluted with CH2Cl2 (30 mL) and saturated NaHCO3 solution (30 mL), the organic layer was 
extracted, and the aqueous layer was washed with CH2Cl2 (3  30 mL). The organics were dried 
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over MgSO4 and filtered, and the volatile components were removed under reduced pressure to 
give a light brown crude oil. The oil was purified by flash chromatography (SiO2, hexanes/ethyl 
acetate, elution gradient 20:1/10:1/5:1/3:1/1:1) to give 0.18 g (93.6%) of 25 as a white foam: Rf 
0.20 (hexanes/ethyl acetate, 3:2); IR (thin film, cm
-1
) 3330, 3065, 2928, 1717, 1664, 1590, 1562, 
1516, 1449, 1392, 1327, 1249, 1168, 1113, 1032, 998, 760, 738, 721; 
1
H NMR (300 MHz, 
CDCl3) δ 7.79 (d, J = 7 Hz, 2H), 7.62 (app d, J = 7 Hz, 3H), 7.43 (t, J = 7 Hz, 2H), 7.34 (t, J = 7 
Hz, 2H), 7.23-7.08 (m, 2H), one proton of conformers [5.74 (s), 5.46 (s)], 4.36 (d, J = 7 Hz, 2H), 
4.24 (m, 1H), 3.75 (dd, J = 4, 17 Hz, 1H), 3.49 (dd, J = 4, 17 Hz, 1H), 3.26 (s, 3H), 2.34 (s, 3H); 
13
C NMR (300 MHz, CDCl3) δ 168.3, 156.2, 145.9, 143.9, 141.3, 139.6, 136.2, 135.6, 134.7, 
133.6, 133.5, 133.2, 130.1, 129.5, 129.1, 128.6, 127.9, 127.7, 127.2, 127.1, 126.9, 126.6, 126.3, 
125.7, 125.2, 124.6, 124.3, 124.0, 121.0, 120.3, 120.1, 120.0, 119.8, 119.3, 67.1, 47.1, 43.3, 36.5, 
29.7, 17.8; HRMS (EI) m/z calcd for C25H23N2O3Br 478.0892, found 478.0890. 
 
Methyl 2-(2-(benzyloxy)-2-oxoethoxy)-6-(2-(tert-butoxy)-2-oxoethoxy)-2'-methyl-3'-(methyl 
amino)-[1,1'-biphenyl]-4-carboxylate (3). In a resealable oven-dried Schlenk flask containing a 
magnetic stir bar, 1.27 g (2.50 mmol) of benzoate 4, 0.93 g (3.75 mmol) of boronic ester 5, 0.092 
g (0.100 mmol) of tris[dibenzylideneacetone]dipalladium(0), 0.164 g (0.400 mmol) of 2-
dicyclohexylphosphino-2′,6′-dimethoxybiphenyl (SPhos ligand), and 1.73 g (7.50 mmol) of 
K3PO4 monohydrate were added and dried under reduced pressure for 2 min. Toluene (15 mL) 
was added, and the solution was degassed using the freeze-pump-thaw method three times under 
a nitrogen atmosphere. The Schlenk flask was sealed; the reaction mixture was vigorously stirred 
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at 90 °C for 15 h, and cooled to room temperature. The mixture was diluted with CH2Cl2 (225 
mL) and water (225 mL); the organic layer was extracted, and the aqueous layer was washed 
with additional CH2Cl2 (3  225 mL). The organic layers were dried over MgSO4 and filtered, 
and the volatile components were removed under reduced pressure to give a brown crude oil. 
The oil was purified by flash chromatography (SiO2, hexanes/ethyl acetate, elution gradient 
5:1/4:1/3:1) to give 0.502 g (36.5%) of 3 as a brown oil/foam: Rf 0.38 (hexanes/ethyl acetate, 
3:2); IR (thin film, cm
-1
) 3440, 2930, 2815, 1752, 1722, 1587, 1513, 1493, 1436, 1368, 1327, 
1233, 1191, 1134, 1080, 1029, 996, 844, 786, 753; 
1
H NMR (500 MHz, CDCl3) δ 7.41-7.25 (m, 
5H), 7.25-7.15 (m, 3H), 6.66 (d, J = 8 Hz, 1H), 6.63 (d, J = 8 Hz, 1H), 5.17 (s, 2H), 4.63 (s, 2H), 
4.48 (s, 2H), 3.90 (s, 3H), 3.65 (broad s, 1H), 2.92 (s, 3H), 1.89 (s, 3H), 1.44 (s, 9H); 
13
C NMR 
(300 MHz, CDCl3) δ 168.6, 167.8, 166.4, 156.3, 156.1, 147.0, 141.6, 135.2, 132.7, 130.1, 128.6, 
128.4, 128.4, 126.0, 125.6, 121.5, 119.3, 108.8, 106.8, 106.5, 82.3, 66.9, 66.1, 65.6, 52.3, 31.0, 
28.0, 14.0; HRMS (Q-TOF) m/z calcd for for [M+Na]
+
 C31H35NO8Na 572.2260, found 572.2312. 
 
Methyl 3'-((S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-N-methylpropanamido)-2-
(2-(benzyloxy)-2-oxoethoxy)-6-(2-(tert-butoxy)-2-oxoethoxy)-2'-methyl-[1,1'-biphenyl]-4-
carboxylate (27). To 0.24 g (0.437 mmol) of carboxylate 3 in 4.0 mL of CHCl3 was added 0.17 
g (0.6 mmol) of Fmoc-alanine acid chloride 20-int (generated according to General Procedure A 
and used immediately thereafter) in 2.5 mL of CHCl3 followed by 4.0 mL of saturated NaHCO3 
solution, and the reaction mixture was stirred at room temperature for 20 min. The solution was 
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diluted with CH2Cl2 (60 mL) and saturated NaHCO3 solution (60 mL), the organic layer was 
extracted, and the aqueous layer was washed with CH2Cl2 (3  60 mL). The organics were dried 
over MgSO4 and filtered, and the volatile components were removed under reduced pressure to 
give a light brown crude oil. The oil was purified by flash chromatography (SiO2, hexanes/ethyl 
acetate, elution gradient 10:1/5:1/2:1/1:1) to give 0.30 g (82%) of 27 as a white foam: Rf 0.25 
(hexanes/ethyl acetate, 3:2); IR (thin film, cm
-1
) 3303, 3064, 2927, 2855, 1752, 1722, 1653, 
1581, 1501, 1450, 1393, 1368, 1329, 1236, 1193, 1135, 1080, 1030, 997, 863, 845, 806, 759, 
739; 
1
H NMR (500 MHz, CDCl3) δ 7.81-7.74 (m, J = 8 Hz, 2H), 7.66-7.57 (d, J = 8 Hz; m; d, J 
= 8 Hz; 2H), 7.45-7.38 (m, 2H), 7.38-7.26 (m, 7H), 7.26-7.17 (m, 4H), 7.16-7.09 (m, 1H), 5.81-
5.73 (m, J = 9 Hz, 1H), 5.23-5.16 (m, 2H), six protons of conformers [4.91 (d, J = 12 Hz), 4.83 
(d, J = 16 Hz), 5.02 (d, J = 12 Hz), 4.75-4.63 (m), 4.55-4.46 (m)], four protons [4.40-4.30 (m), 
4.30-4.15 (m)], three protons of conformers [3.93 (s), 3.91 (s), 3.90 (s)], three protons of 
conformers [3.32 (s), 3.30 (s), 3.28 (s), 3.25 (s)], three protons of conformers [2.05 (s), 2.04 (s), 
2.01 (s), 1.99 (s)], nine protons of conformers [1.47 (s), 1.46 (s), 1.35 (s)], three protons of 
conformers [1.23 (t, J = 8 Hz), 1.11 (d, J = 7 Hz), 1.06 (d, J = 7 Hz)]; 
13
C NMR (500 MHz, 
CDCl3) δ 173.4, 173.1, 168.7, 168.3, 168.2, 168.2, 168.0, 167.5, 167.4, 167.3, 166.2, 156.3, 
156.1, 156.0, 155.7, 155.5, 155.0, 144.1, 144.1, 144.0, 144.0, 141.3, 141.0, 136.0, 135.7, 135.6, 
135.2, 135.1, 135.1, 131.3, 130.9, 130.8, 128.7, 128.6, 128.4, 128.3, 128.1, 127.7, 127.1, 127.0, 
126.5, 126.3, 123.6, 123.6, 123.3, 120.0, 106.3, 106.0, 82.5, 82.0, 67.2, 67.0, 66.9, 66.8, 66.5, 
65.9, 65.3, 47.9, 47.9, 47.2, 36.8, 36.7, 28.1, 28.0, 28.0, 19.7, 17.9; HRMS (Q-TOF) m/z calcd 
for [M+Na]
+
 C49H50N2O11Na 865.3312, found 865.3275.  = +40.6, c = 1.00, CHCl3. 
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Methyl-3'-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-N-methylacetamido)-2-(2-
(benzyloxy)-2-oxoethoxy)-6-(2-(tert-butoxy)-2-oxoethoxy)-2'-methyl-[1,1'-biphenyl]-4-
carboxylate (28). To 0.24 g (0.44 mmol) of carboxylate 3 in 4.0 mL of CHCl3 was added 0.18 g 
(0.60 mmol) of Fmoc-glycine acid chloride 21-int (generated according to General Procedure A 
and used immediately thereafter) in 2.5 mL of CHCl3 followed by 4.0 mL of saturated NaHCO3 
solution, and the reaction mixture was stirred at room temperature for 20 min. The solution was 
diluted with CH2Cl2 (60 mL) and saturated NaHCO3 solution (60 mL), the organic layer was 
extracted, and the aqueous layer was washed with CH2Cl2 (3  60 mL). The organics were dried 
over MgSO4 and filtered, and the volatile components were removed under reduced pressure to 
give a light brown crude oil. The oil was purified by flash chromatography (SiO2, hexanes/ethyl 
acetate, elution gradient 10:1/5:1/3:1/2:1/1:1) to give 0.29 g (81%) of 28 as a white foam: Rf 0.20 
(hexanes/ethyl acetate, 3:2); IR (thin film, cm
-1
) 3392, 2926, 2855, 1751, 1722, 1660, 1581, 
1421, 1369, 1329, 1299, 1234, 1193, 1134, 1028, 998, 864, 845, 806, 735; 
1
H NMR (500 MHz, 
CDCl3) δ 7.77 (t, J = 8 Hz, 2H), 7.63 (d, J = 8 Hz, 1H), 7.60 (d, J = 8H, 1H), 7.45-7.26 (m, 10H), 
7.23 (app s, 2H), 7.18 (app t, J = 6 Hz, 2H), one proton of conformers [5.74 (app s), 5.56 (broad 
s)], two protons of conformers [5.20 (s), 5.13 (d, J = 13 Hz), 5.07 (d, J = 13 Hz)], two protons of 
conformers [4.78 (d, J = 17 Hz), 4.71 (s), 4.70 (d, J = 17 Hz)], two protons of conformers [4.60 
(d, J = 17 Hz), 4.56-4.50 (m)], 4.39-4.19 (m, 3H), three protons of conformers [3.93 (s), 3.92 
(s)], two protons of conformers [3.80-3.70 (td, J = 5, 14 Hz), 3.70-3.60 (td, J = 5, 14 Hz)], three 
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protons of conformers [3.33 (s), 3.30 (s)], three protons of conformers [2.07 (s), 2.04 (s)], nine 
protons of conformers [1.48 (s), 1.42 (s)]; 
13
C NMR (500 MHz, CDCl3) δ 168.8, 168.2, 167.5, 
167.4, 166.2, 156.1, 155.8, 155.6, 144.0, 144.0, 141.3, 140.3, 135.8, 135.7, 135.1, 135.0, 131.3, 
130.9, 128.7, 128.6, 128.5, 128.4, 128.3, 127.7, 127.1, 126.9, 125.3, 125.2, 123.3, 120.0, 106.5, 
106.4, 106.0, 82.5, 82.3, 67.0, 66.9, 65.9, 65.7, 65.3, 65.1, 52.4, 47.2, 47.1, 43.4, 36.3, 28.1, 28.0, 
14.5; HRMS (Q-TOF) m/z calcd for [M+Na]
+
 C48H48N2O11Na 851.3156, found 851.3071. 
 
Methyl-3'-((S)-2-acetamido-N-methylpropanamido)-2-(2-(benzyloxy)-2-oxoethoxy)-6-(2-
(tert-butoxy)-2-oxoethoxy)-2'-methyl-[1,1'-biphenyl]-4-carboxylate (1). To 0.042 g (0.05 
mmol) of carboxylate 27 in a round-bottom flask was added 0.22 mL of a 20% piperidine/DMF 
solution, and the reaction mixture was stirred at room temperature for 20 min. Then 0.76 mL 
(8.04 mmol) of acetic anhydride and 2.32 mL (28.7 mmol) of pyridine were added, and the 
solution was stirred at room temperature for 30 min. The volatile components were removed 
under reduced pressure to give a yellow crude oil. The oil was purified by flash chromatography 
(SiO2, hexanes/ethyl acetate/methanol elution gradient 1:1:0/0:1:0/0:9:1/0:4:1) to give 0.033 g 
(99%) of 1 as a slightly impure (by 
1
H NMR, <5%) white foam: Rf 0.63 (100% ethyl acetate); IR 
(thin film, cm
-1
) 3329, 2932, 1751, 1723, 1645, 1580, 1423, 1392, 1369, 1329, 1234, 1192, 1134, 
1028, 996, 731; 
1
H NMR (500 MHz, CDCl3) δ 7.40-7.27 (m, 7H), 7.26-7.12 (m, 3H), one proton 
of conformers [6.57 (d,  J = 8 Hz), 6.54 (d,  J = 8 Hz), 6.47 (d,  J = 8 Hz), 6.44 (d, J = 8 Hz),], 
5.22-5.14 (m, 2H), five protons of conformers [4.96 (s), 4.93 (s), 4.80 (d, J = 10 Hz), 4.77 (d, J = 
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10 Hz), 4.73-4.63 (m), 4.59-4.48 (m), 4.39 (quintet, J = 7 Hz)], three protons of conformers [3.93 
(s), 3.93 (s), 3.92 (s), 3.91 (s)], three protons of conformers [3.30 (s), 3.28 (s), 3.25 (s), 3.22 (s)], 
six protons of conformers [2.11 (s), 2.03 (s), 2.03 (s), 2.01 (s), 1.99 (s), 1.99 (s), 1.93 (s), 1.86 
(s)], nine protons of conformers [1.48 (s), 1.47 (s), 1.47 (s), 1.46 (s)], three protons of 
conformers [1.19 (d, J = 7 Hz), 1.17 (d, J = 7 Hz), 1.07 (d, J = 7 Hz), 1.02 (d, J = 7 Hz)]; 
13
C 
NMR (500 MHz, CDCl3) δ 173.5, 173.5, 173.1, 169.1, 168.9, 168.4, 168.4, 168.3, 168.2, 168.1, 
167.5, 167.4, 167.3, 166.3, 166.2, 156.2, 156.1, 155.9, 155.9, 155.7, 155.4, 140.9, 140.8, 140.8, 
140.7, 136.0, 135.7, 135.6, 135.4, 135.2, 135.0, 135.0, 131.2, 131.2, 130.9, 130.8, 130.8, 128.3, 
128.6, 128.6, 128.5, 128.5, 128.5, 128.4, 128.3, 127.9, 127.6, 127.0, 126.9, 126.5, 126.5, 123.5, 
123.5, 123.2, 106.5, 106.3, 106.0, 105.9, 105.8, 105.8, 82.5, 82.0, 67.0, 66.6, 65.9, 65.7, 65.4, 
65.3, 65.3, 65.1, 64.9, 52.4, 52.4, 47.5, 46.5, 46.5, 46.3, 42.5, 36.9, 36.8, 36.7, 36.7, 28.0, 28.0, 
26.4,  25.5, 24.5, 23.4, 23.3, 23.3, 21.5, 19.4, 19.4, 17.6, 17.5, 14.9, 14.9, 14.6, 14.6;  HRMS (Q- 
TOF) m/z calcd for [M+Na]
+
 C36H42N2O10Na 685.2737, found 685.2675.  = +32.4 (c = 
0.98, CHCl3). 
 
Methyl-3'-(2-acetamido-N-methylacetamido)-2-(2-(benzyloxy)-2-oxoethoxy)-6-(2-(tert-
butoxy)-2-oxoethoxy)-2'-methyl-[1,1'-biphenyl]-4-carboxylate (2). To 0.041 g (0.05 mmol) of 
carboxylate 28 in a round-bottom flask was added 0.22 mL of a 20% piperidine/DMF solution, 
and the reaction mixture was stirred at room temperature for 20 min. Then 0.76 mL (8.04 mmol) 
of acetic anhydride and 2.32 mL (28.7 mmol) of pyridine were added, and the solution was 
stirred at room temperature for 30 min. The volatile components were removed under reduced 
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pressure to give a yellow crude oil. The oil was purified by flash chromatography (SiO2, 
hexanes/ethyl acetate/methanol elution gradient 1:1:0/0:1:0/0:9:1/0:4:1) to give 0.031 g (97%) of 
2 as a slightly impure (by 
1
H NMR, <5%) white foam: Rf 0.58 (100% ethyl acetate); IR (thin 
film, cm
-1
) 3338, 2932, 1751, 1723, 1655, 1580, 1423, 1393, 1369, 1329, 1235, 1193, 1135, 
1029, 996, 844, 806, 733; 
1
H NMR (500 MHz, CDCl3) δ 7.38-7.33 (m, 3H), 7.33-7.26 (m, 4H), 
7.22 (s), 7.17 (dd, J = 1, 3 Hz, 1H), 7.14 (d, J = 7 Hz, 1H), 6.52-6.47 (broad app t, 1H), 5.21-5.13 
(m, 2H), four protons of conformers [4.82 (d, J = 17 Hz), 4.73 (d, J = 17 Hz), 4.70 (s), 4.64 (d, J 
= 17 Hz), 4.57-4.50 (m)], three protons of conformers [3.92 (s), 3.92 (s)], two protons of 
conformers [3.78-3.71 (app dd, J = 4, 19 Hz), 3.70-3.60 (td, J = 4, 19 Hz)], three protons of 
conformers [3.31 (s), 3.28 (s)], six protons of conformers [2.10 (s), 2.02 (s), 2.00 (s), 1.98 (s)], 
nine protons of conformers [1.47 (s), 1.47 (s)]; 
13
C NMR (300 MHz, CDCl3) δ 169.7, 168.8, 
168.8, 168.5, 168.2, 167.7, 167.4, 166.2, 156.0, 155.8, 155.8, 155.5, 140.1, 140.1, 135.7, 135.7, 
135.2, 135.0, 131.3, 130.9, 128.6, 128.6, 128.4, 128.4, 127.0, 126.8, 123.2, 123.2, 106.4, 106.2, 
105.9, 105.7, 82.5, 82.3, 67.0, 66.9, 65.9, 65.5, 65.3, 65.0, 52.4, 47.5, 42.5, 42.2, 42.2, 36.3, 28.0, 
26.4, 25.5, 24.5, 23.1, 21.5, 14.5, 14.5; HRMS (EI) m/z calcd for C35H40N2O10 648.2683, found 
648.2672.  
 
(S)-2-Acetamido-N-(3-bromo-2-methylphenyl)-N-methylpropanamide (29). To 0.049 g (0.10 
mmol) of carbamate 23 in a round-bottom flask was added 0.44 mL (0.89 mmol) of a 20% 
piperidine/DMF solution, and the reaction mixture was stirred at room temperature for 20 min. 
Then 1.52 mL (16.1 mmol) of acetic anhydride and 4.62 mL (57.1 mmol) of pyridine were 
added, and the solution was stirred at room temperature for 30 min. The volatile components 
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were removed under reduced pressure to give a brown crude oil. The oil was purified by flash 
chromatography (SiO2, hexanes/ethyl acetate/methanol elution gradient 1:10:0/0:1:0/0:9:1) to 
give 0.028 g (89.4%) of 29 as an off-white foam: Rf 0.16 (100% ethyl acetate); IR (thin film, cm
-
1
) 3305, 3069, 2931, 1648, 1590, 1558, 1460, 1391, 1374, 1281, 1151, 1110, 1034, 997, 792, 
767, 720; 
1
H NMR (300 MHz, CDCl3) δ 7.60 (d, J = 8 Hz, 1H), 7.27-7.07 (m, 2H), one proton of 
conformers [6.65 (s), 6.41 (s)], one proton of conformers [5.08 (quintet, J = 7 Hz), 4.53 (J = 7 
Hz), 4.29 (J = 7 Hz)],  three protons of conformers [3.35 (s), 3.34 (s), 3.19 (s), 3.16 (s)],  three 
protons of conformers [2.31 (s), 2.29 (s), 2.22 (s), 2.21 (s)], three protons of conformers [1.96 
(s), 1.96 (s)], three protons of conformers [1.49 (app t), 1.17 (d, J = 7 Hz), 1.07 (d, J = 7 Hz)]; 
13
C NMR (500 MHz, CDCl3) δ 173.2, 173.1, 169.3, 169.0, 142.1, 141.9, 136.8, 135.5, 133.3, 
133.1, 132.3, 128.6, 128.0, 128.0, 127.2, 126.9, 126.6, 126.2, 46.1, 45.9, 36.8, 36.8, 23.3, 23.2, 
19.2, 18.5, 18.1, 17.8; HRMS (EI) m/z calcd for C13H17N2O2Br 312.0473, found 312.0470. 
 = +27.1 (c = 1.00, CHCl3). 
 
2-Acetamido-N-(3-bromo-2-methylphenyl)-N-methylacetamide (30). To 0.048 g (0.10 mmol) 
of carbamate 25 in a round-bottom flask was added 0.44 mL (0.89 mmol) of a 20% 
piperidine/DMF solution, and the reaction mixture was stirred at room temperature for 20 min. 
Then 1.52 mL (16.1 mmol) of acetic anhydride and 4.62 mL (57.1 mmol) of pyridine were 
added, and the solution was stirred at room temperature for 30 min. The volatile components 
were removed under reduced pressure to give a brown crude oil. The oil was purified by flash 
chromatography (SiO2, hexanes/ethyl acetate/methanol elution gradient 1:10:0/0:1:0/0:9:1) to 
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give 0.025 g (82.2%) of 30 as an off-white foam: Rf 0.14 (100% ethyl acetate); IR (thin film, cm
-
1
) 3318, 3074, 2927, 1655, 1560, 1462, 1440, 1392, 1328, 1285, 1111, 1041, 998, 792, 721; 
1
H 
NMR (300 MHz, CDCl3) δ 7.59 (dd, J = 2, 8 Hz, 1H), 7.17-7.08 (m, 2H), 6.50 (broad s, 1H), 
two protons of conformers [4.26 (d, J = 4 Hz), 3.73 (dd, J = 4, 18 Hz), 3.45 (dd, J = 4, 18 Hz)], 
three protons of conformers [3.26 (s), 3.20 (s)], three protons of conformers [2.28 (s), 2.22 (s)], 
three protons of conformers [2.06 (s), 2.00 (s)]; 
13
C NMR (500 MHz, CDCl3) δ 170.0, 168.3, 
141.1, 139.3, 136.2, 133.6, 132.5, 128.7, 128.0, 127.2, 126.9, 126.3, 42.1, 36.5, 23.0, 17.8; 
HRMS (EI) m/z calcd for C12H15N2O2Br 298.0317, found 298.0321. 
 
Methyl-2-(2-(tert-butoxy)-2-oxoethoxy)-6-hydroxy-2'-methyl-3'-(methylamino)-[1,1'-
biphenyl]-4-carboxylate (31). In a resealable oven-dried Schlenk flask containing a magnetic 
stir bar, 0.25 g (0.68 mmol) of benzoate 10, 0.25 g (1.03 mmol) of boronic ester 5, 0.025 g (0.03 
mmol) of tris[dibenzylideneacetone]dipalladium(0), 0.045 g (0.11 mmol) of 2-
dicyclohexylphosphino-2′,6′-dimethoxybiphenyl (SPhos ligand), and 0.472 g (2.05 mmol) of 
K3PO4 monohydrate were added and dried under reduced pressure for 2 min. Toluene (4.1 mL) 
was added, and the solution was degassed using the freeze-pump-thaw method three times under 
a nitrogen atmosphere. The Schlenk flask was sealed; the reaction mixture was vigorously stirred 
at 90 °C for 15 h, and cooled to room temperature. The mixture was diluted with CH2Cl2 (60 
mL) and water (60 mL); the organic layer was extracted, and the aqueous layer was washed with 
additional CH2Cl2 (3  60 mL). The organic layers were dried over MgSO4 and filtered, and the 
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volatile components were removed under reduced pressure to give a brown crude oil. The oil was 
purified by flash chromatography (SiO2, hexanes/ethyl acetate, elution gradient 10:1/6:1) to give 
0.018 g (6.6%) of 31 as a yellow oil: Rf 0.39 (hexanes/ethyl acetate, 3:2); IR (thin film, cm
-1
) 
3440, 2928, 1750, 1721, 1586, 1497, 1436, 1368, 1340, 1235, 1158, 1119, 1009, 843, 786, 770, 
752, 724; 
1
H NMR (300 MHz, CDCl3) δ 7.37 (d, J = 1 Hz, 1H), 7.28 (t, J = 8 Hz, 1H), 7.05 (d, J 
= 1 Hz, 1H), 6.72 (d, J = 8 Hz, 1H), 6.63 (d, J = 8 Hz, 1H), 5.07 (s, 1H), 4.49 (s, 2H), 3.92 (s, 
3H), 3.78 (broad s, 1H), 2.95 (s, 3H), 1.91 (s, 3H), 1.45 (s, 9H); 
13
C NMR (500 MHz, CDCl3) δ 
168.7, 166.7, 155.6, 154.0, 148.0, 130.7, 130.5, 127.7, 122.0, 118.4, 110.2, 109.8, 104.4, 82.3, 
65.9, 52.3, 30.9, 28.0, 13.7; HRMS (EI) m/z calcd for C22H27NO6 401.1838, found 401.1837. 
 
Methyl 4-bromo-3-(2-(tert-butoxy)-2-oxoethoxy)-5-((tert-butyldimethylsilyl)oxy) benzoate 
(32). To a solution of 0.18 g (0.5 mmol) of benzoate 10 in DMF (2.0 mL) was added 0.11 g (0.68 
mmol) of tert-butyldimethylsilyl chloride and 0.09 g (1.25 mmol) of imidazole. The yellow 
solution was stirred for 24 h at room temperature. The residue was diluted with CH2Cl2 (15 mL) 
and water (15 mL); the organic layer was extracted, and the aqueous layer was washed with 
additional CH2Cl2 (3  15 mL). The organics were dried over MgSO4 and filtered, and the 
volatile components were removed under reduced pressure to give a brown crude oil. The oil was 
purified by flash chromatography (SiO2, hexanes/ethyl acetate elution gradient 9:1/6:1) to give 
0.16 g (67.9%) of 32 as a white solid: Rf 0.62 (hexanes/ethyl acetate, 7:3); mp 58-60 °C; IR (thin 
film, cm
-1
) 2954, 2932, 2859, 1756, 1727, 1581, 1423, 1393, 1368, 1347, 1297, 1243, 1220, 
1161, 1125, 1029, 836, 783, 767; 
1
H NMR (400 MHz, CDCl3) δ 7.17 (s, 1H), 7.03 (s, 1H), 4.60 
(s, 2H), 3.84 (s, 3H), 1.44 (s, 9H), 1.01 (s, 9H), 0.24 (s, 6H); 
13
C NMR (400 MHz, CDCl3) δ 
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167.0, 166.0, 155.8, 154.0, 129.6, 114.1, 111.3, 106.3, 82.5, 66.5, 52.3, 27.9, 25.7, 18.3; HRMS 
(Q-TOF) m/z calcd for [M+Na]
+
 C20H31O6NaSiBr 497.0971, found 497.0975. 
 
2-((3'-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-N-methylpropanamido)-6-(2-
(tert-butoxy)-2-oxoethoxy)-4-(methoxycarbonyl)-2'-methyl-[1,1'-biphenyl]-2-yl)oxy)acetic 
acid (33). To 0.118 g (0.14 mmol) of carboxylate 27 and 0.012 g of 10% Pd/C in a round-bottom 
flask was added 1.7 mL of a 9:1 MeOH/H2O solution. The flask was sealed with a septum; a 
balloon attached to a syringe needle and filled with hydrogen gas was inserted. The reaction 
mixture was stirred at room temperature for 4 h, after which the solution was filtered through a 
pad of Celite and further eluted with ethyl acetate (200 mL). The volatile components were 
removed under reduced pressure to give 0.105 g (100%) of 33 as an off-white foam: Rf 0.20 
(100% ethyl acetate); IR (thin film, cm
-1
) 3328, 2929, 1722, 1651, 1580, 1504, 1449, 1396, 1369, 
1327, 1236, 1135, 1029, 997, 759, 740; 
1
H NMR (500 MHz, CDCl3) δ 7.78 (t, J = 8 Hz, 2H), 
7.63-7.57 (m, 2H), 7.45-7.28 (m, 7H), two protons [7.25 (app d, J =  8 Hz), 7.21 (dd, J = 1, 8 
Hz), 7.20-7.15 (m)], one proton of conformers [6.22 (d, J = 8 Hz), 5.94-5.74 (m)], 4.70-4.48 (m, 
4H), four protons of conformers [4.41-4.34 (m), 4.34-4.26 (m), 4.19 (quintet, J = 8 Hz)], three 
protons of conformers [3.96 (s), 3.95 (s), 3.94 (s), 3.93 (s)], three protons of conformers [3.31 
(s), 3.30 (s), 3.29 (s), 3.26 (s)], three protons of conformers [2.07 (s), 2.05 (s), 2.03 (s), 1.99 (s)], 
nine protons of conformers [1.48 (s), 1.47 (s), 1.46 (s), 1.35 (s)], three protons of conformers 
[1.28 (app d, J = 7 Hz), 1.24 (d, J = 7 Hz), 1.16 (d, J = 7 Hz)]; 
13
C NMR (300 MHz, CDCl3) δ 
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167.9, 167.4, 167.3, 166.3, 166.2, 156.1, 155.9, 155.8, 155.6, 155.1, 144.0, 143.9, 143.7, 141.2, 
140.7, 140.6, 136.0, 135.8, 135.6, 135.0, 131.5, 131.1, 131.0, 130.8, 127.7, 127.5, 127.3, 127.1, 
126.9, 126.6, 125.2, 124.0, 123.4, 119.9, 107.7, 106.8, 106.7, 106.3, 82.6, 82.5, 82.1, 67.4, 67.1, 
66.8,  65.9,  65.8,  52.4, 48.0, 47.6, 47.1, 47.0, 37.1, 36.8, 36.8, 29.7, 28.0, 27.9, 19.6, 19.3,  14.9,   
14.7,  14.5; HRMS (EI) m/z calcd for C42H44N2O11 752.2945, found 752.2913.    = +34.6, 
c = 1.00, CHCl3. 
 
2-((3'-(2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-N-methylacetamido)-6-(2-(tert-
butoxy)-2-oxoethoxy)-4-(methoxycarbonyl)-2'-methyl-[1,1'-biphenyl]-2-yl)oxy)acetic acid 
(34). To 0.125 g (0.15 mmol) of carboxylate 28 and 0.013 g of 10% Pd/C in a round-bottom 
flask was added 1.8 mL of a 9:1 MeOH/H2O solution. The flask was sealed with a septum; a 
balloon attached to a syringe needle and filled with hydrogen gas was inserted. The reaction 
mixture was stirred at room temperature for 4 h, after which the solution was filtered through a 
pad of Celite and further eluted with ethyl acetate (200 mL). The volatile components were 
removed under reduced pressure to give 0.11 g (98.5%) of 34 as an off-white foam: Rf 0.17 
(100% ethyl acetate); IR (thin film, cm
-1
) 3405, 2931, 1723, 1663, 1580, 1517, 1422, 1369, 1329, 
1239, 1136, 1057, 1029, 998, 844, 806, 760, 738; 
1
H NMR (500 MHz, CDCl3) δ 7.78 (d, J = 8 
Hz, 2H), 7.61 (app d, J = 5 Hz, 2H), 7.42 (t, J = 8 Hz, 2H), 7.38-7.25 (m, 6H), 7.16 (app d, J = 7 
Hz, 1H), one proton of conformers [6.17 (app t, J = 4 Hz), 5.77 (broad s)], 4.60-4.48 (m, 4H), 
4.46-4.38 (m, 2H), 4.22 (t, J = 7 Hz, 1H), three protons of conformers [3.96 (s), 3.92 (s)], 3.76-
3.65 (m, 2H), three protons of conformers [3.32 (s), 3.29 (s)], three protons of conformers [2.05 
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(s), 2.02 (s)], nine protons of conformers [1.48 (s), 1.42 (s)]; 
13
C NMR (300 MHz, CDCl3) δ 
169.7, 168.4, 167.4, 166.2, 157.1, 155.9 ,155.8, 143.7, 143.7, 141.2, 139.9, 136.0, 135.7, 135.4, 
131.6, 131.1, 127.7, 127.1, 127.0, 125.2, 125.2, 124.0, 123.5, 120.0, 119.8, 106.7, 82.6, 82.3, 
67.7, 66.3, 65.8, 52.5, 47.1, 46.9, 43.1, 36.6, 36.3, 28.0, 28.0, 14.6, 14.4; HRMS (Q-TOF) m/z 
calcd for [M+Na]
+
 C41H42N2O11Na 761.2686, found 761.2667. 
 
Methyl 3'-((S)-2-acetamido-N-methylpropanamido)-2-(2-(tert-butoxy)-2-oxoethoxy)-6-(2-
(dimethylamino)-2-oxoethoxy)-2'-methyl-[1,1'-biphenyl]-4-carboxylate (35). To a round-
bottom flask equipped with a condenser and nitrogen gas inlet were added 0.044 g (0.06 mmol) 
of acid 33, 0.005 g (0.06 mmol) of dimethylamine hydrochloride, 0.011 g (0.06 mmol) of N-
ethyl-N′-(3-dimethylaminopropyl)carbodiimide hydrochloride, 0.008 g (0.06 mmol) of N-
hydroxybenzotriazole, 0.03 mL (0.19 mmoL) of triethylamine, and acetonitrile (1.02 mL). The 
reaction mixture was stirred at room temperature for 80 h, and the volatile components were 
removed under reduced pressure to give a crude brown solid. The solid was purified by flash 
chromatography (SiO2, ethyl acetate/methanol, elution gradient 1:0/9:1/4:1/1:1) to give 0.044 g 
(0.079 mmol) of impure oil. To a solution of the oil dissolved in CH2Cl2 (0.61 mL) at room 
temperature was added 0.02 mL (0.16 mmol) of acetic anhydride, and the reaction mixture was 
stirred for 30 min. The solution was basified dropwise with saturated K2CO3 solution (pH 9) and 
extracted with CH2Cl2 (3  5 mL). The organic layers were washed with water (2  4 mL), dried 
over MgSO4 and filtered, and the volatile components were removed under reduced pressure to 
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give a light brown crude oil. The oil was purified by flash chromatography (SiO2, hexanes/ethyl 
acetate/methanol, elution gradient 1:1:0/0:1:0/0:9:1) to give 0.018 g (51.6%) of 35 as a yellow 
oil: Rf 0.10 (100% ethyl acetate); IR (thin film, cm
-1
) 3323, 2931, 1750, 1722, 1650, 1580, 1502, 
1422, 1393, 1369, 1324, 1236, 1127, 1024, 996, 845, 807, 732; 
1
H NMR (500 MHz, CDCl3) δ 
7.36-7.23 (m, 3H), 7.23-7.12 (m, 2H), one proton of conformers [6.59-6.51 (m, J = 8 Hz), 6.46 
(d, J = 8 Hz)], five protons of conformers [4.96 (d, J = 15 Hz), 4.84 (d, J = 15 Hz), 4.78 (d, J = 
17 Hz), 4.75 (d, J = 15 Hz), 4.71-4.61 (m), 4.59-4.47 (m), 4.39 (quintet, J = 7 Hz), 4.33 (quintet, 
J = 7 Hz)], three protons of conformers [3.95 (s), 3.95 (s), 3.93 (s)], three protons of conformers 
[3.30 (s), 3.29 (s), 3.26 (s), 3.24 (s)], six protons of conformers [2.94 (s), 2.93 (s), 2.92 (s), 2.91 
(s), 2.90 (s), 2.87 (s), 2.84 (s)], six protons of conformers [2.06 (s), 2.01 (s), 2.01 (s), 2.00 (s), 
1.93 (s), 1.92 (s)], nine protons of conformers [1.47 (s), 1.47 (s), 1.46 (s)], three protons of 
conformers [1.19 (t, J = 6 Hz), 1.08 (d, J = 6 Hz), 1.05 (d, J = 6 Hz)]; 
13
C NMR (500 MHz, 
CDCl3) δ 173.5, 173.2, 173.1, 173.0, 169.1, 169.0, 168.5, 168.4, 168.1, 167.8, 167.5, 167.5, 
167.3, 167.1, 167.0, 166.9, 166.5, 166.4, 166.3, 156.4, 156.1, 155.9, 155.8, 155.8, 155.7, 155.5, 
140.9, 140.8, 136.0, 136.0, 135.9, 135.8, 135.2, 131.4, 131.2, 131.1, 131.0, 130.9, 130.9, 130.6, 
130.4, 127.7, 127.5, 127.0, 126.9, 126.9, 126.8, 126.4, 126.4, 123.4, 123.3, 123.0, 106.7, 106.6, 
106.5, 106.4, 106.3, 106.1, 106.1, 106.0, 82.5, 82.5, 81.9, 67.6, 67.3, 66.9, 65.9, 65.8, 65.7, 65.4, 
52.4, 52.4, 46.6, 46.5, 46.3, 46.2, 36.9, 36.8, 36.7, 36.4, 36.3, 36.1, 35.7, 35.6, 35.5, 29.7, 28.0, 
28.0, 23.4, 23.3, 19.4, 19.2, 17.8, 17.5, 15.0, 15.0, 14.7; HRMS (EI) m/z calcd for C31H41N3O9 
599.2843, found 599.2837.  = +40.3, c = 1.00, CHCl3. 
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Methyl 3'-(2-acetamido-N-methylacetamido)-2-(2-(tert-butoxy)-2-oxoethoxy)-6-(2-(dimethyl 
amino)-2-oxoethoxy)-2'-methyl-[1,1'-biphenyl]-4-carboxylate (36). To a round-bottom flask 
equipped with a condenser and nitrogen gas inlet were added 0.049 g (0.07 mmol) of acid 34, 
0.005 g (0.07 mmol) of dimethylamine hydrochloride, 0.013 g (0.07 mmol) of N-ethyl-N′-(3-
dimethylaminopropyl)carbodiimide hydrochloride, 0.009 g (0.07 mmol) of N-
hydroxybenzotriazole, 0.031 mL (0.22 mmoL) of triethylamine, and acetonitrile (1.15 mL). The 
reaction mixture was stirred at room temperature for 80 h, and the volatile components were 
removed under reduced pressure to give a crude brown solid. The solid was purified by flash 
chromatography (SiO2, ethyl acetate/methanol, elution gradient 9:1/4:1/1:1) to give 0.048 g (0.09 
mmol) of impure oil. To a solution of the oil dissolved in CH2Cl2 (0.68 mL) at room temperature 
was added 0.02 mL (0.18 mmol) of acetic anhydride, and the reaction mixture was stirred for 30 
min. The solution was basified dropwise with saturated K2CO3 solution (pH 9) and extracted 
with CH2Cl2 (3  5 mL). The organic layers were washed with water (2  4 mL), dried over 
MgSO4 and filtered, and the volatile components were removed under reduced pressure to give a 
light brown crude oil. The oil was purified by flash chromatography (SiO2, hexanes/ethyl 
acetate/methanol, elution gradient 1:1:0/0:1:0/0:9:1) to give 0.019 g (47.8%) of 36 as a yellow 
oil: Rf 0.09 (100% ethyl acetate); IR (thin film, cm
-1
) 3338, 2931, 1749, 1722, 1657, 1580, 1503, 
1422, 1369, 1325, 1237, 1128, 1025, 996, 844, 807, 733; 
1
H NMR (500 MHz, CDCl3) δ 7.34-
7.27 (m, 3H), 7.20 (app s, 1H), 7.17-7.12 (m, 1H), one proton of conformers [6.52 (app t), 6.49 
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(app t)], 4.79 (s, 1H), three protons of conformers [4.73 (d, J = 14 Hz), 4.69 (d, J = 14 Hz), 4.63 
(d, J = 17 Hz), 4.56-4.48 (m)], 3.93 (s, 3H), two protons of conformers [3.78-3.60 (m, J = 4, 18 
Hz), 3.54 (dd, J = 4, 18 Hz)], three protons of conformers [3.31 (s), 3.29 (s)], six protons of 
conformers [2.93 (s), 2.91 (s), 2.89 (s), 2.89 (s)], six protons of conformers [2.05 (s), 2.04 (s), 
2.00 (s)], nine protons of conformers [1.47 (s), 1.47 (s)]; 
13
C NMR (500 MHz, CDCl3) δ 169.7, 
169.6, 168.9, 168.6, 167.7, 167.4, 167.3, 167.0, 166.4, 166.4, 156.1, 155.9, 155.8, 155.6, 155.3, 
140.1, 140.1, 136.0, 136.0, 135.8, 135.7, 131.4, 131.3, 131.0, 131.0, 126.9, 126.9, 126.8, 126.8, 
123.1, 123.0, 106.6, 106.4, 106.2, 106.0, 82.5, 82.3, 67.2, 67.0, 65.9, 65.5, 53.5, 52.4, 42.2, 42.1, 
36.4, 36.3, 35.7, 35.6, 29.7, 28.0, 23.1, 14.6; HRMS (EI) m/z calcd for C30H39N3O9 585.2686, 
found 585.2686. 
 
Methyl 3'-(3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-N-methylpropanamido)-2-(2-
(benzyloxy)-2-oxoethoxy)-6-(2-(tert-butoxy)-2-oxoethoxy)-2'-methyl-[1,1'-biphenyl]-4-
carboxylate (38). To 0.20 g (0.37 mmol) of carboxylate 3 in 4.0 mL of CHCl3 was added 0.15 g 
(0.55 mmol) of Fmoc-β-alanine acid chloride 37-int (generated according to General Procedure 
A and used immediately thereafter) in 2.5 mL of CHCl3 followed by 4.0 mL of saturated 
NaHCO3 solution, and the reaction mixture was stirred at room temperature for 20 min. The 
solution was diluted with CH2Cl2 (60 mL) and saturated NaHCO3 solution (60 mL), the organic 
layer was extracted, and the aqueous layer was washed with CH2Cl2 (3  60 mL). The organics 
were dried over MgSO4 and filtered, and the volatile components were removed under reduced 
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pressure to give a light brown crude oil. The oil was purified by flash chromatography (SiO2, 
hexanes/ethyl acetate, elution gradient 4:1/2:1/1:1) to give 0.25 g (81.9%) of 38 as a white foam: 
Rf 0.14 (hexanes/ethyl acetate 3:2); IR (thin film, cm
-1
) 3411, 2950, 1752, 1721, 1648, 1581, 
1504, 1421, 1391, 1369, 1329, 1238, 1193, 1135, 1078, 999, 759, 739; 
1
H NMR (500 MHz, 
CDCl3) δ 7.77 (t, J = 7 Hz, 2H), 7.62 (d, J = 7 Hz, 1H), 7.59 (d, J = 7 Hz, 1H), 7.44-7.38 (m, 
2H), 7.38-7.28 (m, 7H), 7.28-7.23 (m, 3H), 7.21 (d, J = 7 Hz, 1H), 7.16-7.11 (m, 1H), 5.80-5.72 
(m, 1H), 5.22-5.09 (m, 2H), 4.71-4.60 (m, 2H), 4.57-4.44 (m, 2H), 4.34 (d, J = 8 Hz, 1H), 4.32 
(d, J = 8 Hz, 1H), 4.21 (quartet, J = 8 Hz, 1H), three protons of conformers [3.94 (s), 3.94 (s)], 
3.52-3.40 (m, 2H), three protons of conformers [3.29 (s), 3.26 (s)], 2.39-2.19 (m, 2H), three 
protons of conformers [1.98 (s), 1.97 (s)], nine protons of conformers [1.47 (s), 1.45 (s)]; 
13
C 
NMR (300 MHz, CDCl3) δ 172.2, 168.1, 167.9, 167.4, 167.2, 166.1, 156.3, 155.9, 155.7, 144.1, 
142.0, 141.3, 135.4, 135.1, 130.9, 130.8, 128.6, 126.6, 128.5, 128.5, 128.4, 127.6, 127.0, 126.7, 
125.2, 123.6, 120.0, 106.7, 106.5, 106.2, 106.1, 82.5, 82.4, 77.7, 77.5, 77.3, 76.9, 67.0, 66.6, 
65.9, 65.8, 65.3, 52.4, 47.2, 37.1, 35.9, 34.2, 28.0, 14.5; HRMS (Q-TOF) m/z calcd for [M+Na]
+
 
C49H50N2O11Na 865.3312, found 865.3262. 
 
Methyl 3'-(3-acetamido-N-methylpropanamido)-2-(2-(benzyloxy)-2-oxoethoxy)-6-(2-(tert-
butoxy)-2-oxoethoxy)-2'-methyl-[1,1'-biphenyl]-4-carboxylate (39). To 0.231 g (0.27 mmol) 
of carboxylate 38 dissolved in CH2Cl2 (0.83 mL) was added 0.37 mL (2.47 mmol) of 1,8-
diazabicyclo[5.4.0]undec-7-ene, and the reaction mixture was stirred at room temperature for 20 
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min. The volatile components were removed under reduced pressure, and the residue was 
dissolved in CH2Cl2 (2.11 mL). Then 0.05 mL (0.55 mmol) of acetic anhydride and 0.04 mL 
(0.55 mmol) of pyridine were added, and the solution was stirred at room temperature for 30 
min. The volatile components were removed under reduced pressure; methanol (5.0 mL) and 
water (5.0 mL) were added to the residue, upon which a white solid formed and dissolved back 
into solution. The aqueous solution was extracted with ethyl acetate (3  15 mL); the organics 
were dried over MgSO4 and filtered, and the volatile components were removed under reduced 
pressure to give a yellow crude oil. The oil was purified by flash chromatography (SiO2, 
hexanes/ethyl acetate/methanol elution gradient 1:1:0/0:1:0/0:9:1/0:4:1) to give 0.091 g (50%) of 
39 as a white foam: Rf 0.18 (100% ethyl acetate); IR (thin film, cm
-1
) 3404, 2951, 1750, 1723, 
1652, 1581, 1531, 1422, 1392, 1369, 1329, 1235, 1192, 1135, 1029, 997, 845, 807, 770, 733, 
699, 452; 
1
H NMR (500 MHz, CDCl3) δ 7.46-7.19 (m, 9H), 7.11 (app ddd, J = 1, 4, 8 Hz, 1H), 
one proton of conformers [6.54 (broad s), 6.01 (broad s)], 5.24-5.16 (m, 2H), 4.69 (app s, 2H), 
4.54-4.49 (m, 2H), three protons of conformers [3.97 (s), 3.93 (s), 3.93 (s)], 3.54-3.38 (m, 2H), 
three protons of conformers [3.30 (s), 3.27 (s), 3.24 (s)], 2.31-2.14 (m, 2H), six protons of 
conformers [1.98 (s), 1.98 (s), 1.96 (s), 1.95 (s), 1.94 (s)], nine protons of conformers [1.50 (s), 
1.48 (s), 1.47 (s)]; 
13
C NMR (300 MHz, CDCl3) δ 172.6, 169.8, 168.1, 168.0, 167.3, 167.2, 
166.1, 155.8, 155.7, 155.6, 141.8, 135.3, 135.1, 135.0, 130.9, 128.6, 128.5, 128.5, 128.4, 128.3, 
127.0, 126.7, 123.5, 106.6, 106.4, 106.1, 106.0, 82.5, 82.4, 67.0, 65.9, 65.8, 65.3, 65.2, 52.4, 
36.3, 35.9, 35.2, 33.8, 28.0, 28.0, 23.3, 15.45, 14.4; HRMS (Q-TOF) m/z calcd for [M+Na]
+
 
C36H42N2O10Na 685.2737, found 685.2714. 
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2-((3'-(3-Acetamido-N-methylpropanamido)-6-(2-(tert-butoxy)-2-oxoethoxy)-4-(methoxy 
carbonyl)-2'-methyl-[1,1'-biphenyl]-2-yl)oxy)acetic acid (40). To 0.07 g (0.11 mmol) of 
carboxylate 39 and 0.008 g of 10% Pd/C in a round-bottom flask was added 1.26 mL of a 9:1 
MeOH/H2O solution. The flask was sealed with a septum; a balloon attached to a syringe needle 
and filled with hydrogen gas was inserted. The reaction mixture was stirred at room temperature 
for 4 h, after which the solution was filtered through a pad of Celite and further eluted with ethyl 
acetate (150 mL). The volatile components were removed under reduced pressure to give 0.060 g 
(99.7%) of 40 as an off-white foam: Rf 0.09 (100% ethyl acetate); IR (thin film, cm
-1
) 3385, 
2932, 2361, 1750, 1723, 1652, 1581, 1436, 1421, 1393, 1369, 1329, 1236, 1135, 1028, 997; 
1
H 
NMR (500 MHz, CDCl3) δ 7.37-7.20 (m, 4H), 7.12 (d, J = 7 Hz, 1H), one proton of conformers 
[6.89 (broad s), 6.60 (broad s), 6.02 (broad s)], 4.67-4.45 (m, 4H), three protons of conformers 
[3.97 (s), 3.96 (s)], 3.68-3.56 (m, 1H), 3.34-3.22 (m, 4H), two protons of conformers [2.58-2.49 
(m), 2.40-2.31 (m), 2.21-2.14 (m)], six protons of conformers [1.99 (s), 1.98 (s), 1.96 (s), 1.95 
(s)], nine protons of conformers [1.49 (s), 1.47 (s)]; 
13
C NMR (300 MHz, CDCl3) δ 172.7, 172.5, 
172.0, 169.7, 167.4, 167.3, 166.2, 155.9, 155.8, 155.6, 141.7, 135.5, 135.3, 131.7, 131.6, 131.1, 
131.0, 128.2, 127.7, 126.9, 126.7, 123.7, 123.4, 108.6, 107.7, 106.9, 106.7, 106.3, 82.8, 82.5, 
82.4, 68.9, 66.2, 65.8, 53.4, 52.5, 52.4, 37.4, 36.3, 35.9, 35.6, 35.2, 33.7, 32.9, 28.0, 23.2, 23.0, 
15.4, 14.5; HRMS (Q-TOF) m/z calcd for [M+Na]
+
 C29H36N2O10Na 595.2268, found 595.2229. 
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Methyl-3'-(3-acetamido-N-methylpropanamido)-2-(2-(tert-butoxy)-2-oxoethoxy)-6-(2-
(dimethylamino)-2-oxoethoxy)-2'-methyl-[1,1'-biphenyl]-4-carboxylate (41). To a round-
bottom flask equipped with a condenser and nitrogen gas inlet were added 0.040 g (0.07 mmol) 
of acid 40, 0.008 g (0.07 mmol) of dimethylamine hydrochloride, 0.013 g (0.07 mmol) of N-
ethyl-N′-(3-dimethylaminopropyl)carbodiimide hydrochloride, 0.009 g (0.07 mmol) of N-
hydroxybenzotriazole, 0.03 mL (0.23 mmoL) of triethylamine, and acetonitrile (1.73 mL). The 
reaction mixture was stirred at room temperature for 80 h, and the volatile components were 
removed under reduced pressure to give a crude brown solid. The solid was purified by flash 
chromatography (SiO2, hexanes/ethyl acetate/methanol, 1:1:0/0:1:0/0:9:1) to give 0.031 g 
(73.6%) of 41 as a colorless oil: Rf 0.11 (100% ethyl acetate); IR (thin film, cm
-1
) 3324, 2931, 
1749, 1722, 1654, 1580, 1421, 1391, 1369, 1325, 1237, 1128, 996, 844, 808, 733; 
1
H NMR (500 
MHz, CDCl3) δ 7.32-7.24 (m, 3H), 7.20 (app dd, J = 1, 6 Hz, 1H), 7.11 (app dd, J = 1, 6 Hz, 
1H), one proton of conformers [6.75 (app t, J = 6 Hz), 6.65 (app t, J = 6 Hz)], 4.74-4.66 (m, 2H), 
4.56-4.47 (m, 2H), 3.94 (s, 3H), 3.54-3.37 (m, 2H), three protons of conformers [3.25 (s), 3.24 
(s)], six protons of conformers [2.92 (s), 2.92 (s), 2.87 (s)], 2.31-2.10 (m, 2H), six protons of 
conformers [1.99 (s), 1.95 (s), 1.94 (s)], nine protons of conformers [1.46 (s), 1.46 (s)]; 
13
C NMR 
(500 MHz, CDCl3) δ 172.7, 172.3, 170.4, 170.2, 167.4, 167.3, 167.1, 167.0, 166.4, 166.3, 156.0, 
155.9, 155.7, 141.7, 135.6, 135.5, 135.3, 135.3, 131.0, 131.0, 130.9, 126.9, 126.9, 126.7, 126.5, 
125.2, 123.3, 123.3, 118.2, 110.6, 106.7, 106.5, 106.4, 106.3, 82.5, 82.5, 67.2, 66.8, 65.9, 65.8, 
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52.4, 36.3, 36.2, 36.0, 35.9, 35.7, 35.3, 35.3, 35.3, 33.7, 29.7, 28.0, 28.0, 23.3, 23.3, 14.5; HRMS 
(EI) m/z calcd for C31H41N3O9 599.2843, found 599.2847. 
 
Methyl 3'-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-N-methylpropanamido)-2-
(2-((2-(benzyloxy)-2-oxoethyl)amino)-2-oxoethoxy)-6-(2-(tert-butoxy)-2-oxoethoxy)-2'-
methyl-[1,1'-biphenyl]-4-carboxylate (42). A solution of 0.040 g (0.053 mmol) of acid 33 and 
0.011 g (0.053 mmol) of glycine benzyl ester hydrochloride in CH2Cl2/DMF (3:1, 0.28 mL) was 
treated sequentially at 0 °C with 0.005 g (0.053 mmol) of NaHCO3, 0.008 g (0.058 mmol) of N-
hydroxybenzotriazole, and 0.011 g (0.058 mmol) of N-ethyl-N′-(3-dimethylaminopropyl) 
carbodiimide hydrochloride. The reaction mixture was stirred at 0 °C for 2 h and at room 
temperature for 16 h, and then quenched with H2O (1.0 mL). The aqueous layer was extracted 
with ethyl acetate (3  5 mL), and the combined organic layers were washed with H2O (7 mL) 
and brine (7 mL), dried over MgSO4 and filtered, and the volatile components were removed 
under reduced pressure to give a yellow crude oil. The oil was purified by flash chromatography 
(SiO2, hexanes/ethyl acetate, 1:1/0:1) to give 0.047 g (99%) of 42 as a yellow oil/foam: Rf 0.74 
(100% ethyl acetate); IR (thin film, cm
-1
) 3408, 2929, 1749, 1721, 1657, 1580, 1531, 1450, 1419, 
1392, 1369, 1328, 1238, 1193, 1130, 1029, 998, 738; 
1
H NMR (300 MHz, CDCl3) δ 7.86-7.70 
(m, 3H), 7.70-7.50 (m, 2H), 7.48-7.13 (m, 13H), one proton of conformers [6.92 (app t), 6.50 
(app t), 6.39 (app t, J = 5 Hz)], one proton of conformers [5.79 (d, J = 8 Hz), 5.73 (d, J = 8 Hz), 
5.64 (d, J = 8 Hz), 5.56 (d, J = 9 Hz)], 5.16-5.00 (m, 2H), 4.72-4.02 (m, 10H), 4.01-3.90 (m, 
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3H), three protons of conformers [3.43 (s), 3.29 (s), 3.28 (s), 3.27 (s), 3.23 (s)], three protons of 
conformers [2.07 (s), 2.04 (s), 2.03 (s), 2.01 (s), 1.93 (s), 1.90 (s), 1.89 (s)], nine protons of 
conformers [1.46 (s), 1.45 (s), 1.33 (s)], three protons of conformers [1.21 (d, J = 7 Hz), 1.15 (d, 
J = 7 Hz), 1.11 (d, J = 7 Hz), 1.05 (d, J = 7 Hz)]; 
13
C NMR (500 MHz, CDCl3) δ 173.5, 173.2, 
169.1, 169.0, 168.8, 168.6, 167.9, 167.8, 167.2, 167.2, 166.1, 156.2, 155.8, 155.7, 155.6, 155.2, 
155.0, 144.0, 143.9, 143.8, 143.8, 143.7, 141.4, 141.3, 141.2, 140.7, 136.0, 135.8, 135.5, 135.4, 
135.3, 135.1, 135.0, 131.5, 131.3, 130.7, 130.5, 130.1, 128.7, 128.7, 128.6, 128.5, 128.5, 128.4, 
128.4, 128.3, 128.2, 128.1, 127.7, 127.3, 127.1, 126.9, 126.8, 126.6, 126.5, 125.3, 125.2, 124.0, 
123.1, 120.1, 120.0, 117.0, 111.3, 107.0, 106.7, 82.7, 82.6, 82.2, 68.7, 67.6, 67.6, 67.3,  67.2, 
67.0,  66.9,  66.9, 66.8, 65.9, 65.4, 52.6, 52.5, 47.9, 47.4, 47.3, 47.1, 47.1, 47.0,  40.9, 40.7,  40.7,  
36.8, 36.6, 36.5, 29.7, 28.0, 27.9, 19.7, 19.5, 18.0, 14.9, 14.8, 14.5;   = +22.4, c = 1.00, 
CHCl3. 
 
Methyl 3'-(2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-N-methylacetamido)-2-(2-((2-
(benzyloxy)-2-oxoethyl)amino)-2-oxoethoxy)-6-(2-(tert-butoxy)-2-oxoethoxy)-2'-methyl-
[1,1'-biphenyl]-4-carboxylate (43). A solution of 0.042 g (0.057 mmol) of acid 34 and 0.012 g 
(0.057 mmol) of glycine benzyl ester hydrochloride in CH2Cl2/DMF (3:1, 0.30 mL) was treated 
sequentially at 0 °C with 0.005 g (0.057 mmol) of NaHCO3, 0.009 g (0.063 mmol) of N-
hydroxybenzotriazole, and 0.012 g (0.063 mmol) of N-ethyl-N′-(3-dimethylaminopropyl)- 
carbodiimide hydrochloride. The reaction mixture was stirred at 0 °C for 2 h and at room 
temperature for 16 h, and then quenched with H2O (1.0 mL). The aqueous layer was extracted 
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with ethyl acetate (3  5 mL), and the combined organic layers were washed with H2O (7 mL) 
and brine (7 mL), dried over MgSO4 and filtered, and the volatile components were removed 
under reduced pressure to give a yellow crude oil. The oil was purified by flash chromatography 
(SiO2, hexanes/ethyl acetate, 1:1/0:1) to give 0.047 g (93.2%) of 43 as a yellow oil/foam: Rf 0.60 
(100% ethyl acetate); IR (thin film, cm
-1
) 3408, 3065, 2930, 1748, 1721, 1667, 1581, 1529, 1420, 
1393, 1369, 1328, 1239, 1193, 1132, 1059, 999, 917, 844, 806, 738; 
1
H NMR (300 MHz, 
CDCl3) δ 7.85-7.71 (m, 3H), 7.63-7.51 (m, 3H), 7.46-7.10 (m, 13H), one proton of conformers 
[6.51 (t, J = 5 Hz), 6.45 (t, J = 5 Hz)], one proton of conformers [5.74 (t, J = 5 Hz), 5.63 (t, J = 5 
Hz)], 5.15 (s, 1H), one proton of conformers [5.07 (d, J = 12 Hz),  5.01 (d, J = 12 Hz)], 4.64-4.42 
(m, 4H), 4.40-3.91 (m, 9H), two protons of conformers [3.69 (quartet of doublets, J = 5, 18 Hz), 
3.45 (dd, J = 5, 18 Hz)], three protons of conformers [3.33 (s), 3.31 (s), 3.27 (s)], three protons of 
conformers [2.03 (s), 2.00 (s), 1.90 (s)], nine protons of conformers [1.47 (s), 1.46 (s), 1.40 (s)]; 
13
C NMR (500 MHz, CDCl3) δ 169.2, 169.0, 168.8, 167.8, 167.8, 167.4, 167.2, 166.0, 157.8, 
156.2, 156.1, 155.9, 155.8, 155.1, 154.9, 143.8, 141.5, 141.2, 140.7, 140.7, 140.6, 135.7, 135.5, 
135.4, 135.3, 135.2, 135.1, 134.8, 131.4, 131.0, 130.9, 130.9, 130.1, 129.4, 129.1, 128.7, 128.6, 
128.6, 128.5, 128.4, 128.4, 128.3, 127.8, 127.7, 127.6, 127.5, 127.4, 127.3, 127.1, 126.7, 126.6, 
125.2, 125.2, 124.4, 123.2, 120.4, 120.1, 120.0, 116.8, 111.5, 107.0, 106.9, 90.6, 82.7, 82.6, 82.5, 
67.7, 67.6, 67.3, 67.2, 67.1, 65.9, 65.7, 65.6, 64.7, 52.6, 47.1, 47.0, 43.4, 43.1, 40.9, 40.7, 36.4, 
36.3, 29.7, 28.0, 28.0, 14.6, 14.5, 14.5.  
 
2-Bromo-N,N-dimethylacetamide (62). To 1.05 mL (12.7 mmol) of bromoacetyl chloride 65 
and 1.25 g (15.2 mmol) of dimethylamine hydrochloride in a round-bottom flask equipped with a 
condenser and nitrogen gas inlet were added CH2Cl2 (72.2 mL) and 4.4 mL (33.3 mmol) of 
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triethylamine, and the mixture was stirred for 2 h at room temperature. The mixture was washed 
with 2.0 M HCl (40 mL), 2.0 M NaOH (40 mL) and brine (40 mL); the organic layer was dried 
over MgSO4 and filtered, and the volatile components were removed under reduced pressure to 
give 0.82 g (38.6%) of 62 as a yellow oil: Rf 0.52 (hexanes/ethyl acetate, 4:1); IR (thin film, cm
-
1
) 3419, 2945, 1736, 1649, 1503, 1467, 1405, 1259, 1201, 1148, 1081, 1024, 980, 931, 794, 750; 
1
H NMR (300 MHz, CDCl3) δ 4.08 (s, 2H), 3.10 (s, 3H), 2.99 (s, 3H); 
13
C NMR (300 MHz, 
CDCl3) δ 166.4, 41.2, 37.6, 35.9; HRMS (Q-TOF) m/z calcd for [M+Na]
+
 C4H8NOBrNa 
187.9687, found 187.9660. 
 
Methyl-4-bromo-3-(2-(tert-butoxy)-2-oxoethoxy)-5-(2-(dimethylamino)-2-oxoethoxy) 
benzoate (46). In a round-bottom flask, 1.08 g (3.0 mmol) of benzoate 10, 0.55 g (3.3 mmol) of 
dimethylacetamide 62, and 0.5 g (3.6 mmol) of K2CO3 were dissolved in acetone (15.0 mL), and 
the reaction mixture was refluxed for 18 h. The volatile components were removed under 
reduced pressure, and the residue was diluted with ethyl acetate (30 mL) and water (30 mL); the 
organic layer was extracted, and the aqueous layer was washed with additional ethyl acetate (3  
30 mL). The organic layers were dried over MgSO4 and filtered, and the volatile components 
were removed under reduced pressure to give a crude yellow oil. The oil was purified by flash 
chromatography (SiO2, hexanes/ethyl acetate elution gradient 7:1/4:1/2:1/0:1) to give 1.54 g 
(78.8%) of 46 as a white solid: Rf 0.13 (hexanes/ethyl acetate, 1:1); mp 110-112 °C; IR (thin 
film, cm
-1
) 3480, 2980, 2951, 1750, 1723, 1667, 1586, 1501, 1423, 1368, 1332, 1242, 1158, 
1127, 1064, 1026, 845, 808, 761; 
1
H NMR (400 MHz, CDCl3) δ 7.15 (s, 1H), 7.03 (s, 1H), 4.74 
(s, 2H), 4.57 (s, 2H), 3.80 (s, 3H), 3.02 (s, 3H), 2.88 (s, 3H), 1.40 (s, 9H); 
13
C NMR (400 MHz, 
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CDCl3) δ 166.9, 166.6, 165.8, 155.7, 155.5, 130.0, 107.6, 107.1, 106.9, 82.7, 68.0, 66.4, 52.4, 
36.6, 35.6, 27.9; HRMS (Q-TOF) m/z calcd for [M+Na]
+
 C18H24NO7BrNa 468.0634, found 
468.0623. 
 
Methyl-2-(2-(tert-butoxy)-2-oxoethoxy)-6-(2-(dimethylamino)-2-oxoethoxy)-2'-methyl-3'-
(methylamino)-[1,1'-biphenyl]-4-carboxylate (45). In a resealable oven-dried Schlenk flask 
containing a magnetic stir bar, 1.45 g (3.25 mmol) of benzoate 46, 1.21 g (4.88 mmol) of boronic 
ester 5, 0.12 g (0.13 mmol) of tris[dibenzylideneacetone]dipalladium(0), 0.21 g (0.52 mmol) of 
2-dicyclohexylphosphino-2′,6′-dimethoxybiphenyl (SPhos ligand), and 2.25 g (9.76 mmol) of 
K3PO4 monohydrate were added and dried under reduced pressure for 2 min. Toluene (6.5 mL) 
was added, and the solution was degassed using the freeze-pump-thaw method three times under 
a nitrogen atmosphere. The Schlenk flask was sealed; the reaction mixture was vigorously stirred 
at 90 °C for 16 h, and cooled to room temperature. The mixture was diluted with CH2Cl2 (20 
mL) and water (20 mL); the organic layer was extracted, and the aqueous layer was washed with 
additional CH2Cl2 (3  20 mL). The organic layers were dried over MgSO4 and filtered, and the 
volatile components were removed under reduced pressure to give a brown crude oil. The oil was 
purified by flash chromatography (SiO2, hexanes/ethyl acetate elution gradient 12:1/10:1/5:1) to 
give 0.38 g (24.3%) of 45 as an orange oil: Rf 0.33 (100% ethyl acetate); IR (thin film, cm
-1
) 
3583, 3431, 2979, 2931, 2815, 1750, 1721, 1665, 1587, 1493, 1421, 1368, 1350, 1324, 1235, 
1160, 1127, 1077, 1019, 996, 754, 723; 
1
H NMR (400 MHz, CDCl3) δ 7.36 (d, J = 1 Hz, 1H), 
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7.20 (s, 1H), 7.18 (d, J = 8 Hz, 1H), 6.64 (t, J = 8 Hz, 2H), 4.64 (s, 2H), 4.49 (s, 2H), 3.93 (s, 
3H), 3.68 (broad s, 1H), 2.94 (s, 3H), 2.89 (s, 3H), 2.78 (s, 3H), 1.91 (s, 3H), 1.46 (s, 9H); 
13
C 
NMR (400 MHz, CDCl3) δ 167.8, 167.4, 166.5, 156.3, 156.1, 147.0, 133.0, 130.3, 125.9, 125.6, 
121.4, 119.3, 108.6, 107.4, 106.7, 82.3, 68.4, 66.0, 52.3, 36.4, 35.7, 31.0, 28.0, 14.0; HRMS (Q-
TOF) m/z calcd for [M+H]
+
 C26H35N2O7 487.2444, found 487.2446. 
 
Methyl 3'-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-N-methylacetamido)-2-(2-(tert-
butoxy)-2-oxoethoxy)-6-(2-(dimethylamino)-2-oxoethoxy)-2'-methyl-[1,1'-biphenyl]-4-
carboxylate (63). To 0.38 g (0.79 mmol) of carboxylate 45 in 5.0 mL of CHCl3 was added 0.27 
g (0.87 mmol) of Fmoc-glycine acid chloride 21-int (generated according to General Procedure 
A and used immediately thereafter) in 3.0 mL of CHCl3 followed by 3.0 mL of saturated 
NaHCO3 solution, and the reaction mixture was stirred at room temperature for 20 min. The 
solution was diluted with CH2Cl2 (20 mL) and saturated NaHCO3 solution (20 mL), the organic 
layer was extracted, and the aqueous layer was washed with CH2Cl2 (3  20 mL). The organics 
were dried over MgSO4 and filtered, and the volatile components were removed under reduced 
pressure to give a light brown crude oil. The oil was purified by flash chromatography (SiO2, 
hexanes/ethyl acetate elution gradient 2:3/1:10) to give 0.28 g (82.8%) of 63 as a white gel/foam: 
Rf 0.38 (100% ethyl acetate); IR (thin film, cm
-1
) 3410, 2947, 1721, 1663, 1580, 1502, 1421, 
1368, 1325, 1238, 1128, 1056, 997, 756; 
1
H NMR (500 MHz, CDCl3) δ 7.72 (d, J = 7 Hz, 2H), 
7.58 (broad s, 2H), 7.37-7.13 (m, 9H), one proton of conformers [5.86 (broad s), 5.79 (broad s)], 
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4.72-4.46 (m, 4H), 4.32-4.25 (m, 2H), 4.20-4.18 (m, 1H), 3.89 (s, 3H), 3.70-3.54 (m, 2H), three 
protons of conformers [3.29 (s), 3.27 (s)], six protons of conformers [2.87 (s), 2.82 (s), 2.81 (s), 
2.78 (s)], three protons of conformers [2.06 (s), 2.05 (s)], nine protons of conformers [1.45 (s), 
1.39 (s)]; 
13
C NMR (500 MHz, CDCl3) δ 168.6, 167.3, 167.1, 166.9, 166.3, 166.2, 156.2, 156.1, 
156.0, 155.8, 144.0, 143.9, 141.2, 140.4, 136.0, 135.8, 135.8, 131.3, 131.1, 127.6, 127.6, 127.0, 
127.0, 126.8, 126.8, 125.2, 125.1, 125.1, 123.4, 119.9, 119.9, 106.9, 106.5, 106.4, 82.3, 82.2, 
67.4, 67.2, 67.0, 66.1, 65.8, 52.2, 47.2, 43.3, 36.2, 36.2, 35.5, 28.0, 28.0, 14.5; HRMS (Q-TOF) 
m/z calcd for [M+H]
+
 C43H48N3O10 766.3340, found 766.3338. 
 
Methyl-3'-(2-acetamido-N-methylacetamido)-2-(2-(tert-butoxy)-2-oxoethoxy)-6-(2-
(dimethylamino)-2-oxoethoxy)-2'-methyl-[1,1'-biphenyl]-4-carboxylate (64). To 0.27 g (0.36 
mmol) of carboxylate 63 in a round-bottom flask were added 0.48 mL (3.22 mmol) of 1,8-
diazabicyclo[5.4.0]undec-7-ene and DMF (1.08 mL), and the reaction mixture was stirred at 
room temperature for 30 min. Then 0.07 mL (0.72 mmol) of acetic anhydride and 0.06 mL (0.72 
mmol) of pyridine were added, and the solution was stirred at room temperature for 30 min. The 
volatile components were removed under reduced pressure to give a brown crude oil. The oil was 
purified by flash chromatography (SiO2, hexanes/ethyl acetate/methanol elution gradient 
5:1:0/1:1:0/1:10:0/0:1:0/0:9:1) to give 0.18 g (87.5%) of 64 as a yellow gel/foam: Rf 0.22 (100% 
ethyl acetate); IR (thin film, cm
-1
) 3408, 2934, 1749, 1721, 1655, 1580, 1422, 1369, 1325, 1237, 
1128, 1026, 996, 751; 
1
H NMR (400 MHz, CDCl3) δ 7.29-7.25 (m, 3H), 7.17-7.11 (m, 2H), one 
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proton of conformers [6.62 (t, J = 4 Hz), 6.57 (t, J = 4 Hz)], four protons of conformers [4.75 (s); 
4.71,4.63 (ABq, JAB = 14 Hz); 4.60,4.49 (ABq, JAB = 16 Hz); 4.52,4.47 (ABq, JAB = 16 Hz)], 
3.90 (s, 3H), 3.74-3.49 (m, J = 18 Hz, 4 Hz, 2H), three protons of conformers [3.27 (s), 3.25 (s)], 
six protons of conformers [2.89 (s), 2.87 (s), 2.86 (s)], three protons of conformers [2.02 (s), 2.00 
(s), 1.96 (s)], 1.96 (s, 3H), nine protons of conformers [1.43 (s), 1.43 (s)]; 
13
C NMR (400 MHz, 
CDCl3) δ 169.8, 169.7, 168.9, 168.6, 167.7, 167.4, 167.4, 167.0, 166.4, 166.3, 156.1, 155.8, 
155.8, 155.6, 140.1, 135.9, 135.9, 135.7, 135.7, 131.3, 131.3, 131.0, 130.9, 126.9, 126.9, 126.8, 
126.7, 123.1, 123.0, 106.6, 106.4, 106.1, 106.0, 82.5, 82.2, 67.2, 67.0, 65.8, 65.5, 52.4, 42.2, 
42.1, 36.5, 36.3, 36.3, 35.6, 35.6, 28.0, 23.0, 14.5; HRMS (Q-TOF) m/z calcd for [M+H]
+
 
C30H40N3O9 586.2765, found 586.2770. 
 
Methyl-3'-(2-acetamido-N-methylacetamido)-2-(2-(dimethylamino)-2-oxoethoxy)-2'-
methyl-6-(2-(methylamino)-2-oxoethoxy)-[1,1'-biphenyl]-4-carboxylate (44). To a solution of 
0.15 g (0.25 mmol) of carboxylate 64 in CH2Cl2 (0.38 mL) at room temperature was added 0.38 
mL of trifluoroacetic acid, and the reaction mixture was stirred for 2 h. The volatile components 
were removed under reduced pressure to give a brown crude oil. To this crude oil, in a round-
bottom flask equipped with a condenser and nitrogen gas inlet, were added 0.018 g (0.27 mmol) 
of methylamine hydrochloride, 0.052 g (0.27 mmol) of N-ethyl-N′-(3-dimethylaminopropyl)- 
carbodiimide hydrochloride, 0.037 g (0.27 mmol) of N-hydroxybenzotriazole, 0.07 mL (0.37 
mmoL) of N,N-diisopropylethylamine, and CH2Cl2 (1.24 mL). The reaction mixture was stirred 
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at room temperature for 16 h, and then the reaction mixture was diluted with ethyl acetate (10 
mL) and washed with 1.0 M HCl (3 mL) and saturated NaHCO3 solution (3 mL). The organic 
layers were combined, dried over MgSO4 and filtered, and the volatile components were 
removed under reduced pressure to give a reddish brown crude oil. The oil was purified by flash 
chromatography (SiO2, hexanes/ethyl acetate/methanol elution gradient 1:9:0/0:1:0/0:9:1/0:4:1/ 
0:0:1) to give 0.023 g (17.2%) of 44 as an off-white foam/gel: Rf 0.12 (ethyl acetate/methanol, 
3:1); IR (thin film, cm
-1
) 3359, 2923, 2853, 1723, 1658, 1462, 1377, 1260, 1120; 
1
H NMR (400 
MHz, CDCl3) δ 7.40-7.23 (m, 4H), 7.22 (d, J = 8 Hz, 1H), one proton of conformers [6.52 (broad 
s), 6.47 (broad s)], one proton of conformers [6.21 (broad s), 6.08 (broad s), 5.89 (broad d, J = 4 
Hz), four protons of conformers [4.83 (s), 4.77-4.73 (m), 4.56-4.44 (m)], 3.95 (s, 3H), two 
protons of conformers [3.78,3.55 (ABq of doublets, J = 18, 4 Hz), 3.70,3.57 (ABq of doublets, J 
= 18, 4 Hz)], three protons of conformers [3.37 (s), 3.30 (s), 3.28 (s)], six protons of conformers 
[2.94 (s), 2.92 (s), 2.91 (s)], three protons of conformers [2.73 (d, J = 5 Hz), 2.70 (d, J = 5 Hz)], 
six protons of conformers [2.08 (s), 2.04 (s), 2.01 (s), 2.00 (s), 1.91 (s)]; 
13
C NMR (400 MHz, 
CDCl3) δ 169.9, 169.7, 168.6, 168.5, 168.1, 168.1, 167.0, 166.6, 166.2, 166.1, 156.2, 155.9, 
155.4, 154.9, 140.7, 140.7, 136.1, 136.0, 135.9, 135.7, 131.7, 131.7, 131.0, 127.4, 127.2, 127.1, 
127.0, 123.3, 123.1, 107.6, 107.4, 107.2, 107.1, 68.5, 68.1, 66.6, 66.4, 60.4, 53.5, 52.6, 42.1, 
41.6, 36.4, 36.3, 36.1, 35.6, 35.6, 25.7, 25.7, 23.1, 23.0, 21.1, 14.6, 14.5, 14.2; HRMS (Q-TOF) 
m/z calcd for [M+H]
+
 C27H35N4O8 543.2455, found 543.2450. 
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Methyl-3'-(2-((S)-2-acetamidopropanamido)-N-methylacetamido)-2-(2-(benzyloxy)-2-
oxoethoxy)-6-(2-(tert-butoxy)-2-oxoethoxy)-2'-methyl-[1,1'-biphenyl]-4-carboxylate (66). To 
1.33 g (1.61 mmol) of carboxylate 28 in a round-bottom flask were added 2.17 mL (14.5 mmol) 
of 1,8-diazabicyclo[5.4.0]undec-7-ene and DMF (4.83 mL), and the reaction mixture was stirred 
at room temperature for 30 min. The reaction mixture was purified by flash chromatography 
(SiO2, ethyl acetate/methanol elution gradient 9:1/4:1/1:1) to give a crude oil of the free amine 
that was confirmed by 
1
H NMR (300 MHz, CDCl3) δ 7.33-7.09 (m, 10H), 5.16 (s, 2H), 4.65 (d, J 
= 10 Hz, 2H), 4.48 (d, J = 9 Hz, 2H), three protons of conformers [3.91 (s), 3.90 (s)], three 
protons of conformers [3.26 (s), 3.22 (s)], 3.14-3.06 (m, 2H), 2.39 (broad s, 2H), three protons of 
conformers [2.03 (s), 2.02 (s), 1.99 (s), 1.96 (s)], 1.44 (s, 9H). The crude product and 0.21 g 
(1.61 mmol) of N-acetyl alanine 18 were dissolved in CH2Cl2 (6.43 mL), and then 0.34 mL (1.93 
mmol) of N,N-diisopropylethylamine was added via syringe. To avoid epimerization, 0.84 g 
(1.61 mmol) of (benzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate was then 
immediately added to the reaction mixture, and the solution was stirred at room temperature for 1 
h. The volatile components were removed under reduced pressure to give a brown crude oil. The 
oil was purified by flash chromatography (SiO2, hexanes/ethyl acetate/methanol elution gradient 
1:9:0/0:1:0/0:9:1/0:4:1) to furnish a crude oil, which was dissolved in ethyl acetate (15 mL) and 
washed with saturated NH4Cl solution (4  10 mL) to remove excess N,N-diisopropylethylamine 
and give 0.45 g (58.3%) of 66 as an off-white gel/foam: Rf 0.49 (ethyl acetate/methanol, 9:1); IR 
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(thin film, cm
-1
)  3316, 2980, 2933, 1751, 1723, 1656, 1580, 1525, 1423, 1395, 1370, 1329, 
1299, 1236, 1135, 1029,  997, 845, 805, 753; 
1
H NMR (400 MHz, CDCl3) δ 7.32-6.92 (m, 10H), 
5.10-5.07 (m, 2H), 4.70-4.37 (m, 4H), three protons of conformers [3.85 (s), 3.83 (s)], 3.76-3.54 
(m, 2H), 3.31-3.14 (m, 3H), 2.02-1.87 (m, 6H), 1.39 (s, 9H), 1.29-1.26 (m, 3H); 
13
C NMR (400 
MHz, CDCl3) δ 172.6, 170.8, 168.7, 168.4, 168.1, 167.5, 167.3, 167.2, 166.1, 155.9, 155.8, 
155.5, 155.1, 140.5, 140.2, 135.6, 135.3, 135.1, 135.0, 131.3, 131.2, 130.9, 128.5, 128.4, 128.3, 
127.3, 126.9, 126.5, 126.3, 123.4, 123.2, 106.8, 106.4, 106.0, 105.9, 82.5, 67.7, 66.9, 65.8, 65.7, 
65.2,  55.1, 52.4, 52.1, 49.1, 41.9, 41.3, 36.6, 36.3, 36.1, 27.9, 22.9, 18.4, 16.9, 14.6,  14.4,  14.2;  
HRMS (Q-TOF) m/z calcd for [M+H]
+
 C38H46N3O11 720.3132, found 720.3186.  = -10.9, 
c = 1.00, CHCl3. 
 
Methyl-3'-(2-((S)-2-acetamidopropanamido)-N-methylacetamido)-2-(2-(benzyloxy)-2-
oxoethoxy)-2'-methyl-6-(2-(((S)-1-(methylamino)-1-oxopropan-2-yl)amino)-2-oxoethoxy)-
[1,1'-biphenyl]-4-carboxylate (68). To a solution of 0.44 g (0.61 mmol) of carboxylate 66 in 
CH2Cl2 (0.93 mL) at room temperature was added 0.93 mL of trifluoroacetic acid, and the 
reaction mixture was stirred for 2 h. The volatile components were removed under reduced 
pressure to give a crude oil of the free amine that was confirmed by 
1
H NMR (400 MHz, CDCl3) 
δ 12.45 (broad s, 1H), 7.76 (broad s, 1H), 7.63 (broad s, 1H), 7.33-7.14 (m, 10H), 5.26-5.13 (m, 
2H), 4.73-4.62 (m, 5H), 3.92 (s, 3H), 3.75-3.69 (m, 2H), 3.39-3.27 (m, 3H), 2.01 (broad s, 6H), 
1.44-1.30 (m, 3H). A solution of this crude oil and 0.075 g (0.73 mmol) of N-methylated alanine 
67 in CH2Cl2/DMF (1:1, 3.22 mL) was treated sequentially at 0 °C with 0.062 g (0.73 mmoL) of 
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NaHCO3, 0.099 g (0.73 mmol) of N-hydroxybenzotriazole, and 0.14 g (0.73 mmol) of N-ethyl-
N′-(3-dimethylaminopropyl)carbodiimide hydrochloride. The reaction mixture was stirred at 0 
°C for 2 h and at room temperature for 16 h, and then quenched with H2O (2.0 mL). The aqueous 
layer was extracted with ethyl acetate (3  10 mL), and the combined organic layers were 
washed with H2O (10 mL) and brine (10 mL), dried over MgSO4 and filtered, and the volatile 
components were removed under reduced pressure to give a brown crude oil. The oil was 
purified by flash chromatography (SiO2, hexanes/ethyl acetate/methanol elution gradient 
1:1:0/1:9:0/0:1:0/0:9:1/0:8:1) to give 0.29 g (62%) of 68 as an off-white gel/foam: Rf 0.52 (ethyl 
acetate/methanol, 9:1); IR (thin film, cm
-1
)  3303, 3073, 2940, 1657, 1535, 1420, 1329, 1243, 
1203, 1135, 999, 803, 753; 
1
H NMR (400 MHz, MeOD) δ 7.50-7.27 (m, 10H), 5.15 (d, J = 7 Hz, 
2H), 4.76-4.72 (m, 2H), two protons of conformers [4.58 (s), 4.65-4.49 (m, J = 14 Hz)], 4.36-
4.35 (m, 2H), three protons of conformers [3.92 (s), 3.90 (s)], 3.72-3.55 (m, 2H), three protons of 
conformers [3.33 (s), 3.27 (s), 3.24 (s), 3.18 (s)], three protons of conformers [2.74 (s), 2.73 (s), 
2.69 (s)], six protons of conformers [2.05 (s), 2.01 (broad s)], six protons of conformers [1.35 
(app t, J = 6 Hz), 1.28 (d, J = 7 Hz), 1.22 (app t, J = 6 Hz)]; 
13
C NMR (400 MHz, MeOD) δ 
174.2, 174.1, 174.0, 173.8, 173.4, 173.3, 173.2, 172.5, 171.8, 169.2, 169.1, 168.6, 168.4, 168.4, 
166.3, 166.2, 161.9, 161.5, 155.8, 155.8, 155.7, 155.5, 140.9, 140.9, 135.6, 135.6, 135.6, 135.5, 
135.4, 135.4, 131.2, 131.2, 131.1, 131.0, 130.9, 128.2, 128.1, 128.0, 128.0, 127.1, 127.0, 126.5, 
125.8, 123.5, 123.5, 123.4, 118.3, 117.1, 115.4, 110.4, 107.1, 107.0, 106.9, 106.4, 106.3, 72.3, 
67.4, 67.3, 67.2, 66.5, 65.0, 64.8, 62.9, 53.6, 51.8, 51.4, 49.8, 49.3, 41.4, 35.5, 35.4, 35.4, 25.2, 
25.1, 25.0, 21.3, 21.1, 17.4, 16.6, 16.6, 16.6, 16.4, 16.1, 13.6; HRMS (Q-TOF) m/z calcd for 
[M+Na]
+
 C38H45N5O11Na 770.3013, found 770.3008.  = -9.97, c = 1.00, MeOH. 
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2-((3'-(2-((S)-2-Acetamidopropanamido)-N-methylacetamido)-4-(methoxycarbonyl)-2'-
methyl-6-(2-(((S)-1-(methylamino)-1-oxopropan-2-yl)amino)-2-oxoethoxy)-[1,1'-biphenyl]-
2-yl)oxy)acetic acid (49). To 0.28 g (0.37 mmol) of carboxylate 68 and 0.028 g of 10% Pd/C in 
a round-bottom flask was added 4.4 mL of MeOH. The flask was sealed with a septum; a balloon 
attached to a syringe needle and filled with hydrogen gas was inserted. The reaction mixture was 
stirred at room temperature for 4 h, after which the solution was filtered through a pad of silica 
gel (SiO2) and further eluted with ethyl acetate (150 mL). The volatile components were 
removed under reduced pressure to give 0.23 g (91.8%) of 49 as a light brown gel/foam: Rf 0.01 
(ethyl acetate/methanol, 3:1); IR (thin film, cm
-1
)  3314, 3090, 2938, 1656, 1544, 1419, 1329, 
1248, 1205, 1134, 1000, 840, 802, 753, 722; 
1
H NMR (400 MHz, MeOD) δ 7.51-7.31 (m, 5H), 
4.73-4.49 (m, 4H), 4.35-4.34 (m, 2H), 3.92 (s, 3H), 3.73-3.52 (m, 2H), three protons of 
conformers [3.27 (s), 3.25 (s), 3.24 (s)], three protons of conformers [2.73 (s), 2.69 (s)], 2.06 (s, 
3H), 2.00 (s, 3H), 1.36-1.21 (m, 6H); 
13
C NMR (400 MHz, MeOD) δ 174.2, 173.4, 173.2, 172.0, 
171.5, 169.3, 169.2, 168.5, 166.4, 161.6, 156.3, 155.9, 155.7, 155.6, 155.4, 140.9, 135.8, 135.7, 
135.7, 135.5, 135.5, 135.4, 131.1, 131.1, 128.2, 127.0, 126.5, 125.8, 123.5, 123.5, 123.4, 118.3, 
117.1, 115.5, 110.5, 106.7, 106.4, 72.3, 67.4, 67.3, 67.2, 65.6, 64.9, 64.9, 62.9, 53.6, 51.8, 51.4, 
49.8, 49.7, 49.3, 49.2, 41.4, 35.5, 35.5, 35.4, 25.3, 25.1, 25.1, 21.3, 21.1, 20.1, 18.4, 17.5, 17.4, 
16.8, 16.7, 16.5, 16.4, 16.1, 13.6; HRMS (Q-TOF) m/z calcd for [M+H]
+
 C31H40N5O11 658.2724, 
found 658.2747.  = -11.0, c = 1.00, MeOH. 
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Methyl-3'-(2-((S)-2-acetamidopropanamido)-N-methylacetamido)-2'-methyl-2-(2-(((S)-1-
(methylamino)-1-oxopropan-2-yl)amino)-2-oxoethoxy)-6-(2-(methylamino)-2-oxoethoxy)-
[1,1'-biphenyl]-4-carboxylate (47). To a round-bottom flask equipped with a condenser and 
nitrogen gas inlet were added 0.12 g (0.18 mmol) of acid 49, 0.019 g (0.27 mmol) of 
methylamine hydrochloride, 0.053 g (0.27 mmol) of N-ethyl-N′-(3-dimethylaminopropyl)- 
carbodiimide hydrochloride, 0.037 g (0.27 mmol) of N-hydroxybenzotriazole, 0.06 mL (0.33 
mmoL) of N,N-diisopropylethylamine, and CH2Cl2 (0.91 mL). The reaction mixture was stirred 
at room temperature for 16 h, and then the reaction mixture was diluted with ethyl acetate (10 
mL) and washed with 1.0 M HCl (3 mL) and saturated NaHCO3 solution (3 mL). The organic 
layers were combined, dried over MgSO4 and filtered, and the volatile components were 
removed under reduced pressure to give a brown crude oil. The oil was purified by flash 
chromatography (SiO2, two columns, hexanes/ethyl acetate elution gradient both 1:0/19:1/9:1) to 
give 0.007 g (5.7%) of 47 as a light brown gel: Rf 0.39 (ethyl acetate/methanol, 3:1); IR (thin 
film, cm
-1
)  3583, 3317, 2924, 2854, 1723, 1659, 1548, 1417, 1328, 1259, 1121, 1044, 800, 753; 
1
H NMR (400 MHz, MeOD) δ 7.45-7.35 (m, 5H), 4.63-4.55 (m, 4H), 4.41-4.30 (m, 2H), 3.98 (s, 
3H), 3.69-3.55 (m, 2H), three protons of conformers [3.31 (s), 3.29 (s), 3.28 (s)], six protons of 
conformers [2.75 (s), 2.75 (s), 2.74 (s), 2.72 (s), 2.71 (s), 2.69 (s), 2.68 (s)], six protons of 
conformers [2.08 (s), 2.07 (s), 2.02 (s), 2.01 (s), 2.01 (s)], 1.39 (d, J = 7 Hz, 3H), 1.25 (d, J = 6 
Hz, 3H); 
13
C NMR (700 MHz, MeOD) δ 173.8, 173.5, 173.2, 173.1, 171.7, 169.5, 169.4, 169.2, 
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169.1, 168.4, 168.3, 168.3, 166.1, 156.0, 156.0, 155.8, 155.5, 141.2, 141.2, 135.6, 135.4, 131.6, 
131.5, 131.0, 130.9, 127.4, 127.0, 123.9, 110.0, 107.9, 107.7, 107.4, 107.3, 70.2, 68.0, 67.3, 67.1, 
54.8, 53.4, 51.6, 48.9, 43.5, 41.9, 41.4, 41.1, 40.7, 38.4, 36.4, 35.4,  33.7, 31.6, 29.3, 29.0, 28.9, 
27.0, 24.9, 24.6, 22.3, 21.1, 17.3, 17.3, 16.6, 15.6, 13.4, 13.0; HRMS (Q-TOF) m/z calcd for 
[M+H]
+
 C32H43N6O10 671.3041, found 671.3046.  = -10.0, c = 1.00, MeOH. 
 
Methyl-3'-(2-((S)-2-acetamidopropanamido)-N-methylacetamido)-2'-methyl-2-(2-(((S)-4-
methyl-1-(methylamino)-1-oxopentan-2-yl)amino)-2-oxoethoxy)-6-(2-(((S)-1-(methyl 
amino)-1-oxopropan-2-yl)amino)-2-oxoethoxy)-[1,1'-biphenyl]-4-carboxylate (48). A 
solution of 0.10 g (0.15 mmol) of acid 49 and 0.026 g (0.18 mmol) of N-methylated leucine 69 in 
CH2Cl2/DMF (1:1, 0.80 mL) was treated sequentially at 0 °C with 0.015 g (0.18 mmoL) of 
NaHCO3, 0.025 g (0.18 mmol) of N-hydroxybenzotriazole, and 0.035 g (0.18 mmol) of N-ethyl-
N′-(3-dimethylaminopropyl)carbodiimide hydrochloride. The reaction mixture was stirred at 0 
°C for 2 h and at room temperature for 16 h, and then quenched with H2O (2.0 mL). The aqueous 
layer was extracted with ethyl acetate (3  10 mL), and the combined organic layers were 
washed with H2O (10 mL) and brine (10 mL), dried over MgSO4 and filtered, and the volatile 
components were removed under reduced pressure to give a brown crude oil. The oil was 
purified by flash chromatography (SiO2, two columns, ethyl acetate/methanol elution gradient 
both 1:0/9:1/8:1/7:1) to give 0.054 g (45.4%) of 48 as an off-white gel/foam: Rf 0.32 (ethyl 
acetate/methanol, 3:1); IR (thin film, cm
-1
)  3301, 3079, 2955, 1722, 1654, 1538, 1417, 1328, 
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1242, 1131, 805, 754; 
1
H NMR (400 MHz, CDCl3) δ 7.48-6.89 (m, 9H), 6.60-6.46 (m, 1H), one 
proton of conformers [6.43 (d, J = 8 Hz), 6.26 (d, J = 8 Hz)], 4.57-4.36 (m, 7H), three protons of 
conformers [3.96 (s), 3.94 (s)], 3.69-3.62 (m, 2H), three protons of conformers [3.34 (s), 3.28 
(s)], six protons of conformers [2.75 (s), 2.70 (s)], six protons of conformers [2.01 (s), 1.99 (s), 
1.97 (s)], 1.47-1.42 (m, 2H), 1.35 (d, J = 7 Hz, 3H), 1.30-1.20 (m, 3H), 1.14 (t, J = 7 Hz, 1H), 
0.87-0.79 (m, 6H); 
13
C NMR (400 MHz, CDCl3) δ 172.9, 172.8, 178.8, 172.7, 172.6, 172.4, 
172.3, 172.1, 171.8, 171.7, 171.6, 171.2, 170.5, 170.4, 170.3, 168.7, 168.6, 168.5, 168.2, 167.7, 
167.6, 167.4, 167.3, 167.3, 167.2, 165.9, 156.1, 155.9, 155.9, 155.8, 154.8, 154.7, 154.7, 141.4, 
141.3, 141.3, 135.6, 135.5, 135.5, 135.4, 135.3, 135.2, 135.2, 131.9, 131.8, 130.7, 130.5, 127.9, 
127.8, 127.7, 127.6, 127.6, 127.5, 126.9, 123.6, 123.6, 123.5, 123.4, 123.3, 108.5, 108.3, 108.2, 
108.0, 107.4, 107.4, 107.3, 107.3, 72.3, 68.9, 68.4, 68.3, 67.5, 67.4, 64.1, 60.4, 53.5, 52.6, 51.4, 
50.9, 50.8, 49.0, 49.0, 48.9, 48.8, 48.7, 48.5, 48.0, 44.1, 41.8, 41.8, 41.7, 41.6, 41.2, 41.0, 40.8, 
37.0, 36.8, 36.3, 36.2, 36.1, 29.7, 29.3, 26.4, 26.2, 26.2, 26.1, 25.8, 24.9, 24.8, 24.7, 24.6, 24.5, 
24.5, 24.0, 23.4, 23.4, 23.2, 23.1, 23.0, 22.9, 22.9, 22.8, 22.8, 22.7, 22.0, 22.0, 22.0, 21.9, 21.4, 
21.3, 21.2, 21.1, 19.1, 18.8, 18.6, 18.4, 18.4, 18.3, 18.1, 15.5, 15.4, 15.1, 14.7, 14.7, 14.2; HRMS  
(Q-TOF) m/z calcd for [M+H]
+
 C38H54N7O11 784.3881, found 784.3872.  = +3.53, c = 
1.00, MeOH. 
 
    
(S)-Benzyl (1-(methylamino)-1-oxopropan-2-yl)carbamate (72). To a round-bottom flask 
equipped with a condenser and nitrogen gas inlet were added 3.0 g (13.4 mmol) of acid 70, 1.0 g 
(14.8 mmol) of methylamine hydrochloride, 2.8 g (14.8 mmol) of N-ethyl-N′-(3-
dimethylaminopropyl)carbodiimide hydrochloride, 2.0 g (14.8 mmol) of N-
hydroxybenzotriazole, 3.5 mL (20.2 mmoL) of N,N-diisopropylethylamine, and CH2Cl2 (67.2 
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mL). The reaction mixture was stirred at room temperature for 16 h, and then the reaction 
mixture was diluted with ethyl acetate (20 mL) and washed with 1.0 M HCl (20 mL), saturated 
NaHCO3 solution (20 mL) and brine (20 mL). The organic layers were combined, dried over 
MgSO4 and filtered, and the volatile components were removed under reduced pressure to give 
3.16 g (99.5%) of 72 as a white solid: Rf 0.04 (hexanes/ethyl acetate, 7:3); mp 127-129 °C; IR 
(thin film, cm
-1
) 3299, 3092, 3035, 2980, 2940, 2805, 1654, 1539, 1453, 1411, 1375, 1327, 1247, 
1163, 1121, 1067, 1029, 737; 
1
H NMR (400 MHz, CDCl3) δ 7.29 (broad s, 1H), 7.22 (s, 5H), 
6.43 (d, J = 7 Hz, 1H), 5.02,4.95 (ABq, JAB= 12 Hz, 2H), 4.23 (broad t, J = 7 Hz, 1H), 2.64 (d, J 
= 5 Hz, 3H), 1.27 (d, J = 7 Hz, 3H); 
13
C NMR (400 MHz, CDCl3) δ 173.1, 156.1, 136.2, 128.5, 
128.2, 128.0, 67.0, 50.6, 26.2, 18.7; HRMS (Q-TOF) m/z calcd for [M+H]
+
 C12H17N2O3 
237.1239, found 237.1224.  = -19.7, c = 1.00, CHCl3. 
    
(S)-Benzyl (4-methyl-1-(methylamino)-1-oxopentan-2-yl)carbamate (73). To a round-bottom 
flask equipped with a condenser and nitrogen gas inlet were added 1.57 g (5.90 mmol) of acid 
71, 0.44 g (6.22 mmol) of methylamine hydrochloride, 1.24 g (6.49 mmol) of N-ethyl-N′-(3-
dimethylaminopropyl)carbodiimide hydrochloride, 0.88 g (6.49 mmol) of N-
hydroxybenzotriazole, 1.54 mL (8.85 mmoL) of N,N-diisopropylethylamine, and CH2Cl2 (29.5 
mL). The reaction mixture was stirred at room temperature for 16 h, and then the reaction 
mixture was diluted with ethyl acetate (20 mL) and washed with 1.0 M HCl (20 mL), saturated 
NaHCO3 solution (20 mL) and brine (20 mL). The organic layers were combined, dried over 
MgSO4 and filtered, and the volatile components were removed under reduced pressure to give 
1.58 g (100%) of 73 as a white solid: Rf 0.09 (hexanes/ethyl acetate, 7:3); mp 124-126 °C; IR 
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(thin film, cm
-1
)  3305, 3033, 2960, 2874, 1685, 1652, 1564, 1537, 1468, 1415, 1390, 1324, 
1283, 1241, 1162, 1133, 1108, 1047, 969, 835, 756, 733; 
1
H NMR (400 MHz, CDCl3) δ 7.30 (s, 
5H), 6.98, 6.62 (2 broad s, 1H), 5.96 (broad s, 1H), 5.10,5.01 (ABq, J = 12 Hz, 2H), 4.29-4.18 
(broad q, J = 9 Hz, 1H), 2.73 (d, J = 4 Hz, 3H), 1.69-1.52 (m, 3H), 0.92 (d, J = 3 Hz, 6H); 
13
C 
NMR (400 MHz, CDCl3) δ 173.3, 156.5, 136.3, 128.5, 128.1, 127.9, 66.9, 53.6, 41.6, 26.2, 24.7, 
22.9, 22.0; HRMS (Q-TOF) m/z calcd for [M+H]
+
 C15H23N2O3 279.1709, found 279.1704. 
 = -25.2, c = 1.00, CHCl3. 
   
(S)-2-Amino-N-methylpropanamide (67). To 3.1 g (13.1 mmol) of carboxylate 72 and 0.40 g 
of 10% Pd/C in a round-bottom flask was added 110.0 mL of MeOH. The flask was sealed with 
a septum; a balloon attached to a syringe needle and filled with hydrogen gas was inserted. The 
reaction mixture was stirred at room temperature for 24 h (the reaction was monitored by TLC 
for completion and the balloon was refilled with hydrogen gas after 12 h), after which the 
solution was filtered through a pad of silica gel (SiO2) and further eluted with ethyl acetate (300 
mL). The volatile components were removed under reduced pressure to give a crude oil. The oil 
was purified by flash chromatography (SiO2, ethyl acetate/methanol elution gradient 
1:0/9:1/1:1/0:1) to give 1.14 g (85.3%) of 67 as a yellow oil: Rf 0.06 (ethyl acetate/methanol, 
9:1); IR (thin film, cm
-1
) 3350, 2979, 2160, 1655, 1562, 1453, 1413, 1374, 1318, 1270, 1161, 
1041, 962, 849; 
1
H NMR (400 MHz, CDCl3) δ 7.68 (broad s, 1H), 3.47 (q, J = 7 Hz, 1H), 2.73 
(d, J = 5 Hz, 3H), 2.28 (broad s, 2H),  1.27 (d, J = 7 Hz, 3H); 
13
C NMR (400 MHz, CDCl3)  δ 
176.3,  128.3,  50.4, 25.6, 21.3; HRMS (EI) m/z calcd for [M]
+
 C4H10N2O 102.0793, found 
102.0844.  = +2.12, c = 1.00, MeOH. 
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(S)-2-Amino-N,4-dimethylpentanamide (69). To 1.5 g (5.4 mmol) of carboxylate 73 and 0.15 g 
of 10% Pd/C in a round-bottom flask was added 64.2 mL of MeOH. The flask was sealed with a 
septum; a balloon attached to a syringe needle and filled with hydrogen gas was inserted. The 
reaction mixture was stirred at room temperature for 24 h (the reaction was monitored by TLC 
for completion and the balloon was refilled with hydrogen gas after 12 h), after which the 
solution was filtered through a pad of silica gel (SiO2) and further eluted with ethyl acetate (300 
mL). The volatile components were removed under reduced pressure to give a crude oil. The oil 
was purified by flash chromatography (SiO2, hexanes/ethyl acetate/methanol elution gradient 
1:1:0/0:1:0/0:9:1/0:1:1/0:0:1) to give 0.53 g (67.7%) of 69 as a yellow oil: Rf 0.11 (ethyl 
acetate/methanol, 9:1); IR (thin film, cm
-1
) 3295, 3088, 2956, 1655, 1468, 1411, 1368, 1267, 
1161, 898, 845; 
1
H NMR (400 MHz, CDCl3) δ 7.45 (broad s, 1H), 3.38 (d, J = 9 Hz, 1H), 2.75 
(d, J = 5 Hz, 3H), 2.12 (broad s, 2H), 1.66 (m, 2H), 1.31 (t, J = 9 Hz, 1H), 0.91 (d, J = 6 Hz, 3H), 
0.88 (d, J = 6 Hz, 3H);  
13
C NMR (400 MHz, CDCl3) δ 175.9, 53.4, 43.9, 25.8, 24.8, 23.3,  21.4;  
HRMS (Q-TOF) m/z calcd for [M+H]
+
 C7H17N2O 145.1341, found 145.1299.  = +9.59, c 
= 1.00, MeOH. 
 
Di-tert-butyl-2,2'-((4-(methoxycarbonyl)-2'-methyl-3'-(methylamino)-[1,1'-biphenyl]-2,6-
diyl)bis(oxy))diacetate (58). In a resealable oven-dried Schlenk flask containing a magnetic stir 
bar, 5.11 g (10.7 mmol) of benzoate 11, 4.0 g (16.1 mmol) of boronic ester 5, 0.35 g (0.38 mmol) 
 170 
of tris[dibenzylideneacetone]dipalladium(0), 0.62 g (1.50 mmol) of 2-dicyclohexylphosphino-
2′,6′-dimethoxybiphenyl (SPhos ligand), and 6.50 g (28.2 mmol) of K3PO4 monohydrate were 
added and dried under reduced pressure for 2 min. Toluene (18.8 mL) was added, and the 
solution was degassed using the freeze-pump-thaw method three times under a nitrogen 
atmosphere. The Schlenk flask was sealed; the reaction mixture was vigorously stirred at 90 °C 
for 16 h, and cooled to room temperature. The mixture was diluted with CH2Cl2 (40 mL) and 
water (40 mL); the organic layer was extracted, and the aqueous layer was washed with 
additional CH2Cl2 (3  40 mL). The organic layers were dried over MgSO4 and filtered, and the 
volatile components were removed under reduced pressure to give a brown crude oil. The oil was 
purified by flash chromatography (SiO2, hexanes/ethyl acetate elution gradient 9:1/6:1/5:1) to 
give 1.25 g (25.8%) of 58 as a brown oil: Rf 0.34 (hexanes/ethyl acetate, 7:3); IR (thin film, cm
-1
) 
3440, 2979, 2933, 2815, 1751, 1724, 1588, 1513, 1492, 1437, 1393, 1369, 1329, 1233, 1161, 
1133, 1029, 997, 942, 844, 754, 723; 
1
H NMR (400 MHz, CDCl3) δ 7.24-7.21 (m, 3H), 6.69 (t, J 
= 8 Hz, 2H), 4.50 (s, 4H), 3.94 (s, 3H), 3.73 (broad s, 1H), 2.93 (s, 3H), 1.96 (s, 3H), 1.49 (s, 
18H); 
13
C NMR (400 MHz, CDCl3) δ 167.8, 166.5, 156.3, 147.1, 132.9, 129.9, 126.0, 125.4, 
121.5, 119.3, 108.7, 106.6, 82.2, 66.1, 52.2, 30.9, 28.0, 14.1; HRMS (Q-TOF) m/z calcd for 
[M+H]
+
 C28H38NO8 516.2597, found 516.2597. 
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Di-tert-butyl-2,2'-((3'-((S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-N-methyl 
propanamido)-4-(methoxycarbonyl)-2'-methyl-[1,1'-biphenyl]-2,6-diyl)bis(oxy))diacetate 
(56). To 0.50 g (0.97 mmol) of carboxylate 58 in 11.0 mL of CHCl3 was added 0.35 g (1.07 
mmol) of Fmoc-alanine acid chloride 20-int (generated according to General Procedure A and 
used immediately thereafter) in 7.0 mL of CHCl3 followed by 11.0 mL of saturated NaHCO3 
solution, and the reaction mixture was stirred at room temperature for 20 min. The solution was 
diluted with CH2Cl2 (50 mL) and saturated NaHCO3 solution (50 mL), the organic layer was 
extracted, and the aqueous layer was washed with CH2Cl2 (3  50 mL). The organics were dried 
over MgSO4 and filtered, and the volatile components were removed under reduced pressure to 
give a light brown crude oil. The oil was purified by flash chromatography (SiO2, hexanes/ethyl 
acetate elution gradient 5:1/3:1) to give 0.66 g (84.1%) of 56 as a brown gel/foam: Rf 0.13 
(hexanes/ethyl acetate, 7:3); IR (thin film, cm
-1
) 3306, 2980, 1750, 1722, 1651, 1581, 1504, 
1450, 1423, 1394, 1369, 1331, 1235, 1134, 1079, 1031, 998, 941, 844, 805, 757; 
1
H NMR (400 
MHz, CDCl3) δ 7.71 (d, J = 7 Hz, 2H), 7.61 (broad s, 2H), 7.34-7.16 (m, 9H), one proton of 
conformers [6.23 (d, J = 8 Hz), 6.09 (d, J = 8 Hz), 5.90 [(broad s)], 4.70-4.50 (m, 4H), 4.36-4.32 
(m, 2H), 4.21-4.16 (m, 2H), three protons of conformers [3.89 (s), 3.88 (s)], 3.29 (s, 3H), three 
protons of conformers [2.12 (s), 2.09 (s)], 18 protons of conformers [1.45 (s), 1.33 (s)], three 
protons of conformers [1.25 (d, J = 6 Hz), 1.17 (d, J = 6 Hz)]; 
13
C NMR (400 MHz, CDCl3) δ 
175.3, 173.6, 173.4, 168.0, 167.5, 167.4, 167.4, 166.2, 166.2, 156.2, 155.9, 155.8, 155.7, 155.1, 
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144.1, 144.0, 144.0, 143.9, 143.8, 141.2, 140.9, 136.1, 135.8, 135.7, 135.3, 131.4, 131.0, 130.8, 
130.6, 127.7, 127.1, 126.9, 126.5, 125.3, 123.4, 123.1, 120.0, 106.2, 106.1, 82.4, 82.3, 81.9, 66.9, 
66.8, 65.8, 65.5,  53.6,  52.3, 52.3, 47.9, 47.7, 47.1, 36.8, 36.6, 28.0, 27.9, 21.0, 19.6, 18.7, 17.6,  
15.0,  14.8, 14.2; HRMS (Q-TOF) m/z calcd for [M+H]
+
 C46H53N2O11 809.3649, found 
809.3668.  = +35.5, c = 1.00, CHCl3. 
 
Di-tert-butyl-2,2'-((3'-((S)-2-((S)-2-acetamidopropanamido)-N-methylpropanamido)-4-
(methoxycarbonyl)-2'-methyl-[1,1'-biphenyl]-2,6-diyl)bis(oxy))diacetate (74). To 0.67 g 
(0.83 mmol) of carboxylate 56 in a round-bottom flask were added 5.0 mL (33.1 mmol) of tris(2-
aminoethyl)amine and CH2Cl2 (5.0 mL); the reaction mixture was stirred at room temperature for 
30 min and was monitored by TLC for verification of deprotection. Then ethyl acetate (15 mL) 
was added, and the organic layer was extracted with brine (10 mL). The organic layer was 
further extracted with phosphate buffer (pH = 5.5, 50 mM, 3  15 mL), then dried over MgSO4 
and filtered. The volatile components were removed under reduced pressure to give a crude oil of 
the free amine that was confirmed by 
1
H NMR (300 MHz, CDCl3) δ 7.32-7-13 (m, 7H), 4.50-
4.43 (m, 4H), 3.91 (s, 3H), one proton of conformers [3.49 (m), 3.32 (m)], three protons of 
conformers [3.14 (s), 3.12 (s)], 2.02 (s, 3H), 18 protons of conformers [1.44 (s), 1.43 (s)], three 
protons of conformers [1.12 (d, J = 7 Hz), 1.06 (d, J = 7 Hz)]. Then 0.44 g (0.74 mmol) of the 
crude free amine and 0.15 g (1.12 mmol) of N-acetyl alanine 18 were dissolved in CH2Cl2 (4.5 
mL), and 0.24 mL (1.34 mmol) of N,N-diisopropylethylamine was added via syringe. To avoid 
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epimerization, 0.58 g (1.12 mmol) of (benzotriazol-1-yloxy)tripyrrolidinophosphonium 
hexafluorophosphate was then immediately added to the reaction mixture, and the solution was 
stirred at room temperature for 1 h. The volatile components were removed under reduced 
pressure to give a brown crude oil. The oil was purified by flash chromatography (SiO2, 
hexanes/ethyl acetate/methanol elution gradient 1:9:0/0:1:0/0:9:1) to furnish a crude oil, which 
was dissolved in ethyl acetate (30 mL) and washed with saturated NH4Cl solution (4  10 mL) to 
remove excess N,N-diisopropylethylamine and give 0.33 g (82.5%) of 74 as an off-white 
gel/foam: Rf 0.33 (ethyl acetate/methanol, 9:1); IR (thin film, cm
-1
)  3303, 2980, 2935, 1751, 
1725, 1647, 1580, 1538, 1424, 1394, 1370, 1330, 1234, 1133, 1029, 997, 845, 806, 754; 
1
H 
NMR (400 MHz, CDCl3) δ one proton of conformers [7.41 (d, J = 6 Hz), 7.34 (d, J = 7 Hz)], 
7.29-7.09 (m, 5H), one proton of conformers [6.96 (broad s), 6.76 (d, J = 6 Hz)], 4.67-4.31 (m, 
6H), 3.84 (s, 3H), three protons of conformers [3.23 (s), 3.19 (s)], three protons of conformers 
[2.00 (s), 1.95 (s)], 1.89 (s, 3H), 1.38 (s, 18H), three protons of conformers [1.31 (d, J = 7 Hz), 
1.24 (d, J = 7 Hz)], three protons of conformers [1.12 (d, J = 6 Hz), 1.03 (d, J = 6 Hz)]; 
13
C 
NMR (400 MHz, CDCl3) δ 173.0, 172.7, 171.9, 171.3, 170.0, 169.6, 168.1, 167.4, 167.4, 167.3, 
166.2, 166.1, 156.0, 155.8, 155.7, 155.6, 140.8, 135.9, 135.7, 135.5, 135.1, 131.4, 130.8, 130.7, 
130.5, 127.5, 126.9, 126.8, 126.4, 123.2, 123.0, 106.3, 106.2, 106.0, 106.0, 82.4, 82.3, 82.1, 65.9, 
65.8, 65.8, 65.4, 60.3, 53.5, 52.3, 52.2, 48.8,  48.7,  46.4, 46.3, 36.8, 36.6, 28.0, 27.9, 27.9, 23.0, 
22.9, 20.9, 19.1, 18.8, 17.0,  14.9,  14.6, 14.1; HRMS (Q-TOF) m/z calcd for [M+H]
+
 
C36H50N3O11 700.3445, found 700.3447.  = +29.4, c = 1.00, CHCl3. 
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Methyl-3'-((S)-2-((S)-2-acetamidopropanamido)-N-methylpropanamido)-2'-methyl-2,6-
bis(2-(((S)-1-(methylamino)-1-oxopropan-2-yl)amino)-2-oxoethoxy)-[1,1'-biphenyl]-4-
carboxylate (50). To a solution of 0.29 g (0.41 mmol) of carboxylate 74 in CH2Cl2 (0.63 mL) at 
room temperature was added 0.63 mL of trifluoroacetic acid, and the reaction mixture was stirred 
for 2 h. The volatile components were removed under reduced pressure to give a crude oil of the 
free acid that was confirmed by 
1
H NMR (300 MHz, CDCl3) δ 12.37 (broad s, 2H), one proton 
of conformers [7.77 (s), 7.72 (d, J = 7 Hz)], one proton of conformers [7.53 (broad s), 7.43 
(broad s), 7.38-7.18 (m, 5H), 4.71-4.58 (m, 5H), 4.44 (quintet, J = 8 Hz, 1H), 3.94 (s, 3H), three 
protons of conformers [3.29 (s), 3.26 (s)], six protons of conformers [2.06 (s), 2.01 (s), 1.96 (s)], 
six protons of conformers [1.38 (d, J = 7 Hz), 1.28 (m), 1.22 (d, J = 8 Hz)]. A solution of this 
crude oil and 0.10 g (0.99 mmol) of N-methylated alanine 67 in CH2Cl2/DMF (1:1, 2.18 mL) 
was treated sequentially at 0 °C with 0.084 g (0.99 mmoL) of NaHCO3, 0.14 g (0.99 mmol) of 
N-hydroxybenzotriazole, and 0.19 g (0.99 mmol) of N-ethyl-N′-(3-dimethylaminopropyl)- 
carbodiimide hydrochloride. The reaction mixture was stirred at 0 °C for 2 h and at room 
temperature for 16 h, and then quenched with H2O (4.0 mL). The aqueous layer was extracted 
with ethyl acetate (3  20 mL), and the combined organic layers were washed with H2O (10 mL) 
and brine (10 mL), dried over MgSO4 and filtered, and the volatile components were removed 
under reduced pressure to give a brown crude oil. The oil was purified by flash chromatography 
(SiO2, two columns, ethyl acetate/methanol elution gradient, 9:1/4:1 then 8:1/7:1/6:1) to give 
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0.17 g (55.6%) of 50 as an off-white gel/foam: Rf 0.76 (ethyl acetate/methanol, 9:1); IR (thin 
film, cm
-1
)  3304, 3075, 2986, 2936, 1721, 1654, 1535, 1417, 1374, 1327, 1244, 1131, 865, 753; 
1
H NMR (300 MHz, MeOD)  δ 7.52-7.28 (m, 5H), 4.64-4.61 (m, 4H), 4.38-4.32 (m, 4H), 3.95 
(s, 3H), three protons of conformers [3.29 (s), 3.23 (s)], six protons of conformers [2.73 (s), 2.70 
(s)], six protons of conformers [2.06 (s), 2.03 (s), 2.00 (s), 1.97 (s)], 12 protons of conformers 
[1.50 (d, J = 7 Hz), 1.38 (d, J = 7 Hz), 1.30 (d, J = 7 Hz), 1.24 (d, J = 7 Hz), 1.12 (d, J = 7 Hz)]; 
13C NMR (400 MHz, MeOD) δ 175.4, 173.6, 173.6, 173.4, 173.3, 173.2, 172.6, 171.7, 171.6, 
170.3, 170.2, 169.2, 168.4, 168.3, 166.2, 156.0, 155.8, 155.6, 155.5, 141.8, 141.6, 141.6, 135.8, 
135.5, 135.5, 134.9, 131.3, 130.9, 130.6, 128.0, 127.4, 127.0, 126.9, 126.0, 125.3, 123.7, 117.3, 
110.5, 107.5, 107.2, 67.8, 67.3, 63.1, 60.2, 51.9, 49.8, 49.1, 46.5, 46.0, 37.7, 36.2, 35.9, 25.4, 
25.3,  25.2, 21.4,  21.4, 19.8, 18.2, 17.8, 17.7, 17.6, 17.5, 17.3, 16.9, 16.5,  15.7, 14.3, 14.0, 13.3;  
HRMS (Q-TOF) m/z calcd for [M+H]
+
 C36H50N7O11 756.3568, found 756.3617.  = -2.48, 
c = 1.00, MeOH. 
 
 
Di-tert-butyl-2,2'-((3'-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-N-methyl 
acetamido)-4-(methoxycarbonyl)-2'-methyl-[1,1'-biphenyl]-2,6-diyl)bis(oxy))diacetate (57). 
To 0.50 g (0.97 mmol) of carboxylate 58 in 11.0 mL of CHCl3 was added 0.34 g (1.07 mmol) of 
Fmoc-glycine acid chloride 21-int (generated according to General Procedure A and used 
immediately thereafter) in 7.0 mL of CHCl3 followed by 11.0 mL of saturated NaHCO3 solution, 
and the reaction mixture was stirred at room temperature for 20 min. The solution was diluted 
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with CH2Cl2 (50 mL) and saturated NaHCO3 solution (50 mL), the organic layer was extracted, 
and the aqueous layer was washed with CH2Cl2 (3  50 mL). The organics were dried over 
MgSO4 and filtered, and the volatile components were removed under reduced pressure to give a 
light brown crude oil. The oil was purified by flash chromatography (SiO2, hexanes/ethyl acetate 
elution gradient 3:1/1:1) to give 0.71 g (92%) of 57 as a light yellow gel/foam: Rf 0.39 
(hexanes/ethyl acetate 1:1); IR (thin film, cm
-1
) 3413, 2978, 1750, 1724, 1664, 1581, 1512, 1423, 
1394, 1369, 1330, 1234, 1133, 1056, 1030, 998, 845, 758; 
1
H NMR (300 MHz, CDCl3) δ 7.73 
(d, J = 7 Hz, 2H), 7.62 (d, J = 7 Hz, 2H), 7.39-7.12 (m, 9H), one proton of conformers [5.89 
(broad s), 5.72 (broad s)], 4.64-4.49 (m, 4H), 4.39-4.18 (m, 3H), 3.91 (s, 3H), 3.66 (broad s, 2H), 
3.31 (s, 3H), 2.10 (s, 3H), 18 protons of conformers [1.46 (s), 1.41 (s)]; 
13
C NMR (400 MHz, 
CDCl3) δ 168.9, 167.5, 167.4, 166.2, 156.1, 156.0, 155.7, 144.0, 144.0, 141.2, 140.3, 135.9, 
135.8, 131.3, 130.8, 127.7, 127.1, 126.9, 125.2, 125.2, 123.1, 119.9, 119.6, 106.2, 106.1, 82.4, 
82.2, 67.0, 65.9, 65.7, 52.3, 47.2, 43.4, 36.2, 28.0, 28.0, 14.6; HRMS (Q-TOF) m/z calcd for 
[M+Na]
+
 C45H50N2O11Na 817.3312, found 817.3322. 
 
Di-tert-butyl-2,2'-((3'-(2-((S)-2-(((benzyloxy)carbonyl)amino)propanamido)-N-methyl 
acetamido)-4-(methoxycarbonyl)-2'-methyl-[1,1'-biphenyl]-2,6-diyl)bis(oxy))diacetate (75). 
To 0.60 g (0.75 mmol) of carboxylate 57 in a round-bottom flask were added 4.52 mL (29.9 
mmol) of tris(2-aminoethyl)amine and CH2Cl2 (4.52 mL); the reaction mixture was stirred at 
room temperature for 30 min and was monitored by TLC for verification of deprotection. Then 
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ethyl acetate (15 mL) was added, and the organic layer was extracted with brine (10 mL). The 
organic layer was further extracted with phosphate buffer (pH = 5.5, 50 mM, 3  10 mL), then 
dried over MgSO4 and filtered. The volatile components were removed under reduced pressure 
to give a crude oil of the free amine that was confirmed by 
1H NMR (400 MHz, MeOD) δ 7.40-
7.22 (m, 5H), 4.59-4.54 (m, 4H), 3.94 (s, 3H), two protons of conformers [3.96-3.84 (m), 3.24-
3.04 (m)], 3.26 (s, 3H), three protons of conformers [2.17 (s), 2.07 (s)], 18 protons of conformers 
[1.47 (s), 1.46 (s)]. Then 0.32 g (0.56 mmol) of crude free amine and 0.15 g (0.67 mmol) of acid 
70 were dissolved in CH2Cl2 (3.35 mL), and then 0.15 mL (0.84 mmol) of N,N-
diisopropylethylamine was added via syringe. To avoid epimerization, 0.35 g (0.67 mmol) of 
(benzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate was immediately added 
to the reaction mixture, and the solution was stirred at room temperature for 1 h. The volatile 
components were removed under reduced pressure to give a brown crude oil. The oil was 
purified by flash chromatography (SiO2, hexanes/ethyl acetate/methanol elution gradient 
1:1:0/1:9:0/0:1:0/0:9:1) to furnish a crude oil, which was dissolved in ethyl acetate (30 mL) and 
washed with saturated NH4Cl solution (4  10 mL) to remove excess N,N-diisopropylethylamine 
and give 0.34 g (77.2%) of 75 as a light brown gel/foam: Rf 0.45 (ethyl acetate/methanol 9:1); IR 
(thin film, cm
-1
)  3324, 2979, 1750, 1723, 1655, 1580, 1523, 1423, 1395, 1370, 1331, 1301, 
1235, 1133, 1029, 998, 845, 753; 
1
H NMR (400 MHz, CDCl3) δ 7.29 (broad s, 6H), 7.20-7.13 
(m, 4H), one proton of conformers [5.88 (broad d, J = 6 Hz), 5.84 (broad d, J = 6 Hz)], 5.14-5.01 
(m, 2H), 4.58-4.47 (m, 4H), 4.35-4.26 (m, 1H), three protons of conformers [3.91 (s), 3.91 (s)], 
3.76-3.55 (m, 2H), three protons of conformers [3.24 (s), 3.24 (s)], 2.02 (s, 3H), 18 protons of 
conformers [1.45 (s), 1.43 (s), 1.42 (s)], three protons of conformers [1.37 (d, J = 6 Hz), 1.34 (d, 
J = 6 Hz)]; 
13
C NMR (400 MHz, CDCl3) δ 173.0, 172.9, 171.2, 169.1, 167.7, 167.6, 167.4, 
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166.2, 156.4, 156.2, 155.9, 155.9, 155.7, 155.7, 140.2, 136.2, 135.7, 135.6, 131.4, 130.7, 128.5, 
128.1, 128.1, 127.5, 126.9, 123.1, 106.3, 106.2, 82.5, 82.3, 67.0, 67.0, 65.9,  65.7,  60.4, 52.4, 
50.7, 42.0, 36.4, 36.3, 28.0, 28.0, 27.8, 21.0, 18.7, 18.5, 14.6, 14.5,  14.2; HRMS (Q-TOF) m/z 
calcd for [M+H]
+
 C41H52N3O12 778.3551, found 778.3533.  = -3.90, c = 1.00, MeOH. 
 
(2S,2'S)-Dibenzyl 2,2'-((2,2'-((3'-(2-((S)-2-(((benzyloxy)carbonyl)amino)propanamido)-N-
methylacetamido)-4-(methoxycarbonyl)-2'-methyl-[1,1'-biphenyl]-2,6-diyl)bis(oxy)) 
bis(acetyl))bis(azanediyl))dipropanoate (76). To a solution of 0.30 g (0.39 mmol) of 
carboxylate 75 in CH2Cl2 (0.58 mL) at room temperature was added 0.58 mL of trifluoroacetic 
acid, and the reaction mixture was stirred for 2 h. The volatile components were removed under 
reduced pressure to give a crude oil of the free acid that was confirmed by 
1
H NMR (400 MHz, 
CDCl3) δ 10.30 (broad s, 2H), 7.74 (broad s, 1H), 7.43-7.15 (broad m, 9 H), 6.10 (broad s, 1H), 
5.12-5.03 (broad m, 2H), 4.70-4.58 (broad m, 4H), 4.33 (broad s, 1H), 3.93 (s, 3H), 3.78 (broad 
m, 2H), 3.27 (s, 3H), 2.01 (s, 3H), 1.37 (s, 3H). A solution of this crude oil and 0.18 g (0.85 
mmol) of L-alanine benzyl ester hydrochloride in CH2Cl2/DMF (1:1, 2.03 mL) was treated 
sequentially at 0 °C with 0.07 g (0.85 mmoL) of NaHCO3, 0.11 g (0.85 mmol) of N-
hydroxybenzotriazole, and 0.16 g (0.85 mmol) of N-ethyl-N′-(3-dimethylaminopropyl)- 
carbodiimide hydrochloride. The reaction mixture was stirred at 0 °C for 2 h and at room 
temperature for 16 h, and then quenched with H2O (2.0 mL). The aqueous layer was extracted 
with ethyl acetate (3  10 mL), and the combined organic layers were washed with H2O (10 mL) 
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and brine (10 mL), dried over MgSO4 and filtered, and the volatile components were removed 
under reduced pressure to give a brown crude oil. The oil was purified by flash chromatography 
(SiO2, hexanes/ethyl acetate elution gradient 1:1/1:3/1:6) to give 0.29 g (78.4%) of 76 as an off-
white gel/foam: Rf 0.53 (ethyl acetate/methanol, 9:1); IR (thin film, cm
-1
)  3404, 3317, 2935, 
2360, 1722, 1677, 1580, 1525, 1453, 1418, 1388, 1326, 1242, 1151, 1128, 1067, 1001, 807, 751; 
1
H NMR (400 MHz, CDCl3) δ 7.44, (d, J = 9 Hz), 7.37-7.19 (m, 20H), one proton of conformers 
[6.92 (d, J = 7 Hz), 6.72 (d, J = 7 Hz)], one proton of conformers [6.47 (d, J = 8 Hz), 6.37 (d, J = 
8 Hz)], 5.92 (broad s, 1H), 5.16-4.98 (m, 6H), 4.54-4.51 (m, 6H), 4.31 (broad s, 1H), 3.91 (s, 
3H), 3.74-3.55 (m, 2H), 2.82 (s, 3H), 1.98 (s, 3H), nine protons of conformers [1.33 (d, J = 7 
Hz), 1.27 (d, J = 7 Hz), 1.22 (d, J = 7 Hz),]; 
13
C NMR (400 MHz, CDCl3) δ 172.5, 172.5, 172.2, 
172.1, 172.0, 171.9, 171.9, 168.7, 168.4, 167.2, 167.1, 167.0, 166.9, 165.9, 165.8, 162.6, 155.9, 
155.8, 155.6, 155.4, 155.2, 155.1, 154.9, 154.9, 141.2, 141.1, 136.4, 135.6, 135.5, 135.4, 135.4, 
135.3, 135.3, 134.8, 132.0, 131.9, 131.8, 130.6, 130.5, 129.4, 128.6, 128.6, 128.5, 128.5, 128.5, 
128.4, 128.3, 128.1, 128.0, 128.0, 127.8, 127.6, 127.5, 126.7, 126.5, 123.6, 123.3, 123.2, 108.1, 
107.8, 107.4, 68.1, 67.9, 67.5, 67.1, 67.0, 67.0, 66.7, 53.6, 52.6, 50.4, 47.9, 47.7, 47.4, 47.3, 41.8, 
41.7, 37.0, 36.8, 36.5, 36.3, 36.2, 31.4, 19.0, 18.9, 18.3, 18.2, 18.1, 18.1, 18.0, 17.2, 15.0, 14.9, 
14.6, 14.5; HRMS (Q-TOF) m/z calcd for [M+Na]
+
 C53H57N5O14Na 1010.3800, found 
1010.3802.  = -4.23, c = 1.00, CHCl3. 
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(2S,2'S)-2,2'-((2,2'-((3'-(2-((S)-2-Aminopropanamido)-N-methylacetamido)-4-(methoxy 
carbonyl)-2'-methyl-[1,1'-biphenyl]-2,6-diyl)bis(oxy))bis(acetyl))bis(azanediyl))dipropanoic 
acid (51). To 0.26 g (0.26 mmol) of carboxylate 76 and 0.078 g of 10% Pd/C in a round-bottom 
flask was added 3.13 mL of MeOH. The flask was sealed with a septum; a balloon attached to a 
syringe needle and filled with hydrogen gas was inserted. The reaction mixture was stirred at 
room temperature for 4 h, after which the solution was filtered through a pad of silica gel (SiO2) 
and further eluted with ethyl acetate (250 mL). The volatile components were removed under 
reduced pressure to give 0.15 g (84.6%) of 51 as a light brown gel/foam: Rf 0.04 (ethyl 
acetate/methanol, 3:1); IR (thin film, cm
-1
)  3400, 2925, 1996, 1721, 1656, 1578, 1416, 1326, 
1253, 1125, 1005, 868, 844, 807, 746; 
1
H NMR (400 MHz, MeOD) δ 7.45-7.36 (m, 5H), 4.65-
4.52 (m, 4H), 4.38 (m, J = 4 Hz, 1H), 4.30 (m, J = 4 Hz, 1H), 4.04 (q, J = 7 Hz, 1H), 3.95 (s, 
3H), 3.78-3.63 (m, 2H), three protons of conformers [3.28 (s), 3.26 (s)], three protons of 
conformers [2.06 (s), 2.05 (s)], 1.54 (dd, J = 7, 3 Hz, 3H), 1.34-1.28 (m, 6H); 
13
C NMR (400 
MHz, MeOD) δ 175.0, 174.4, 174.2, 170.1, 170.0, 169.2, 169.0, 168.3, 168.2, 168.2, 168.1, 
166.1, 166.1, 155.7, 155.5, 155.4, 141.1, 141.1, 135.5, 135.4, 135.3, 135.2, 131.6, 131.5, 130.9, 
127.4, 123.7,  123.5,  107.4, 107.3, 67.5, 67.2, 67.2, 51.8, 48.9, 41.5, 41.4, 35.5, 17.1, 17.0,  16.2,  
16.2, 13.6; HRMS (Q-TOF) m/z calcd for [M+H]
+
 C31H40N5O12 674.2673, found 674.2725. 
 = +11.7, c = 1.00, MeOH. 
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2,2'-((3'-((S)-2-Amino-N-methylpropanamido)-4-(methoxycarbonyl)-2'-methyl-[1,1'-
biphenyl]-2,6-diyl)bis(oxy))diacetic acid (52). To 0.67 g (0.83 mmol) of carboxylate 56 in a 
round-bottom flask were added 5.0 mL (33.1 mmol) of tris(2-aminoethyl)amine and CH2Cl2 (5.0 
mL); the reaction mixture was stirred at room temperature for 30 min and was monitored by TLC 
for verification of deprotection. Then ethyl acetate (15 mL) was added, and the organic layer was 
extracted with brine (10 mL). The organic layer was further extracted with phosphate buffer (pH 
= 5.5, 50 mM, 3  15 mL), then dried over MgSO4 and filtered. The volatile components were 
removed under reduced pressure to give a crude oil of the free amine that was confirmed by 
1
H 
NMR (300 MHz, CDCl3) δ 7.32-7-13 (m, 7H), 4.50-4.43 (m, 4H), 3.91 (s, 3H), one proton of 
conformers [3.49 (m), 3.32 (m)], three protons of conformers [3.14 (s), 3.12 (s)], 2.02 (s, 3H), 18 
protons of conformers [1.44 (s), 1.43 (s)], three protons of conformers [1.12 (d, J = 7 Hz), 1.06 
(d, J = 7 Hz)]. To a solution of 0.10 g (0.17 mmol) of the crude free amine in CH2Cl2 (0.26 mL) 
at room temperature was added 0.26 mL of trifluoroacetic acid, and the reaction mixture was 
stirred for 2 h. The volatile components were removed under reduced pressure to give a brown 
crude oil. The oil was purified by flash chromatography (SiO2, ethyl acetate/methanol elution 
gradient 9:1/4:1/2:1/1:1/1:4/0:1) to give 0.07 g (87%) of 52 as a light brown gel/foam: Rf 0.18 
(ethyl acetate/methanol, 1:1); IR (thin film, cm
-1
)  3381, 2922, 1662, 1412, 1202, 1125, 800; 
1
H 
NMR (400 MHz, MeOD) δ 7.41-7.27 (m, 5H), 4.76-4.43 (m, 4H), 4.04-3.95 (m, 1H), three 
protons of conformers [3.94 (s), 3.92 (s), 3.91 (s), 3.90 (s)], three protons of conformers [3.34 
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(s), 3.34 (s), 3.34 (s), 3.33 (s), 3.33 (s), 3.31 (s), 3.30 (s), 3.26 (s)], three protons of conformers 
[2.09 (s), 2.05 (s)], three protons of conformers [1.38 (d, J = 7 Hz)  1.34 (d, J = 7 Hz), 1.22 (d, J 
= 7 Hz)]; 
13
C NMR (400 MHz, MeOD) δ 172.8, 172.6, 170.1, 169.9, 169.7, 169.4, 169.3, 169.2, 
166.6, 166.6, 166.5, 156.7, 156.6, 156.5, 156.4, 156.3, 156.2, 155.8, 155.8, 155.5, 140.0, 140.0, 
140.0, 139.9, 136.8, 136.6, 136.2, 136.0, 135.5, 135.4, 135.3, 132.0, 131.8, 131.7, 131.6, 131.0, 
130.9, 130.8, 130.7, 127.3, 127.2, 127.0, 126.8, 126.7, 126.4, 123.2, 123.2, 123.1, 123.0, 107.0, 
106.6, 106.5, 106.4, 106.2, 106.0, 105.9, 105.3, 64.7, 64.7, 64.6, 53.5, 51.6, 51.6, 36.0, 35.8, 
35.7, 16.1, 16.0, 14.5, 14.4, 14.1, 14.0, 13.7, 13.6, 13.1; HRMS (Q-TOF) m/z calcd for [M+H]
+
 
C23H27N2O9 475.1717, found 475.1719.  = +21.8, c = 1.00, MeOH. 
 
2,2'-((3'-(2-Amino-N-methylacetamido)-4-(methoxycarbonyl)-2'-methyl-[1,1'-biphenyl]-2,6-
diyl)bis(oxy))diacetic acid (53). To 0.60 g (0.75 mmol) of carboxylate 57 in a round-bottom 
flask were added 4.52 mL (29.9 mmol) of tris(2-aminoethyl)amine and CH2Cl2 (4.52 mL); the 
reaction mixture was stirred at room temperature for 30 min and was monitored by TLC for 
verification of deprotection. Then ethyl acetate (15 mL) was added, and the organic layer was 
extracted with brine (10 mL). The organic layer was further extracted with phosphate buffer (pH 
= 5.5, 50 mM, 3  10 mL), then dried over MgSO4 and filtered. The volatile components were 
removed under reduced pressure to give a crude oil of the free amine that was confirmed by 
1
H 
NMR (400 MHz, MeOD) δ 7.40-7.22 (m, 5H), 4.59-4.54 (m, 4H), 3.94 (s, 3H), two protons of 
conformers [3.96-3.84 (m), 3.24-3.04 (m)], 3.26 (s, 3H), three protons of conformers [2.17 (s), 
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2.07 (s)], 18 protons of conformers [1.47 (s), 1.46 (s)]. To a solution of 0.10 g (0.17 mmol) of the 
crude free amine in CH2Cl2 (0.27 mL) at room temperature was added 0.27 mL of trifluoroacetic 
acid, and the reaction mixture was stirred for 2 h. The volatile components were removed under 
reduced pressure to give a brown crude oil. The oil was purified by flash chromatography (SiO2, 
ethyl acetate/methanol elution gradient 9:1/4:1/2:1/1:1/1:4/0:1) to give 0.072 g (89%) of 53 as a 
brown gel/foam: Rf 0.11 (ethyl acetate/methanol, 1:1); IR (thin film, cm
-1
)  3583, 3458, 2921, 
2851, 1664, 1415, 1199, 1125; 
1
H (400 MHz, MeOD) δ 7.37-7.26 (m, 5H), 4.77-4.48 (m, 4H), 
three protons of conformers [3.94 (s), 3.93 (s)], 3.64-3.48 (m, 2H), three protons of conformers 
[3.38 (s), 3.34 (s), 3.34 (s), 3.34 (s), 3.33 (s), 3.33 (s), 3.31 (s)], three protons of conformers 
[2.05 (s), 2.04 (s), 1.99 (s)]; 
13
C NMR (400 MHz, MeOD) δ 166.5, 166.4, 166.1, 156.3, 156.2, 
156.1, 139.6, 136.2, 135.5, 132.0, 131.9, 131.0, 130.9, 126.7, 126.6, 123.1, 106.3, 106.0, 64.7, 
51.6, 50.9, 40.5, 36.7, 35.1, 13.4, 13.1; HRMS (Q-TOF) m/z calcd for [M+H]
+
 C22H25N2O9 
461.1560, found 461.1569.  
 
Di-tert-butyl-2,2'-((3'-((S)-2-acetamido-N-methylpropanamido)-4-(methoxycarbonyl)-2'-
methyl-[1,1'-biphenyl]-2,6-diyl)bis(oxy))diacetate (77). To 0.050 g (0.062 mmol) of 
carboxylate 56 in a round-bottom flask was added 0.28 mL (0.56 mmol) of a 20% 
piperidine/DMF solution, and the reaction mixture was stirred at room temperature for 30 min. 
Then 0.94 mL (9.99 mmol) of acetic anhydride and 2.86 mL (35.4 mmol) of pyridine were 
added, and the solution was stirred at room temperature for 30 min. The volatile components 
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were removed under reduced pressure to give a brown crude oil. The oil was purified by flash 
chromatography (SiO2, hexanes/ethyl acetate elution gradient 1:1/1:2/1:5/1:10) to give 0.035 g 
(89.9%) of 77 as a light brown gel/foam: Rf 0.02 (hexanes/ethyl acetate, 7:3); IR (thin film, cm
-1
)  
3582, 3325, 2926, 1751, 1725, 1645, 1581, 1438, 1392, 1369, 1330, 1234, 1133, 1029, 998, 845, 
754; 
1
H NMR (400 MHz, CDCl3) δ 7.34-7.12 (m, 5H), one proton of conformers [6.62 (d, J = 7 
Hz), 6.51 (d, J = 8 Hz), four protons of conformers [4.78,4.55 (ABq, JAB = 16 Hz), 4.53-4.48 
(m)], one proton of conformers [4.68 (quintet, J = 7 Hz), 4.40 (quintet, J = 7 Hz)], three protons 
of conformers [3.93 (s), 3.92 (s)], three protons of conformers [3.30 (s), 3.26 (s)], three protons 
of conformers [2.06 (s), 2.01 (s)], three protons of conformers [2.00 (s), 1.92 (s)], 18 protons of 
conformers [1.46 (s), 1.45 (s)], three protons of conformers [1.19 (d, J = 6 Hz), 1.07 (d, J = 7 
Hz)]; 
13
C NMR (400 MHz, CDCl3) δ 173.5, 173.1, 169.1, 168.4, 168.1, 167.5, 167.5, 167.4, 
166.3, 166.3, 156.1, 155.8, 155.8, 155.6, 140.8, 140.7, 136.0, 135.8, 135.7, 135.2, 131.3, 130.9, 
130.7, 130.6, 128.2, 127.6, 127.0, 126.8, 126.5, 123.3, 122.9, 106.2, 106.0, 82.5, 81.9, 65.9, 65.9, 
65.8, 65.4, 52.4, 52.3, 46.6, 46.3, 36.9, 36.7, 29.7, 29.4, 28.0, 28.0, 24.5, 23.4, 23.3, 22.7, 19.4, 
17.5, 15.0, 14.7, 14.2; HRMS (Q-TOF) m/z calcd for [M+Na]
+
 C33H42N2O10Na  651.2894, found 
651.2953.  = +23.9, c = 1.00, CHCl3. 
 
Di-tert-butyl-2,2'-((3'-(2-acetamido-N-methylacetamido)-4-(methoxycarbonyl)-2'-methyl-
[1,1'-biphenyl]-2,6-diyl)bis(oxy))diacetate (78). To 0.04 g (0.05 mmol) of carboxylate 57 in a 
round-bottom flask was added 0.22 mL (0.45 mmol) of a 20% piperidine/DMF solution, and the 
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reaction mixture was stirred at room temperature for 30 min. Then 0.77 mL (8.12 mmol) of 
acetic anhydride and 2.33 mL (28.8 mmol) of pyridine were added, and the solution was stirred 
at room temperature for 30 min. The volatile components were removed under reduced pressure 
to give a brown crude oil. The oil was purified by flash chromatography (SiO2, hexanes/ethyl 
acetate elution gradient 1:5/1:20) to give 0.028 g (90.1%) of 78 as a light brown gel/foam: Rf 
0.22 (hexanes/ethyl acetate, 1:1); IR (thin film, cm
-1
)  3583, 3380, 2925, 2359, 1724, 1657, 1581, 
1424, 1369, 1330, 1235, 1133, 845; 
1
H NMR (400 MHz, CDCl3) δ 7.35-7.14 (m, 5H), 6.51 
(broad s, 1H), four protons of conformers [4.64,4.53 (ABq, JAB = 16 Hz), 4.55,4.50 (ABq, JAB = 
16 Hz)], 3.93 (s, 3H), 3.70 (qd, J = 18, 4 Hz, 2H), 3.32 (s, 3H), 2.05 (s, 3H), 2.00 (s, 3H), 1.47 (s, 
18H); 
13
C NMR (400 MHz, CDCl3) δ 169.7, 168.9, 167.7, 167.4, 166.3, 155.9, 155.7, 140.1, 
135.8, 135.7, 131.3, 130.7, 127.0, 126.8, 123.1, 106.1, 105.9, 82.5, 82.2, 65.9, 65.6, 52.3, 42.2, 
36.3, 28.0, 23.1, 14.6; HRMS (Q-TOF) m/z calcd for [M+Na]
+
 C32H42N2O10Na 637.2737, found 
637.2771.  
 
2,2'-((3'-((S)-2-Acetamido-N-methylpropanamido)-4-(methoxycarbonyl)-2'-methyl-[1,1'-
biphenyl]-2,6-diyl)bis(oxy))diacetic acid (54). To a solution of 0.03 g (0.05 mmol) of 
carboxylate 77 in CH2Cl2 (0.07 mL) at room temperature was added 0.07 mL of trifluoroacetic 
acid, and the reaction mixture was stirred for 2 h. The volatile components were removed under 
reduced pressure to give 0.032 g (99%) of 54 as a brown gel/foam: Rf 0.04 (ethyl 
acetate/methanol, 9:1); IR (thin film, cm
-1
)  3583, 3335, 2925, 2854, 1723, 1620, 1580, 1437, 
 186 
1326, 1237, 1214, 1142, 1028, 997, 756; 
1
H NMR (400 MHz, MeOD) δ 7.46 (m, 5H), 4.75-4.64 
(m, 4H), one proton of conformers [4.45 (q, J = 7 Hz), 4.35 (quintet, J = 7 Hz)], 3.95 (s, 3H), 
three protons of conformers [3.25 (s), 3.22 (s)], three protons of conformers [2.07 (s), 2.04 (s)], 
three protons of conformers [1.97 (s), 1.91 (s)], three protons of conformers [1.23 (d, J = 7 Hz), 
1.10 (d, J = 7 Hz)]; 
13
C NMR (400 MHz, MeOD) δ 173.9, 173.7, 171.3, 170.8, 170.7, 170.6, 
170.4, 170.4, 170.3, 169.3, 169.2, 166.5, 166.4, 156.3, 156.1, 156.0, 156.0, 156.0, 141.1, 141.0, 
135.9, 135.8, 134.9, 131.1, 130.8, 130.7, 130.7, 127.4, 126.8, 126.2, 126.1, 123.7, 106.0, 105.9, 
64.8,  64.7, 64.6, 51.6, 51.2, 46.6, 46.5, 35.9, 35.8, 21.0, 20.8, 17.2, 15.3, 13.9, 13.7;  HRMS (Q- 
TOF) m/z calcd for [M+H]
+
 C25H29N2O10  517.1822, found 517.1823.  = +31.1, c = 1.00, 
MeOH. 
 
2,2'-((3'-(2-Acetamido-N-methylacetamido)-4-(methoxycarbonyl)-2'-methyl-[1,1'-
biphenyl]-2,6-diyl)bis(oxy))diacetic acid (55). To a solution of 0.03 g (0.05 mmol) of 
carboxylate 78 in CH2Cl2 (0.08 mL) at room temperature was added 0.08 mL of trifluoroacetic 
acid, and the reaction mixture was stirred for 2 h. The volatile components were removed under 
reduced pressure to give 0.025 g (100%) of 55 as a brown gel/foam: Rf 0.02 (ethyl 
acetate/methanol, 9:1); IR (thin film, cm
-1
)  3326, 2928, 2361, 1722, 1626, 1580, 1435, 1325, 
1240, 1141, 1029, 998, 865, 805, 757; 
1
H NMR (400 MHz, CDCl3) δ 7.35-7-13 (m, 6H), four 
protons of conformers [4.71 (s), 4.56 (s)], 3.95 (s, 3H), 3.73 (q, J = 17 Hz, 2H), 3.28 (s, 3H), 
2.04 (s, 3H), 1.98 (s, 3H); 
13
C NMR (400 MHz, CDCl3) δ 172.4, 171.7, 169.9, 168.4, 166.3, 
156.0, 155.5, 139.7, 136.0, 135.2, 131.6, 131.3, 127.2, 126.9, 123.8, 107.1, 106.7, 66.4, 64.8, 
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52.6, 42.4, 36.8, 29.7, 22.7, 14.2; HRMS (Q-TOF) m/z calcd for [M-H]
+
 C24H25N2O10  501.1509, 
found 501.1508.  
  
tert-Butyl 4-bromo-3,5-dihydroxybenzoate (79). To a solution of 5.25 g (14.2 mmol) benzoate 
83 in THF (132.0 mL) was added 0.66 g (0.57 mmol) of catalytic 
tetrakis(triphenylphosphine)Pd(0). The yellow solution was stirred for 5 min at room 
temperature, and then 1.61 g (42.7 mmol) of sodium borohydride was added. After stirring at 
room temperature for 1 h, the reaction was quenched and acidified to pH 3-4 with dropwise 
addition of 1.0 M HCl; the solvent was then removed under reduced pressure. The residue was 
diluted with CH2Cl2 (110 mL) and water (100 mL); the organic layer was extracted, and the 
aqueous layer was washed with additional CH2Cl2 (3  100 mL). The organics were dried over 
MgSO4 and filtered, and the volatile components were removed under reduced pressure to give a 
brown crude oil. The oil was purified by flash chromatography (SiO2, hexanes/ethyl acetate 
elution gradient 10:1/8:1) to give 3.37 g (81.9%) of 79 as a white solid: Rf 0.31 (hexanes/ethyl 
acetate 7:3); mp 160-162 °C; IR (thin film, cm
-1
) 3391, 2980, 1680, 1593, 1503, 1426, 1369, 
1279, 1159, 1122, 1040, 973, 869, 844, 758; 
1
H NMR (400 MHz, CDCl3) δ 7.29 (s, 2H), 6.32 
(broad s, 2H), 1.60 (s, 9H); 
13
C NMR (400 MHz, CDCl3) δ 165.4, 153.3, 132.5, 108.8, 103.9, 
82.2, 28.2; HRMS (Q-TOF) m/z calcd for [M+]
+
 C11H13O4Br 287.9997, found 287.9966. 
 
Methyl 3,5-bis(allyloxy)-4-bromobenzoate (82). In a round-bottom flask, 4.21 g (17.0 mmol) 
of benzoate 9, 3.26 mL (37.8 mmol) of allyl bromide, and 5.22 g (37.8 mmol) of K2CO3 were 
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dissolved in acetone (85.8 mL), and the reaction mixture was refluxed for 18 h. The volatile 
components were removed under reduced pressure, and the residue was diluted with ethyl acetate 
(110 mL) and water (100 mL); the organic layer was extracted, and the aqueous layer was 
washed with additional ethyl acetate (3  100 mL). The organic layers were dried over MgSO4 
and filtered, and the volatile components were removed under reduced pressure to give 5.84 g 
(100%) of 82 as a white solid: Rf 0.53 (hexanes/ethyl acetate 7:3); mp 57-59 °C; IR (thin film, 
cm
-1
) 3089, 2990, 2951, 1722, 1649, 1582, 1421, 1364, 1331, 1243, 1125, 1022, 997, 929, 860, 
763; 
1
H NMR (300 MHz, CDCl3) δ 7.29 (s, 2H), 6.11 (doublet of quintets, J = 17, 5 Hz, 2H), 
5.54 (doublet of ABq, J = 17, 2 Hz, 2H), 5.35 (app dd, J = 11, 2 Hz, 2H), 4.70 (dt, J = 5, 2 Hz, 
4H), 3.94 (s, 3H); 
13
C NMR (300 MHz, CDCl3) δ 166.2, 155.9, 132.3, 129.8, 117.8, 107.6, 
106.7, 69.8, 52.4; HRMS (Q-TOF) m/z calcd for [M+Na]
+
 C14H15O4BrNa 349.0051, found 
349.0024. 
 
tert-Butyl 3,5-bis(allyloxy)-4-bromobenzoate (83). In a round-bottom flask sealed with a 
septum, 0.30 g (0.87 mmol) of benzoate 82 and 0.12 mL (0.87 mmol) of tert-butyl acetate were 
combined. To the flask was added 0.009 mL (0.009 mmol) tert-butoxide (1M solution in THF) 
via syringe, and the reaction mixture was then stirred under reduced pressure (vacuum) for 5 min 
at room temperature. The flask was then backfilled with nitrogen and an additional equivalent 
each of tert-butyl acetate (0.12 mL) and tert-butoxide (0.009 mL) were added, and the reaction 
mixture was stirred under reduced pressure (vacuum) for 5 min at room temperature. The above 
procedure of additions was repeated ten times until the conversion of the methyl ester to the tert-
butyl ester was complete by TLC. The reaction mixture was then passed through a pad of silica 
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gel (SiO2) and washed with ethyl acetate (150 mL). The volatile components were removed 
under reduced pressure to give 0.31 g (96.4%) of 83 as a yellow oil: Rf 0.64 (hexanes/ethyl 
acetate, 7:3); IR (thin film, cm
-1
) 3399, 3088, 2979, 2932, 1712, 1650, 1582, 1456, 1421, 1368, 
1331, 1252, 1163, 1125, 1037, 996, 929, 849, 766; 
1
H NMR (300 MHz, CDCl3) δ 7.21 (s, 2H), 
6.10 (doublet of quintets, J = 17, 5 Hz, 2H), 5.54 (doublet of ABq, JAB = 17, 2 Hz, 1H), 5.35 
(doublet of ABq, JAB = 11, 1 Hz, 1H), 4.69 (dt, J = 5, 2 Hz, 4H), 1.62 (s, 9H); 
13
C NMR (300 
MHz, CDCl3) δ 164.9, 155.9, 132.5, 131.8, 117.8, 107.3, 106.8, 81.5, 69.9, 28.1; HRMS (Q-
TOF) m/z calcd for [M-C4H8]
+
 C13H14O4Br 313.0075, found 313.0045. 
 
tert-Butyl 3-(allyloxy)-4-bromo-5-hydroxybenzoate (61). To a solution of 0.073 g (0.20 mmol) 
of benzoate 83 in THF (2.81 mL) was added 0.005 g (0.004 mmol) of catalytic 
tetrakis(triphenylphosphine)Pd(0). The yellow solution was stirred for 5 min at room 
temperature, and then 0.008 g (0.20 mmol) of sodium borohydride was added. After stirring at 
room temperature for 1 h, the reaction was quenched and acidified to pH 3-4 with dropwise 
addition of 1.0 M HCl; the solvent was then removed under reduced pressure. The residue was 
diluted with CH2Cl2 (15 mL) and water (10 mL); the organic layer was extracted, and the 
aqueous layer was washed with additional CH2Cl2 (3  15 mL). The organics were dried over 
MgSO4 and filtered, and the volatile components were removed under reduced pressure to give a 
brown crude oil. The oil was purified by flash chromatography (SiO2, hexanes/ethyl acetate 
elution gradient 20:1/15:1) to give 0.031 g (48%) of 61 as a white solid: Rf 0.54 (hexanes/ethyl 
acetate, 7:3); mp 100-102 °C; IR (thin film, cm
-1
) 3388, 2979, 2932, 1711, 1687, 1587, 1496, 
1457, 1425, 1369, 1352, 1255, 1161, 1118, 1084, 1037, 982, 928, 868, 847, 804, 768; 
1
H NMR 
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(300 MHz, CDCl3) δ 7.31 (d, J = 1 Hz, 1H), 7.14 (d, J = 1 Hz, 1H), 6.09 (doublet of quintets, J = 
17, 5 Hz, 1H), 5.85 (broad s, 1H),  5.52 (app dd, J = 16, 2 Hz, 1H), 5.37 (app dd, J = 11, 2 Hz, 
1H), 4.67 (app d, J = 5 Hz, 2H), 1.61 (s, 9H); 
13
C NMR (400 MHz, CDCl3) δ 165.1, 155.4, 
153.4, 132.4, 132.3, 118.0, 109.7, 105.5, 105.3, 81.8, 69.9, 28.1; HRMS (Q-TOF) m/z calcd for 
[M-C4H8]
+
 C10H9O4Br 271.9684, found 271.9659. 
 
tert-Butyl 3-(allyloxy)-5-(2-(benzyloxy)-2-oxoethoxy)-4-bromobenzoate (84). In a round-
bottom flask, 0.13 g (0.39 mmol) of benzoate 61, 0.08 mL (0.47 mmol) of benzyl bromoacetate, 
and 0.065 g (0.47 mmol) of K2CO3 were dissolved in acetone (2.0 mL), and the reaction mixture 
was refluxed for 18 h. The volatile components were removed under reduced pressure, and the 
residue was diluted with ethyl acetate (20 mL) and water (15 mL); the organic layer was 
extracted, and the aqueous layer was washed with additional ethyl acetate (3  20 mL). The 
organic layers were dried over MgSO4 and filtered, and the volatile components were removed 
under reduced pressure to give a crude yellow oil. The oil was purified by flash chromatography 
(SiO2, hexanes/ethyl acetate elution gradient 20:1/15:1) to give 0.18 g (96.3%) of 84 as a 
colorless oil: Rf 0.47 (hexanes/ethyl acetate, 7:3); IR (thin film, cm
-1
) 3404, 3089, 2977, 2932, 
1762, 1711, 1584, 1497, 1454, 1420, 1391, 1368, 1334, 1252, 1192, 1162, 1129, 1037, 963, 849, 
764, 737; 
1
H NMR (400 MHz, CDCl3) δ 7.37 (s, 5H), 7.25 (d, J = 1 Hz, 1H), 7.11 (d, J = 1 Hz, 
1H), 6.09 (doublet of quintets, J = 17, 5 Hz, 1H), 5.55 (dd, J = 17, 1 Hz, 1H), 5.36 (d, J = 10 Hz, 
1H), 5.27 (s, 2H), 4.82 (s, 2H), 4.68 (d, J = 5 Hz, 2H), 1.60 (s, 9H); 
13
C NMR (400 MHz, CDCl3) 
δ 167.9, 164.7, 156.2, 155.4, 135.1, 132.4, 132.0, 128.6, 128.5, 128.4, 118.0, 107.7, 107.5, 106.5, 
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81.7, 70.0, 67.1, 66.2, 28.1; HRMS (Q-TOF) m/z calcd for [M+Na]
+
 C23H25O6BrNa 499.0732, 
found 499.0745. 
 
tert-Butyl 3-(2-(benzyloxy)-2-oxoethoxy)-4-bromo-5-hydroxybenzoate (85). To a solution of 
0.16 g (0.33 mmol) of benzoate 84 in THF (4.7 mL) was added 0.011 g (0.01 mmol) of catalytic 
tetrakis(triphenylphosphine)Pd(0). The yellow solution was stirred for 5 min at room 
temperature, and then 0.019 g (0.49 mmol) of sodium borohydride was added. After stirring at 
room temperature for 2 h, the reaction was quenched and acidified to pH 3-4 with dropwise 
addition of 1.0 M HCl; the solvent was then removed under reduced pressure. The residue was 
diluted with CH2Cl2 (30 mL) and water (20 mL); the organic layer was extracted, and the 
aqueous layer was washed with additional CH2Cl2 (3  30 mL). The organics were dried over 
MgSO4 and filtered, and the volatile components were removed under reduced pressure to give a 
brown crude oil. The oil was purified by flash chromatography (SiO2, hexanes/ethyl acetate 
elution gradient 15:1/10:1) to give 0.12 g (84%) of 85 as a yellow solid: Rf 0.40 (hexanes/ethyl 
acetate, 7:3); mp 77-79 °C; IR (thin film, cm
-1
) 3401, 3066, 3033, 2978, 2933, 1759, 1711, 1588, 
1497, 1425, 1392, 1369, 1256, 1186, 1117, 1037, 999, 968, 872, 847, 803, 767; 
1
H NMR (400 
MHz, CDCl3) δ 7.38 (s, 5H), 7.36 (d, J = 2 Hz, 1H), 7.04 (d, J = 2 Hz, 1H), 6.11 (broad s, 1H), 
5.27 (s, 2H), 4.82 (s, 2H), 1.60 (s, 9H); 
13
C NMR (400 MHz, CDCl3) δ 167.9, 164.7, 154.7, 
153.7, 135.0, 132.6, 128.7, 128.6, 128.4, 110.6, 105.4, 105.1, 81.8, 67.2, 66.1, 28.1; HRMS (Q-
TOF) m/z calcd for [M+Na]
+
 C20H21O6BrNa 459.0419, found 459.0413. 
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4-Nitrobenzyl 2-bromoacetate (86). To 0.33 g (2.4 mmol) of bromoacetic acid 88 and 0.31 g 
(2.0 mmol) of 4-nitrobenzyl alcohol 89 in a round-bottom flask were added 8.0 mL of a 1:1 
CH2Cl2/CH3CN solution and 0.01 g (0.03 mmol) of 4-(dimethylamino)pyridine. Then 0.50 g (2.4 
mmol) of N,N'-dicyclohexylcarbodiimide was added, and the reaction was stirred at room 
temperature for 2 h. The reaction mixture was filtered to remove the white precipitate 
(dicyclohexyl urea), and the filtrate was washed with water (8.0 mL). The organic layers were 
separated and dried over MgSO4 and filtered, and the volatile components were removed under 
reduced pressure to give a yellow crude oil. The oil was purified by flash chromatography (SiO2, 
hexanes/ethyl acetate elution gradient 15:1/10:1/8:1) to give 0.34 g (62%) of 86 as a yellow oil: 
Rf 0.41 (hexanes/ethyl acetate, 7:3); IR (thin film, cm
-1
) 3469, 3113, 3081, 2962, 2857, 2454, 
2294, 1932, 1744, 1607, 1521, 1404, 1348, 1279, 1211, 1157, 1111, 1009, 887, 846, 807, 738; 
1
H NMR (400 MHz, CDCl3) δ 8.14 (d, J = 8 Hz, 2H), 7.52 (d, J = 8 Hz, 2H), 5.27 (s, 2H), 3.92 
(s, 2H); 
13
C NMR (400 MHz, CDCl3) δ 166.9, 147.7, 142.4, 128.4, 123.8, 66.2, 25.7; HRMS (Q-
TOF) m/z calcd for [M+H]
+
 C9H9NO4Br 273.9715, found 273.9724. 
   
tert-Butyl 3-(2-(benzyloxy)-2-oxoethoxy)-4-bromo-5-(2-((4-nitrobenzyl)oxy)-2-oxoethoxy) 
benzoate (60). In a round-bottom flask, 0.40 g (0.91 mmol) of benzoate 85, 0.30 g (1.09 mmol) 
of 4-nitrobenzyl 2-bromoacetate 86, and 0.15 g (1.09 mmol) of K2CO3 were dissolved in acetone 
(4.57 mL), and the reaction mixture was refluxed for 20 h. The volatile components were 
removed under reduced pressure, and the residue was diluted with ethyl acetate (30 mL) and 
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water (20 mL); the organic layer was extracted, and the aqueous layer was washed with 
additional ethyl acetate (3  30 mL). The organic layers were dried over MgSO4 and filtered, and 
the volatile components were removed under reduced pressure to give a crude yellow oil. The oil 
was purified by flash chromatography (SiO2, two columns, hexanes/ethyl acetate elution gradient 
both 6:1/5:1) to give 0.55 g (96%) of 60 as a pale yellow oil: Rf 0.31 (hexanes/ethyl acetate, 7:3); 
IR (thin film, cm
-1
) 3583, 3086, 2978, 1761, 1711, 1585, 1523, 1497, 1442, 1421, 1391, 1368, 
1345, 1279, 1253, 1194, 1136, 1038, 849, 802, 763; 
1
H NMR (400 MHz, CDCl3) δ 8.18 (d, J = 7 
Hz, 2H), 7.49 (d, J = 7 Hz, 2H), 7.36 (s, 5H), 7.12 (s, 2H), 5.34 (s, 2H), 5.26 (s, 2H), 4.87 (s, 
2H), 4.82 (s, 2H), 1.56 (s, 9H); 
13
C NMR (400 MHz, CDCl3) δ 167.8, 167.7, 164.2, 155.6, 155.4, 
147.8, 142.3, 135.0, 132.2, 128.7, 128.6, 128.5, 128.4, 123.8, 107.6, 107.3, 107.1, 82.0, 67.2, 
66.2, 66.1, 65.5, 28.1; HRMS (Q-TOF) m/z calcd for [M+Na]
+
 C29H28NO10BrNa 652.0794, 
found 652.0785. 
  
tert-Butyl 2-(2-(benzyloxy)-2-oxoethoxy)-2'-methyl-3'-(methylamino)-6-(2-((4-nitrobenzyl) 
oxy)-2-oxoethoxy)-[1,1'-biphenyl]-4-carboxylate (87). In a resealable oven-dried Schlenk flask 
containing a magnetic stir bar, 1.41 g (2.24 mmol) of benzoate 60, 1.30 g (5.26 mmol) of boronic 
ester 5, 0.082 g (0.09 mmol) of tris[dibenzylideneacetone]dipalladium(0), 0.15 g (0.36 mmol) of 
2-dicyclohexylphosphino-2′,6′-dimethoxybiphenyl (SPhos ligand), and 1.55 g (6.72 mmol) of 
K3PO4 monohydrate were added and dried under reduced pressure for 2 min. Toluene (7.47 mL) 
was added, and the solution was degassed using the freeze-pump-thaw method three times under 
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a nitrogen atmosphere. The Schlenk flask was sealed; the reaction mixture was vigorously stirred 
at 90 °C for 16 h, and cooled to room temperature. The mixture was diluted with CH2Cl2 (50 
mL) and water (50 mL); the organic layer was extracted, and the aqueous layer was washed with 
additional CH2Cl2 (3  50 mL). The organic layers were dried over MgSO4 and filtered, and the 
volatile components were removed under reduced pressure to give a brown crude oil. The oil was 
purified by flash chromatography (SiO2, hexanes/ethyl acetate elution gradient 9:1/4:1/1:1) to 
give 0.47 g (31.4%) of 87 as a brown oil: Rf 0.20 (hexanes/ethyl acetate, 7:3); IR (thin film, cm
-1
) 
3443, 2976, 2930, 2816, 1759, 1710, 1584, 1523, 1493, 1421, 1368, 1347, 1328, 1280, 1190, 
1163, 1136, 1029, 993, 848, 788, 754; 
1
H NMR (400 MHz, CDCl3) δ 8.22 (d, J = 9 Hz, 2H), 
7.40 (d, J = 9 Hz, 2H), 7.37-7.35 (m, 3H), 7.32-7.30 (m, 2H), 7.23-7.19 (m, 3H), 6.69 (d, J = 8 
Hz, 1H), 6.64 (d, J = 8 Hz, 1H), 5.28 (s, 2H), 5.21 (s, 2H), 4.70 (s, 2H), 4.66 (s, 2H), 2.94 (s, 
3H), 1.89 (s, 3H), 1.60 (s, 9H); 
13
C NMR (400 MHz, CDCl3) δ 168.5, 168.4, 164.9, 156.1, 155.9, 
147.7, 147.1, 142.4, 135.1, 132.6, 132.3, 128.6, 128.5, 128.3, 128.3, 126.1, 125.4, 123.9, 121.4, 
119.3, 108.8, 106.9, 106.6, 81.5, 66.9, 65.6, 65.5, 65.2, 31.0, 28.2, 13.9; HRMS (Q-TOF) m/z 
calcd for [M+Na]
+
 C37H38N2O10Na 693.2424, found 693.2432. 
 
2-((6-(2-(Benzyloxy)-2-oxoethoxy)-4-(tert-butoxycarbonyl)-2'-methyl-3'-(methylamino)-
[1,1'-biphenyl]-2-yl)oxy)acetic acid (59). To a solution of 0.47 g (0.70 mmol) of biaryl 87 in 
THF (1.9 mL) was added a total of 3 equiv of tetrabutylammonium fluoride (1.0 M in THF) at 
room temperature at intervals of 1 equiv (0.84 mL) every 10-15 min. At every interval, the 
reaction was monitored by TLC for the disappearance of the biaryl starting material. After the 
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third equiv, the reaction developed a burgundy-purple color, and the starting material had 
disappeared via TLC. The reaction mixture was then diluted with saturated NH4Cl solution (5.0 
mL) and ethyl acetate (20 mL); the aqueous layer was extracted, and the organic layer was 
washed with 5% NaHCO3 solution (3 x 10 mL). The aqueous NaHCO3 layers were acidified to 
pH 3-4 with dropwise addition of 1.0 M HCl, and extracted with ethyl acetate (3 x 20 mL). The 
organic layers were dried over MgSO4 and filtered, and the volatile components were removed 
under reduced pressure to give a yellow crude oil. The oil was purified by flash chromatography 
(SiO2, hexanes/ethyl acetate elution gradient 2:1/1:1/1:9/0:1) to give 0.11 g (29%) of 59 as a 
yellow oil: Rf 0.35 (ethyl acetate/methanol, 9:1); IR (thin film, cm
-1
) 3583, 3435, 2928, 1758, 
1710, 1580, 1520, 1420, 1368, 1328, 1247, 1192, 1135, 850, 789, 753; 
1
H NMR (400 MHz, 
CD3CN) δ 7.40-7.32 (m, 5H), 7.20 (s, 2H), 7.12 (s, J = 8 Hz, 1H), 6.60 (d, J = 8 Hz, 1H), 6.49 
(d, J = 8 Hz, 1H), 5.18 (s, 2H), 4.70 (s, 2H), 4.61 (s, 2H), 2.88 (s, 3H), 1.80 (s, 3H), 1.60 (s, 9H); 
13
C NMR (400 MHz, CD3CN) δ 169.2, 168.6, 164.7, 156.1, 156.0, 147.7, 135.8, 133.0, 132.3, 
128.6, 128.3, 128.1, 125.9, 124.8, 121.3, 118.7, 108.2, 106.3, 106.1, 81.3, 66.5, 65.3, 64.9, 30.0, 
27.3, 13.3; HRMS (Q-TOF) m/z calcd for [M-H]
+
 C30H32NO8 534.2128, found 534.2148. 
 
2,2'-((4-(Methoxycarbonyl)-2'-methyl-3'-(methylamino)-[1,1'-biphenyl]-2,6-diyl)bis(oxy)) 
diacetic acid (90). To a solution of 0.03 g (0.06 mmol) of carboxylate 58 in CH2Cl2 (0.09 mL) at 
room temperature was added 0.09 mL of trifluoroacetic acid, and the reaction mixture was stirred 
for 2 h. The volatile components were removed under reduced pressure to give 0.023 g (100%) 
of 90 as a brown gel/foam: Rf 0.01 (ethyl acetate/methanol, 3:1); IR (thin film, cm
-1
)  3409, 
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2924, 1718, 1669, 1580, 1420, 1327, 1241, 1200, 1137, 1028, 998, 864, 838, 798, 751, 721; 
1
H 
NMR (400 MHz, MeOD) δ 7.42-7.37 (m, 2H), 7.33-7.32 (m, 3H), 4.69,4.64 (ABq, JAB = 17 Hz, 
4H), 3.95 (s, 3H), 3.10 (s, 3H), 2.23 (s, 3H); 
13
C NMR (400 MHz, MeOD) δ 170.4, 166.3, 156.1, 
136.4, 136.3, 131.1, 130.2, 126.6, 122.7, 120.0, 106.0, 64.6, 53.4, 51.6, 35.3, 12.8; HRMS (Q-
TOF) m/z calcd for [M-H]
+
 C20H20NO8  402.1189, found 402.1173.  
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APPENDIX 
 
1. Select EXSY and 
1
H NMR data from original torsion balances. 
2. Select 
1
H and ROESY NMR data from advanced torsion balances. 
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EXSY for 17 at 298K 
in CDCl3 (500 MHz, 
0.3 s mixing time) 
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EXSY for 29 at 343K in 
toluene-d8 (500 MHz, 
1.4 s mixing time) 
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27  at  rt  in     
CDCl3   
(500 MHz) 
28 at rt in 
CDCl3 
(500 MHz) 
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1 at rt in 
CDCl3   
(500 MHz) 
2 at rt in 
CDCl3  
(500 MHz) 
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44 at rt in 
CDCl3  
(700 MHz) 
44 at rt in 
toluene-d8 
(700 MHz) 
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 ROESY for 47 at rt in MeOD (400 MHz, 0.2 s mixing time) 
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 ROESY for 48 at rt in MeOD (400 MHz, 0.2 s mixing time) 
 205 
 
 
 
 
 ROESY for 49, peak at 13 min, at rt in MeOD (400 MHz, 0.2 s mixing time) 
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 ROESY for 49, peak at 15 min, at rt in MeOD (400 MHz, 0.2 s mixing time) 
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 ROESY for 50 at rt in MeOD (400 MHz, 0.2 s mixing time) 
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 ROESY for 51 at rt in MeOD (400 MHz, 0.2 s mixing time) 
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